Processing 00000000.tx.1: Rockefeller University Press, 0022-1007/2003/12/1817 $5.00 The Journal of Experimental Medicine, Volume 198, Number 12, 1817-1827 Activation of Transforming Growth Factor  by Malaria Parasite-derived Metalloproteinases and a Thrombospondin-like Molecule Fakhreldin M. 

Phrase: "Rockefeller University Press,"

Phrase: "0022-1007/2003/12/1817 $5.00"

Phrase: "The Journal of Experimental Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "Volume 198,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0449468:*Volume [Quantitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]

Phrase: "Number 12,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "1817-1827 Activation of Transforming Growth Factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C2249824:activation of growth [Organism Function]
   748   C1879547:Activation [Activity]

Phrase: "by Malaria Parasite-derived Metalloproteinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "a Thrombospondin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "like Molecule Fakhreldin M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.2: Omer1, J. 

Phrase: "Omer1,"

Phrase: "J."
Processing 00000000.tx.3: Brian de Souza1,2, Patrick H. 

Phrase: "Brian de Souza1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "Patrick H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.4: Corran1,3, Ali A. 

Phrase: "Corran1,"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "Ali A."
Processing 00000000.tx.5: Sultan4 and Eleanor M. 

Phrase: "Sultan4"

Phrase: "and"

Phrase: "Eleanor M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.6: Riley1 1 Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, United Kingdom 2 Department of Immunology and Molecular Pathology, Royal Free and University College London Medical School, London W1T 4JF, United Kingdom 3 Division of Immunobiology, National Institute for Biological Standards and Control, Herts EN6 3QG, United Kingdom 4 Department of Pathology, Michael Heidelberger Division of Immunology, New York University School of Medicine, New York, NY 10016 Address correspondence to Eleanor M. 

Phrase: "Riley1 1 Department of Infectious"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Tropical Diseases,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1336827:Tropical Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "London School of Hygiene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0036375:School [Manufactured Object,Organization]

Phrase: "and"

Phrase: "Tropical Medicine,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041186:Tropical Medicine [Biomedical Occupation or Discipline]
   861   C0013227:Medicine, NOS [Pharmacologic Substance]
   861   C0025118:Medicine [Biomedical Occupation or Discipline]

Phrase: "London WC1E 7HT,"

Phrase: "United Kingdom 2 Department of Immunology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Molecular Pathology,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0596962:Pathology, Molecular [Occupation or Discipline]
  1000   C1979599:Molecular Pathology [Laboratory Procedure]
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "Royal"

Phrase: "Free"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332296:free [Functional Concept]
  1000   C1880497:Free [Qualitative Concept]
  1000   C1996904:Free [Qualitative Concept]

Phrase: "and"

Phrase: "University College London Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   804   C0036375:School [Manufactured Object,Organization]

Phrase: "London W1T 4JF,"

Phrase: "United Kingdom 3 Division of Immunobiology,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1293097:Division [Therapeutic or Preventive Procedure]
   753   C2919030:Division [Organization]
   753   C2919031:Division [Activity]

Phrase: "National Institute for Biological Standards and Control,"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   845   C0678661:Biological control [Biologic Function]
   795   C0005532:Biological [Biomedical Occupation or Discipline]
   795   C0021622:institute [Organization]
   795   C0038137:standards [Intellectual Product]
   795   C0175675:Standards [Qualitative Concept]
   795   C0205460:biological [Qualitative Concept]
   795   C0243148:control [Qualitative Concept]
   795   C1272753:Institute [Idea or Concept]
   795   C1550141:Control [Substance]
   795   C1882979:Control [Conceptual Entity]
   795   C2587213:Control [Functional Concept]
   795   C3245503:national [Intellectual Product]
   795   C3274648:Control [Qualitative Concept]
   762 E C1442989:Standard [Qualitative Concept]
   762 E C2828392:Standard [Intellectual Product]

Phrase: "Herts EN6 3QG,"

Phrase: "United Kingdom 4 Department of Pathology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0587487:Pathology department [Health Care Related Organization]
   753   C1704729:Department [Organization]

Phrase: "Michael Heidelberger Division of Immunology,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1293097:Division [Therapeutic or Preventive Procedure]
   760   C2919030:Division [Organization]
   760   C2919031:Division [Activity]

Phrase: "New York University School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0036375:School [Manufactured Object,Organization]

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "NY 10016 Address correspondence to Eleanor M."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0282413:Correspondence [Intellectual Product]
Processing 00000000.tx.7: Riley, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, United Kingdom. 

Phrase: "Riley,"

Phrase: "Department of Infectious"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Tropical Diseases,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1336827:Tropical Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "London School of Hygiene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0036375:School [Manufactured Object,Organization]

Phrase: "and"

Phrase: "Tropical Medicine,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041186:Tropical Medicine [Biomedical Occupation or Discipline]
   861   C0013227:Medicine, NOS [Pharmacologic Substance]
   861   C0025118:Medicine [Biomedical Occupation or Discipline]

Phrase: "Keppel Street,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0442658:Street [Manufactured Object]
   861   C1301826:Street [Finding]

Phrase: "London WC1E 7HT,"

Phrase: "United Kingdom."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041700:United Kingdom [Geographic Area]
   861   C1708611:Kingdom [Classification]
   827   C0166872:unite [Biomedical or Dental Material]
Processing 00000000.tx.8: Phone: 44-207-927-2706; 

Phrase: "Phone"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C1515258:Phone [Conceptual Entity]
  1000   C1705541:Phone [Manufactured Object]
   907 E C0042939:Voice [Organism Function]
   907 E C3244282:voice [Qualitative Concept]
   893 E C0205382:Vocal [Functional Concept]
   893 E C0871074:phonic [Intellectual Product]

Phrase: ":"

Phrase: "44-207-927-2706"

Phrase: ";"
Processing 00000000.tx.9: Fax: 44-207-927-2807; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "44-207-927-2807"

Phrase: ";"
Processing 00000000.tx.10: email: eleanor.riley{at}lshtm.ac.uk  Abstract Top Abstract Introduction Materials and Methods Results Discussion References  Much of the pathology of malaria is mediated by inflammatory cytokines (such as interleukin 12, interferon , and tumor necrosis factor ), which are part of the immune response that kills the parasite. 

Phrase: "email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "eleanor.riley{at}lshtm.ac.uk  Abstract Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Much of the pathology of malaria"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0024530:Malaria [Disease or Syndrome]
   753   C0030664:Pathology [Biomedical Occupation or Discipline]
   753   C0205469:pathology [Functional Concept]
   753   C0677042:pathology [Pathologic Function]
   753   C2984572:Malaria [Functional Concept]

Phrase: "is"

Phrase: "mediated by inflammatory cytokines"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   770   C0333348:Inflammatory [Functional Concept]
   770   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "("

Phrase: "such as interleukin 12,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0123759:Interleukin-12 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C1524115:Interleukin 12 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "interferon ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "tumor necrosis factor"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1323304:tumor necrosis factor [Molecular Function]
  1000   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0333516:Tumor necrosis [Neoplastic Process]
   827   C0027540:Necrosis [Organ or Tissue Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1334928:Necrosis [Finding]
   827   C1521761:Factor [Functional Concept]
   827   C1578706:Tumor [Intellectual Product]
   827   C2827422:Factor [Conceptual Entity]
   827   C3273930:Tumor [Finding]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "are"

Phrase: "part of the immune response"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1292711:Part of [Spatial Concept]
   760   C0449719:Part [Spatial Concept]
   760   C1709471:Part [Quantitative Concept]

Phrase: "that"

Phrase: "kills"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0162388:kill [Social Behavior]
  1000   C0681205:Kill [Idea or Concept]
  1000   C1550555:kill [Functional Concept]

Phrase: "the parasite."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030498:Parasite [Eukaryote]
Processing 00000000.tx.11: The antiinflammatory cytokine transforming growth factor (TGF)- plays a crucial role in preventing the severe pathology of malaria in mice and TGF- production is associated with reduced risk of clinical malaria in humans. 

Phrase: "The antiinflammatory cytokine transforming growth factor (TGF)-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   884   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C1510411:Transforming [Pathologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a crucial role in preventing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "the severe pathology of malaria"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030664:Pathology [Biomedical Occupation or Discipline]
   760   C0205469:pathology [Functional Concept]
   760   C0677042:pathology [Pathologic Function]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "is"

Phrase: "associated with reduced risk of clinical malaria"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0024530:Malaria [Disease or Syndrome]
   748   C0035647:Risk [Qualitative Concept]
   748   C0205210:Clinical [Qualitative Concept]
   748   C0392756:Reduced [Qualitative Concept]
   748   C2984572:Malaria [Functional Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]
Processing 00000000.tx.12: Here we show that serum-free preparations of Plasmodium falciparum, Plasmodium yoelii 17XL, and Plasmodium berghei schizont-infected erythrocytes, but not equivalent preparations of uninfected erythrocytes, are directly able to activate latent TGF- (LatTGF-) in vitro. 

Phrase: "Here"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that serum-free preparations of Plasmodium falciparum,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C0455052:Preparation [Health Care Activity]
   714   C1521827:Preparation [Functional Concept]

Phrase: "Plasmodium yoelii 17XL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0032155:Plasmodium yoelii [Eukaryote]

Phrase: "and"

Phrase: "Plasmodium berghei schizont-infected erythrocytes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0014772:Erythrocytes [Laboratory Procedure]
   804   C0014792:Erythrocytes [Cell]

Phrase: "but"

Phrase: "not equivalent preparations of uninfected erythrocytes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0455052:Preparation [Health Care Activity]
   719   C1521827:Preparation [Functional Concept]

Phrase: "are"

Phrase: "directly able to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]
   827   C1947931:Directly [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "latent TGF- (TGF-)"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0205275:Latent [Qualitative Concept]
   812   C0220844:growth [Physiologic Function]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.13: Antibodies to thrombospondin (TSP) and to a P. falciparum TSP-related adhesive protein (PfTRAP), and synthetic peptides from PfTRAP and P. berghei TRAP that represent homologues of TGF- binding motifs of TSP, all inhibit malaria-mediated TGF- activation. 

Phrase: "Antibodies to thrombospondin (TSP)"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and to a P. falciparum TSP-related adhesive protein"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   762   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   742   C0001516:Adhesive [Manufactured Object]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0439849:Related [Qualitative Concept]
   742   C0445223:Related [Finding]
   742   C1515981:And [Idea or Concept]
   742   C2982905:Adhesive [Manufactured Object]
   708 E C0163712:Relate [Organic Chemical]

Phrase: "(PfTRAP"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "synthetic peptides from PfTRAP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   770   C1883254:synthetic [Activity]

Phrase: "and"

Phrase: "P. berghei TRAP"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   895   C0082731:P-protein [Amino Acid, Peptide, or Protein,Enzyme]
   895   C1151818:P-protein [Molecular Function]
   799   C0001516:Adhesive [Manufactured Object]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0439849:Related [Qualitative Concept]
   799   C0445223:Related [Finding]
   799   C2982905:Adhesive [Manufactured Object]
   766 E C0163712:Relate [Organic Chemical]
   727 E C0080103:Relation [Family Group]
   727 E C0869014:Relations [Social Behavior]

Phrase: "that"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "homologues of TGF-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1334043:Homologue [Gene or Genome]

Phrase: "binding motifs of TSP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1514562:Motif [Amino Acid Sequence]

Phrase: "all"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "malaria-mediated TGF-"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   884   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0024530:Malaria [Disease or Syndrome]
   804   C0086597:mediated [Social Behavior]
   804   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1510411:Transforming [Pathologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   804   C2984572:Malaria [Functional Concept]
   721 E C1721089:Marsh [Natural Phenomenon or Process]

Phrase: "activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]
Processing 00000000.tx.14: Importantly, TRAP-deficient P. berghei parasites are less able to activate LatTGF- than wild-type parasites and their replication is attenuated in vitro. 

Phrase: "Importantly,"

Phrase: "TRAP-deficient P. berghei parasites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0030498:Parasites [Eukaryote]
   793   C0521066:Parasites. [Functional Concept]

Phrase: "are"

Phrase: "less able to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0085732:Able [Organism Attribute]
   827   C0439092:less [Intellectual Product]
   827   C0547044:Less [Qualitative Concept]
   827   C1299581:Able [Finding]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "LatTGF-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0205275:Latent [Qualitative Concept]
   861   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "than wild-type parasites"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030498:Parasites [Eukaryote]
   827   C0521066:Parasites. [Functional Concept]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "and"

Phrase: "their replication"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0598312:Replication [Genetic Function]
  1000   C1883725:replication [Qualitative Concept]
   928 E C0205173:Replicate [Functional Concept]
   928 E C0205341:Replicate [Functional Concept]

Phrase: "is"

Phrase: "attenuated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332161:Attenuated [Qualitative Concept]
  1000   C0599946:Attenuated [Activity]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.15: We show that activation of TGF- by malaria parasites is a two step process involving TSP-like molecules and metalloproteinase activity. 

Phrase: "We"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that activation of TGF-"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   820   C2249824:activation of growth [Organism Function]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1510411:Transforming [Pathologic Function]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C1879547:Activation [Activity]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]

Phrase: "by malaria parasites"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C1271614:Malarial parasites [Eukaryote]
   861   C0030498:Parasites [Eukaryote]
   861   C0521066:Parasites. [Functional Concept]

Phrase: "is"

Phrase: "a two step process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "TSP-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "like molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:molecules [Substance]
   916 E C1521991:Molecular [Qualitative Concept]

Phrase: "and"

Phrase: "metalloproteinase activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150224:metalloproteinase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.16: Activation of LatTGF- represents a novel mechanism for direct modulation of the host response by malaria parasites. 

Phrase: "Activation of LatTGF-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a novel mechanism for direct modulation of the host response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0441712:Mechanism [Functional Concept]
   739   C1706376:Mechanism [Manufactured Object]

Phrase: "by malaria parasites."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C1271614:Malarial parasites [Eukaryote]
   861   C0030498:Parasites [Eukaryote]
   861   C0521066:Parasites. [Functional Concept]
Processing 00000000.tx.17: Key Words: parasitic protozoa  malaria, falciparum  transforming growth factor   matrix metalloproteinases  thrombospondin 1  Introduction Top Abstract Introduction Materials and Methods Results Discussion References  Much of the overt pathology associated with parasitic infections is immune mediated. 

Phrase: "Key Words"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705313:Word [Idea or Concept]
   789 E C0439824:Verbal [Qualitative Concept]
   761 E C0871946:verb [Intellectual Product]

Phrase: ":"

Phrase: "parasitic protozoa  malaria,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0024530:Malaria [Disease or Syndrome]
   827   C2984572:Malaria [Functional Concept]
   743 E C1721089:Marsh [Natural Phenomenon or Process]

Phrase: "falciparum  transforming growth factor   matrix metalloproteinases  thrombospondin 1  Introduction Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   786   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Much of the overt pathology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030664:Pathology [Biomedical Occupation or Discipline]
   760   C0205469:pathology [Functional Concept]
   760   C0677042:pathology [Pathologic Function]

Phrase: "associated with parasitic infections"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   816   C0030499:parasitic infection [Disease or Syndrome]
   816   C0747256:Parasitic infection [Disease or Syndrome]
   770   C0009450:Infections [Disease or Syndrome]
   770   C0030498:parasitic [Eukaryote]
   770   C0521066:parasitic [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "is"

Phrase: "immune mediated."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086597:mediated [Social Behavior]
   861   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   861   C0439662:Immune [Functional Concept]
Processing 00000000.tx.18: In the case of malaria, parasite killing requires the production of inflammatory cytokines that can have deleterious systemic effects. 

Phrase: "In the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of malaria,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0024530:Malaria [Disease or Syndrome]
  1000   C2984572:Malaria [Functional Concept]
   916 E C1721089:Marsh [Natural Phenomenon or Process]

Phrase: "parasite"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030498:Parasite [Eukaryote]

Phrase: "killing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:Killing [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]

Phrase: "requires"

Phrase: "the production of inflammatory cytokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1327413:cytokine production [Organism Function]
   760   C0033268:production [Occupational Activity]

Phrase: "that"

Phrase: "can"

Phrase: "have"

Phrase: "deleterious systemic effects."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.19: Thus, understanding how proinflammatory cytokines are regulated during infection is crucially important for improving malaria therapy and for designing safe and effective malaria vaccines. 

Phrase: "Thus,"

Phrase: "understanding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understanding [Mental Process]

Phrase: "how proinflammatory cytokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "are"

Phrase: "regulated during infection"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0009450:Infection, NOS [Disease or Syndrome]
   790   C0851285:Regulated [Governmental or Regulatory Activity]
   718 E C0439663:Infected [Functional Concept]

Phrase: "is"

Phrase: "crucially important for improving malaria therapy"

Phrase: "and for designing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "safe"

Phrase: "and"

Phrase: "effective malaria vaccines."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0206255:Malaria Vaccines [Immunologic Factor,Pharmacologic Substance]
   827   C0042210:Vaccines [Immunologic Factor,Pharmacologic Substance]
   793 E C1552558:Vaccine [Intellectual Product]
Processing 00000000.tx.20: In murine malaria infections, TNF- and IFN- act synergistically to induce macrophages to phagocytose parasitized red blood cells and release nitric oxide, which is involved in parasite killing and protection from severe disease (1). 

Phrase: "In murine malaria infections,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0009450:Infections [Disease or Syndrome]
   743 E C0439663:Infected [Functional Concept]
   711 E C0030657:infectivity [Qualitative Concept]

Phrase: "TNF-"

Phrase: "and"

Phrase: "IFN-"

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "synergistically to"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "macrophages to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024432:Macrophages [Cell]
   861   C1546706:Macrophages [Intellectual Product]
   861   C1550652:Macrophages [Body Substance]

Phrase: "phagocytose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031308:phagocytose [Cell Function]

Phrase: "parasitized red blood cells"
Meta Candidates (Total=24; Excluded=11; Pruned=0; Remaining=13)
   923   C0014772:Red Blood Cells [Laboratory Procedure]
   923   C0014792:Red Blood Cells [Cell]
           Red cells
   923   C0439179:% red blood cells [Quantitative Concept]
   923   C1277078:Red blood cells [Pharmacologic Substance]
   861   C0005773:Blood Cells [Cell]
   816 E C2328697:Hemal cell [Cell]
   812   C0005767:Blood [Tissue]
   812   C0005768:blood [Body Substance]
   812   C0007634:Cells [Cell]
   812   C0229664:Blood [Body Substance]
   812   C0332575:Red [Finding]
   812   C1260956:Red [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   741 E C0333275:Bloody [Qualitative Concept]
   729 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   729 E C0392895:Bloods [Population Group]
   729 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   729 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C1558950:VASCULAR [Finding]
   712 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "nitric oxide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "which"

Phrase: "is"

Phrase: "involved in parasite"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0030498:Parasite [Eukaryote]
   790   C1314939:Involved [Functional Concept]

Phrase: "killing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:Killing [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]

Phrase: "and"

Phrase: "protection from severe disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1545588:Protection [Finding]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.21: The ability to mount a rapid IL-12, IFN-, or TNF- response is essential for survival but overproduction of IFN-, TNF-, or lymphotoxin- predisposes to severe pathology (2, 3). 

Phrase: "The ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "mount"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0181909:Mount [Medical Device]
  1000   C0449878:mount [Finding]

Phrase: "a rapid IL-12,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0123759:IL-12 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   901   C1149217:IL-12 [Molecular Function]
   901   C1524115:IL-12 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0020898:IL [Geographic Area]
   827   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0022271:IL [Geographic Area]

Phrase: "IFN-,"

Phrase: "or"

Phrase: "TNF- response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "is"

Phrase: "essential for survival"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205224:Essential [Qualitative Concept]

Phrase: "but"

Phrase: "overproduction of IFN-,"

Phrase: "TNF-,"

Phrase: "or"

Phrase: "lymphotoxin-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0024320:Lymphotoxin [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1527150:Lymphotoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "predisposes to severe pathology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0030664:Pathology [Biomedical Occupation or Discipline]
   770   C0205082:Severe [Qualitative Concept]
   770   C0205469:pathology [Functional Concept]
   770   C0677042:pathology [Pathologic Function]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.22: Essentially the same pattern is seen in human malaria: TNF-, IFN-, and nitric oxide are associated with rapid resolution of fever and parasite clearance (47), but severe Plasmodium falciparum malaria is accompanied by high levels of circulating TNF- (8, 9) and IFN- secretion is associated with fever (7, 10). 

Phrase: "Essentially"

Phrase: "the same pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449774:Pattern [Spatial Concept]

Phrase: "is"

Phrase: "seen in human malaria"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0024530:Malaria [Disease or Syndrome]
   770   C0086418:Human [Human]
   770   C0205397:Seen [Qualitative Concept]
   770   C2984572:Malaria [Functional Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: ":"

Phrase: "TNF-,"

Phrase: "IFN-,"

Phrase: "and"

Phrase: "nitric oxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "are"

Phrase: "associated with rapid resolution of fever"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0015967:Fever [Finding]
   753   C0439831:Rapid [Qualitative Concept]
   753   C1514893:Resolution [Idea or Concept]
   753   C1706463:Resolution [Quantitative Concept]
   753   C2699488:Resolution [Conceptual Entity]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "parasite clearance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0449297:Clearance [Qualitative Concept]
   861   C1382187:Clearance [Clinical Attribute]
   861   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "(47"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "severe Plasmodium falciparum malaria"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   923   C0024535:Plasmodium falciparum Malaria [Disease or Syndrome]
           Malaria, Falciparum
   861   C0032150:Plasmodium falciparum [Eukaryote]
   812   C0024530:Malaria [Disease or Syndrome]
   812   C0032148:Plasmodium [Eukaryote]
   812   C2984572:Malaria [Functional Concept]
   812   C3541306:Plasmodium [Laboratory Procedure]
   729 E C1721089:Marsh [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "accompanied by high levels of circulating TNF- (8,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   744   C0175630:Circulating [Functional Concept]
   744   C0205250:High [Qualitative Concept]
   744   C0441889:Levels [Qualitative Concept]
   744   C1299351:High [Qualitative Concept]
   744   C2700149:HIGH [Intellectual Product]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "9"

Phrase: ")"

Phrase: "and"

Phrase: "IFN- secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "is"

Phrase: "associated with fever"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0015967:Fever [Finding]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(7,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.23: The immunomodulatory cytokines IL-10 and TGF- play a key role in limiting the pathology of malaria (11). 

Phrase: "The immunomodulatory cytokines IL-10"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0085295:il 10 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2983956:IL-10 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0020898:IL [Geographic Area]
   812   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0022271:IL [Geographic Area]
   812   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a key role in limiting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "the pathology of malaria"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0030664:Pathology [Biomedical Occupation or Discipline]
   770   C0205469:pathology [Functional Concept]
   770   C0677042:pathology [Pathologic Function]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.24: Treatment of infected mice with neutralizing antibody to TGF- exacerbates the virulence of lethal Plasmodium berghei strains and transforms a normally resolving Plasmodium chabaudi chabaudi infection into a lethal one (12). 

Phrase: "Treatment of infected mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "with neutralizing antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0475463:Neutralising antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "to TGF-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C1883351:To [Qualitative Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "exacerbates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0436331:exacerbate [Finding]

Phrase: "the virulence of lethal Plasmodium berghei strains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0042765:Virulence [Biologic Function]
   748   C0220936:virulence [Qualitative Concept]

Phrase: "and"

Phrase: "transforms"

Phrase: "a normally"

Phrase: "resolving"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514893:resolving [Idea or Concept]
   966 E C2699488:Resolve [Conceptual Entity]

Phrase: "Plasmodium chabaudi chabaudi infection into a lethal one (12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0024530:Plasmodium Infection [Disease or Syndrome]
   742   C0009450:Infection, NOS [Disease or Syndrome]

Phrase: ")."
Processing 00000000.tx.25: Conversely, treatment of P. bergheiinfected mice with recombinant TGF- up-regulates IL-10, down-regulates TNF-, slows the rate of parasite replication, and extends survival (12). 

Phrase: "Conversely,"

Phrase: "treatment of P. bergheiinfected mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "with recombinant TGF-"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   937   C1527194:Recombinant Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Transforming Growth Factor
   888   C1515377:Recombinant Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   884   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C0332287:With [Qualitative Concept]
   804   C1510411:Transforming [Pathologic Function]
   804   C1514798:recombinant [Organism]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C1705690:With [Intellectual Product]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]

Phrase: "up-regulates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0547043:Up [Spatial Concept]
   861   C1282911:Up [Spatial Concept]

Phrase: "IL-10,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0085295:il 10 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2983956:IL-10 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "down-regulates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "TNF-,"

Phrase: "slows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439834:Slow [Qualitative Concept]

Phrase: "the rate of parasite replication,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "extends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.26: In C57BL/6 mice infected with the normally nonlethal P. chabaudi, mortality is increased in IL-10deficient (IL-10-/-) mice (13) and mortality is further exacerbated by neutralization of TGF- (14). 

Phrase: "In C57BL/6 mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   988   C1521751:C57BL/6 Mouse [Mammal]
           C57BL/6
   913   C0025921:Mice, C57BL [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "infected with the normally nonlethal P. chabaudi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439663:Infected [Functional Concept]

Phrase: "mortality"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026565:Mortality [Quantitative Concept]
  1000   C0026566:mortality [Quantitative Concept]

Phrase: "is"

Phrase: "increased in IL-10deficient (IL-10-/-) mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0020898:IL [Geographic Area]
   760   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0022271:IL [Geographic Area]
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]

Phrase: "(13"

Phrase: ")"

Phrase: "and"

Phrase: "mortality"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026565:Mortality [Quantitative Concept]
  1000   C0026566:mortality [Quantitative Concept]

Phrase: "is"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "exacerbated by neutralization of TGF-"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   814   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   814   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C0436331:Exacerbated [Finding]
   748   C1444749:Exacerbated [Qualitative Concept]
   748   C1510411:Transforming [Pathologic Function]
   748   C1521761:Factor [Functional Concept]
   748   C1578828:Neutralization [Laboratory Procedure]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]
   748   C2987668:Neutralization [Functional Concept]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.27: Similar data are now emerging from human studies. 

Phrase: "Similar data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "emerging from human studies."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0178693:human studies [Research Activity]
   770   C0086418:Human [Human]
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]
Processing 00000000.tx.28: Symptomatic P. falciparum patients have lower than normal levels of circulating TGF- (15, 16) and we have recently shown that the risk of febrile illness is associated with high ratios of IFN-, TNF-, or IL-12 to TGF- (7). 

Phrase: "Symptomatic P. falciparum patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]

Phrase: "have"

Phrase: "lower than normal levels of circulating TGF-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0441994:Lower [Spatial Concept]
   742   C1548802:Lower [Body Location or Region]
   742   C2003888:Lower [Activity]

Phrase: "(15,"

Phrase: "16"

Phrase: ")"

Phrase: "and"

Phrase: "we"

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the risk of febrile illness"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0035647:Risk [Qualitative Concept]

Phrase: "is"

Phrase: "associated with high ratios of IFN-,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0205250:High [Qualitative Concept]
   753   C0456603:Ratios [Quantitative Concept]
   753   C1299351:High [Qualitative Concept]
   753   C1610540:*Ratios [Quantitative Concept]
   753   C2700149:HIGH [Intellectual Product]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1547037:Ratio [Intellectual Product]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "TNF-,"

Phrase: "or"

Phrase: "IL-12 to TGF-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0123759:IL-12 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   790   C1149217:IL-12 [Molecular Function]
   790   C1524115:IL-12 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0020898:IL [Geographic Area]
   753   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0022271:IL [Geographic Area]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.29: We conclude that TGF- plays an essential role in down-regulating the production of potentially pathogenic proinflammatory cytokines. 

Phrase: "We"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an essential role in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "down-regulating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "the production of potentially pathogenic proinflammatory cytokines."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1327413:cytokine production [Organism Function]
   748   C0033268:production [Occupational Activity]
Processing 00000000.tx.30: However, in at least one murine model of malaria infection (Plasmodium yoelii 17XL infection in C57/BL6 mice), a very early burst of active TGF- serves to down-modulate the normal early inflammatory cytokine response, leading to failure to control parasite growth and death of the mice within 6 d (17). 

Phrase: "However,"

Phrase: "in"

Phrase: "at least one murine model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3161035:Model [Intellectual Product]

Phrase: "of malaria infection"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0009450:Infection, NOS [Disease or Syndrome]
   789 E C0439663:Infected [Functional Concept]
   750 E C0030657:infectivity [Qualitative Concept]

Phrase: "(Plasmodium yoelii 17XL infection in C57/BL6 mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0024530:Plasmodium Infection [Disease or Syndrome]
   744   C0009450:Infection, NOS [Disease or Syndrome]

Phrase: ")"

Phrase: ","

Phrase: "a very early"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0442824:Very [Qualitative Concept]
   861   C1279919:Early [Temporal Concept]

Phrase: "burst of active TGF-"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0205177:Active [Functional Concept]
   753   C0220844:growth [Physiologic Function]
   753   C0439818:burst [Qualitative Concept]
   753   C1510411:Transforming [Pathologic Function]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C1881705:BURST [Phenomenon or Process]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]

Phrase: "serves"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "down-modulate"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0205104:Down [Spatial Concept]
   861   C0443264:modulate [Spatial Concept]
   805 E C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805 E C2626739:Lanugo [Eukaryote]

Phrase: "the normal early inflammatory cytokine response,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C1155266:Inflammatory Response [Pathologic Function]
   804   C0871261:Response [Organism Attribute]
   804   C1704632:Response [Finding]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]

Phrase: "leading to failure to"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0231174:Failure [Functional Concept]
   770   C0332152:Leading [Temporal Concept]
   770   C0680095:failure [Individual Behavior]
   770   C1522538:Leading [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "parasite growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "death of the mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011065:Death [Organism Function]
   770   C1306577:Death, NOS [Finding]

Phrase: "within 6"

Phrase: "d ("

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.31: Thus, the outcome of infection depends on the timing of TGF- induction and the ability of a pathogen to modulate the host TGF- response may modify the virulence of the infection. 

Phrase: "Thus,"

Phrase: "the outcome of infection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1274040:Outcome [Functional Concept]

Phrase: "depends on the timing of TGF-"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   800   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   800   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0220844:growth [Physiologic Function]
   744   C0449243:Timing [Temporal Concept]
   744   C0725813:depend [Medical Device]
   744   C1510411:Transforming [Pathologic Function]
   744   C1521761:Factor [Functional Concept]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C1704250:Timing [Conceptual Entity]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]

Phrase: "induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "the ability of a pathogen to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the host TGF-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   884   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C1167395:Host [Organism]
   804   C1510411:Transforming [Pathologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]

Phrase: "response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "may"

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the virulence of the infection."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0042765:Virulence [Biologic Function]
   760   C0220936:virulence [Qualitative Concept]
Processing 00000000.tx.32: TGF- is constitutively produced by a wide range of cells and its activity is regulated primarily by controlling the site and rate of activation of latent TGF- (LatTGF-) to its biologically active form (for review see reference 18). 

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "is"

Phrase: "constitutively"

Phrase: "produced by a wide range of cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   748   C0007634:Cells [Cell]
   748   C0332464:Wide [Spatial Concept]
   748   C1514721:Range [Quantitative Concept]
   748   C2348147:Range [Quantitative Concept]
   748   C3282337:Cells [Cell]
   748   C3542016:Range [Intellectual Product]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "its activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "regulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "primarily by controlling"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0332298:controlling [Functional Concept]
   790   C2587213:Controlling [Functional Concept]
   756 E C0243148:control [Qualitative Concept]
   756 E C1550141:Control [Substance]
   756 E C1882979:Control [Conceptual Entity]
   756 E C3274648:Control [Qualitative Concept]

Phrase: "the site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205145:Site [Spatial Concept]
  1000   C1515974:Site [Body Location or Region]
  1000   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "rate of activation of latent TGF-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C2248082:activation of growth rate [Organism Function]
   767   C0449249:Growth rate [Temporal Concept]
   744   C0871208:Rate [Activity]
   744   C1521828:Rate [Quantitative Concept]

Phrase: "(LatTGF-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0205275:Latent [Qualitative Concept]
   861   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "to its biologically active form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0348078:Form [Qualitative Concept]
   827   C0376315:Form [Manufactured Object]
   827   C1522492:Form [Functional Concept]

Phrase: "("

Phrase: "for review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "reference 18"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514811:Reference [Idea or Concept]
   861   C1706462:Reference [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.33: TGF- is stored inside the cell as a disulfide-bonded homodimer that is noncovalently bound to a disulfide-bonded, homodimeric latency-associated protein (LAP) and, at least in platelets, to a monomeric LatTGF- binding protein. 

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "is"

Phrase: "stored inside the cell"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0007634:Cell [Cell]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   737   C1698986:Store [Functional Concept]

Phrase: "as a disulfide-bonded homodimer"

Phrase: "that"

Phrase: "is"

Phrase: "noncovalently"

Phrase: "bound to a disulfide-bonded, homodimeric latency-associated protein (LAP)"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   762   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   762   C0522527:Protein bound [Qualitative Concept]
   742   C0012771:disulfide [Chemical Viewed Structurally]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0332281:Associated [Qualitative Concept]
   742   C0332297:bound [Spatial Concept]
   742   C1145667:Bound [Activity]
   742   C1167622:Bound [Molecular Function]
   742   C1689898:% bound [Quantitative Concept]
   742   C2349209:Bound [Conceptual Entity]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: ","

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in platelets,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005821:Platelets [Cell]
  1000   C1963076:Platelets [Finding]

Phrase: "to a monomeric LatTGF-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0205275:Latent [Qualitative Concept]
   804   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1883351:To [Qualitative Concept]
   733   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "binding protein."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
Processing 00000000.tx.34: Binding of the cytokine to its receptor requires removal of LatTGF- binding protein and LAP, a process that is catalyzed in vivo by a number of agents including plasmin, cathepsins, calpain, and thrombospondin (TSP; 19, 20). 

Phrase: "Binding of the cytokine"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1149169:cytokine binding [Molecular Function]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "to its receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "requires"

Phrase: "removal of LatTGF-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015252:Removal [Therapeutic or Preventive Procedure]
   770   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "binding protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "LAP,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332281:Associated [Qualitative Concept]
   793 E C0750490:Associate [Idea or Concept]
   793 E C1706221:Associate [Professional or Occupational Group]
   755   C0205275:Latent [Qualitative Concept]

Phrase: "a process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "that"

Phrase: "is"

Phrase: "catalyzed"

Phrase: "in vivo by a number of agents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "plasmin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016016:Plasmin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "cathepsins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007428:Cathepsins [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "calpain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "thrombospondin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(TSP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "; 19,"

Phrase: "20"

Phrase: ")."
Processing 00000000.tx.35: TSP appears to be an important activator of TGF- in that TSP null mice produce active TGF- only after treatment with a TSP peptide containing the TGF-activating domain and this peptide rescues TSP null mice from lethal, multifocal inflammatory disease (21). 

Phrase: "TSP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "an important activator of TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   814   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   814   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C1510411:Transforming [Pathologic Function]
   748   C1521761:Factor [Functional Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]

Phrase: "in that TSP null mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0206745:Null Mouse [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "produce"

Phrase: "active TGF-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0205177:Active [Functional Concept]
   812   C0220844:growth [Physiologic Function]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "after"

Phrase: "treatment with a TSP peptide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "activating domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "this peptide rescues TSP null mice from lethal, multifocal inflammatory disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0206745:Null Mouse [Mammal]
   738   C0025914:Mice [Mammal]
   738   C0025929:mice [Mammal]
   738   C0026809:Mice [Mammal]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.36: Activation of TGF- by TSP is a two step process requiring initial attachment of TSP to TGF- via the GGWSHW motif of TSP, followed by cleavage by a (K)RFK motif (22). 

Phrase: "Activation of TGF-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C2249824:activation of growth [Organism Function]
   760   C1879547:Activation [Activity]

Phrase: "by TSP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "a two step process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "requiring"

Phrase: "initial attachment of TSP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0185023:Attachment [Therapeutic or Preventive Procedure]
   770   C1947904:Attachment [Activity]
   770   C1999228:Attachment [Intellectual Product]

Phrase: "to TGF-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C1883351:To [Qualitative Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "via the GGWSHW motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514562:Motif [Amino Acid Sequence]

Phrase: "of TSP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "followed by cleavage"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0010813:cleavage [Cell Function]
   790   C0596311:Cleavage [Phenomenon or Process]
   790   C1330957:cleavage [Cell Function]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "by a (K)RFK motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1514562:Motif [Amino Acid Sequence]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.37: However, alternative mechanisms of TGF- activation clearly exist as platelet-derived TGF- can be activated in the absence of TSP (23). 

Phrase: "However,"

Phrase: "alternative mechanisms of TGF-"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   833   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C0441712:Mechanisms [Functional Concept]
   753   C1510411:Transforming [Pathologic Function]
   753   C1521761:Factor [Functional Concept]
   753   C1523987:Alternative [Conceptual Entity]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]
   719 E C1706376:Mechanism [Manufactured Object]

Phrase: "activation clearly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "exist as platelet-derived TGF-"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   840   C0040690:Platelet Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   835   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   814   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   814   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   748   C0005821:Platelet [Cell]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C1441547:Derived [Qualitative Concept]
   748   C1510411:Transforming [Pathologic Function]
   748   C1521761:Factor [Functional Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]
   748   C2987476:Exist [Conceptual Entity]
   748   C3245521:derived [Idea or Concept]

Phrase: "can"

Phrase: "be"

Phrase: "activated in the absence of TSP"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]
   753   C1879547:Activated [Activity]
   719 E C1515877:Activate [Functional Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.38: Here we report the results of a series of experiments designed to test the hypothesis that Plasmodium-encoded molecules modulate TGF- activation. 

Phrase: "Here"

Phrase: "we"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "the results of a series of experiments"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   716   C2825142:Experimental Result [Finding]
           Result
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that Plasmodium-encoded molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]
Processing 00000000.tx.39: Importantly, our study demonstrates that malaria parasites contain endogenous TGF-activating moieties that may play a role in modulating the outcome of malaria infections.  

Phrase: "Importantly,"

Phrase: "our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "demonstrates"

Phrase: "that malaria parasites"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C1271614:Malarial parasites [Eukaryote]
   861   C0030498:Parasites [Eukaryote]
   861   C0521066:Parasites. [Functional Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "endogenous TGF-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0205227:Endogenous [Functional Concept]
   812   C0220844:growth [Physiologic Function]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "activating moieties"

Phrase: "that"

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in modulating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "the outcome of malaria infections."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1274040:Outcome [Functional Concept]
Processing 00000000.tx.40: Materials and Methods Top Abstract Introduction Materials and Methods Results Discussion References  Malaria Parasites. 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Malaria Parasites."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C1271614:Malarial parasites [Eukaryote]
   861   C0030498:Parasites [Eukaryote]
   861   C0521066:Parasites. [Functional Concept]
Processing 00000000.tx.41: P. falciparum parasites of the 3D7 strain were grown in A+ human erythrocytes and mature schizonts were harvested as previously described (24). 

Phrase: "P. falciparum parasites of the 3D7 strain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0030498:Parasites [Eukaryote]
   748   C0521066:Parasites. [Functional Concept]

Phrase: "were"

Phrase: "grown in A+ human erythrocytes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0014772:Erythrocytes [Laboratory Procedure]
   760   C0014792:Erythrocytes [Cell]
   760   C0086418:Human [Human]

Phrase: "and"

Phrase: "mature schizonts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0686886:Mature schizont [Eukaryote]
   861   C0562656:Schizonts [Eukaryote]

Phrase: "were"

Phrase: "harvested as previously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1512335:Harvest [Health Care Activity]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.42: Cultures were routinely screened for mycoplasma contamination by PCR (BioWhittaker) and shown to be mycoplasma free. 

Phrase: "Cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "routinely"

Phrase: "screened for mycoplasma contamination"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0026934:Mycoplasma [Bacterium]
   770   C0259846:contamination [Human-caused Phenomenon or Process]
   770   C1881659:CONTAMINATION [Event]
   770   C2349974:Contamination [Idea or Concept]
   737   C0220908:screen [Health Care Activity]
   737   C1305399:screen [Functional Concept]
   737   C1705053:Screen [Medical Device]

Phrase: "by PCR (BioWhittaker"

Phrase: ")"

Phrase: "and"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "mycoplasma"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026934:Mycoplasma [Bacterium]
   928 E C0086820:Mycoplasmal [Bacterium]

Phrase: "free."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332296:free [Functional Concept]
  1000   C1880497:Free [Qualitative Concept]
  1000   C1996904:Free [Qualitative Concept]
Processing 00000000.tx.43: Schizont-infected erythrocytes were washed three times in serum-free medium to remove endogenous serum proteases and other proteins. 

Phrase: "Schizont-infected erythrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014772:Erythrocytes [Laboratory Procedure]
   827   C0014792:Erythrocytes [Cell]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times in serum-free medium to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   757   C0683585:free time [Daily or Recreational Activity]
   748   C0040223:times [Temporal Concept]
   748   C1632851:Times [Quantitative Concept]
   714 E C3541383:Time [Temporal Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "endogenous serum proteases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C1947941:Proteases [Enzyme]

Phrase: "and"

Phrase: "other proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.44: Parasitized erythrocytes were used either as intact (live, parasitized RBCs [pRBCs]) or as a sonicated P. falciparum schizont lysate (PfSL). 

Phrase: "Parasitized erythrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014772:Erythrocytes [Laboratory Procedure]
   861   C0014792:Erythrocytes [Cell]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "either as intact"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205266:Intact [Qualitative Concept]
   790   C1554187:Intact [Idea or Concept]

Phrase: "(live, parasitized RBCs [pRBCs]"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0014792:rbcs [Cell]

Phrase: ")"

Phrase: "or as a sonicated P. falciparum schizont lysate (PfSL)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0562656:Schizont [Eukaryote]
   744   C1881488:Lysate [Physical Object]
Processing 00000000.tx.45: Similarly treated, uninfected erythrocytes (uninfected RBCs [uRBCs]) were used as a control. 

Phrase: "Similarly"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: ","

Phrase: "uninfected erythrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014772:Erythrocytes [Laboratory Procedure]
   861   C0014792:Erythrocytes [Cell]

Phrase: "(uninfected RBCs [uRBCs]"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014792:rbcs [Cell]

Phrase: ")"

Phrase: "were"

Phrase: "used as a control."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1273517:used [Finding]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.46: In some experiments, pRBCs were allowed to undergo schizont rupture in vitro and the supernatant from the ruptured cells was used (pRBC supernatant). 

Phrase: "In some experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "pRBCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014792:rbcs [Cell]

Phrase: "were"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "undergo"

Phrase: "schizont"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0562656:Schizont [Eukaryote]

Phrase: "rupture"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1881712:RUPTURE [Phenomenon or Process]
  1000   C3203359:Rupture [Injury or Poisoning]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "the supernatant from the ruptured cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "(pRBC supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550101:Supernatant [Body Substance]

Phrase: ")."
Processing 00000000.tx.47: Wild-type P. berghei (Pb WT) NK65, P. berghei TSP-related adhesive protein (PbTRAP) knockout parasites (Pb-TRAP-INT2) lacking the 5' promoter sequences and the first 22 codons of the TRAP coding sequence (PbTRAP knockout [Pb TRAP ko]; reference 25), and P. yoelii 17XL schizonts were prepared from the blood of infected C57BL6 mice. 

Phrase: "Wild-type P. berghei"

Phrase: "(Pb WT) NK65,"

Phrase: "P. berghei TSP-related adhesive protein"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   895   C0082731:P-protein [Amino Acid, Peptide, or Protein,Enzyme]
   895   C1151818:P-protein [Molecular Function]
   799   C0001516:Adhesive [Manufactured Object]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0439849:Related [Qualitative Concept]
   799   C0445223:Related [Finding]
   799   C2982905:Adhesive [Manufactured Object]
   766 E C0163712:Relate [Organic Chemical]
   727 E C0080103:Relation [Family Group]
   727 E C0869014:Relations [Social Behavior]

Phrase: "(PbTRAP"

Phrase: ")"

Phrase: "knockout parasites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030498:Parasites [Eukaryote]
   861   C0521066:Parasites. [Functional Concept]

Phrase: "(Pb-TRAP-INT2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0812290:INT2 [Gene or Genome]
   799   C1708016:INT2 [Gene or Genome]
   799   C1825604:INT2 [Gene or Genome]
   709   C1840552:PB Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "the 5' promoter sequences"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "the first 22 codons of the TRAP coding sequence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0009221:Codon [Nucleotide Sequence]
   736   C1095825:Codon [Plant]

Phrase: "(PbTRAP knockout [Pb TRAP ko]"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0560617:knock out [Injury or Poisoning]
   861   C1522225:Knock-out [Experimental Model of Disease]

Phrase: "; reference 25"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514811:Reference [Idea or Concept]
   861   C1706462:Reference [Conceptual Entity]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "P. yoelii 17XL schizonts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0562656:Schizonts [Eukaryote]

Phrase: "were"

Phrase: "prepared from the blood of infected C57BL6 mice."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   750   C1511225:Mouse Blood [Tissue]
   744   C0005767:Blood [Tissue]
   744   C0005768:blood [Body Substance]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0229664:Blood [Body Substance]
   744   C0439663:Infected [Functional Concept]
   711   C1521827:Prepare [Functional Concept]
   709 E C1511227:Mouse Blood Vessel [Tissue]
Processing 00000000.tx.48: Mice were infected with 104 pRBCs of each species. 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "infected with 104 pRBCs of each species."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0014792:rbcs [Cell]
   744   C0439663:Infected [Functional Concept]
   744   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.49: When maximum parasitemia was reached, mice were exsanguinated by cardiac puncture and pRBC purified by centrifugation through 72% Percoll. 

Phrase: "When"

Phrase: "maximum parasitemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242723:Parasitemia [Disease or Syndrome]

Phrase: "was"

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: ","

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "exsanguinated by cardiac puncture"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   770   C0033119:Puncture [Finding]
   770   C0034117:Puncture [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C0232101:Exsanguinated [Finding]
   770   C1522601:Cardiac [Spatial Concept]
   770   C1881711:PUNCTURE [Phenomenon or Process]

Phrase: "and"

Phrase: "pRBC"

Phrase: "purified by centrifugation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C1998793:Purified [Functional Concept]

Phrase: "through 72% Percoll."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0070386:Percoll [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.50: Schizont-infected erythrocytes were washed extensively in serum-free PBS and used either whole or after sonication (pRBC lysate). 

Phrase: "Schizont-infected erythrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014772:Erythrocytes [Laboratory Procedure]
   827   C0014792:Erythrocytes [Cell]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "extensively in serum-free PBS"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0229671:Serum [Body Substance]
   760   C0332296:free [Functional Concept]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   760   C1720830:PBS [Disease or Syndrome]
   760   C1823521:PBS [Gene or Genome]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]

Phrase: "and"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "either whole"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444667:Whole [Quantitative Concept]

Phrase: "or after sonication"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0037680:Sonication [Research Activity]

Phrase: "(pRBC lysate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1881488:Lysate [Physical Object]

Phrase: ")."
Processing 00000000.tx.51: TGF- Activation Assay. 

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "Activation Assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.52: The TGF- activation assay is a modified version of the assay described by Schultz-Cherry et al. 

Phrase: "The TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "activation assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "is"

Phrase: "a modified version of the assay"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "described by Schultz-Cherry et al."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0330657:Cherry [Plant]
   753   C0770609:CHERRY [Food]
   753   C0936039:Cherry [Food]
   753   C1552738:described [Idea or Concept]
Processing 00000000.tx.53: (26). 

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.54: Parasites (intact or lysed) were diluted in PBS containing 0.1% BSA to a final concentration of between 103 and 107 pRBCs per ml. 

Phrase: "Parasites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030498:Parasites [Eukaryote]
  1000   C0521066:Parasites. [Functional Concept]

Phrase: "(intact"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205266:Intact [Qualitative Concept]
  1000   C1554187:Intact [Idea or Concept]

Phrase: "or"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: ")"

Phrase: "were"

Phrase: "diluted in PBS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756   C1720119:Dilute [Functional Concept]
   756   C1948037:Dilute [Functional Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.1% BSA to a final concentration of"

Phrase: "between 103"

Phrase: "and"

Phrase: "107 pRBCs per ml."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0014792:rbcs [Cell]
Processing 00000000.tx.55: Uninfected red cells were used at equivalent concentrations. 

Phrase: "Uninfected red cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0014792:Red cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0332575:Red [Finding]
   827   C1260956:Red [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "used at equivalent concentrations."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0086045:Concentrations [Mental Process]
   770   C0205163:Equivalent [Qualitative Concept]
   770   C0439185:equivalent [Quantitative Concept]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1446561:Concentration [Quantitative Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.56: Either purified, platelet-derived latent human TGF- (huLatTGF-), which comprises TGF- plus the latency-associated peptide LAP (Sigma-Aldrich), or recombinant latent human TGF- (rLatTGF-), also comprising TGF- plus LAP (R&D Systems), was added to parasites at a final concentration of 100 ng/ml and incubated for 2 h at 37C. 

Phrase: "Either"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: ","

Phrase: "platelet-derived latent human TGF-"
Meta Candidates (Total=19; Excluded=1; Pruned=0; Remaining=18)
   911   C0040690:Platelet Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   907   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   893   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   845   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   845   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0005821:Platelet [Cell]
   795   C0018270:'growth' NOS [Organism Function]
   795   C0086418:Human [Human]
   795   C0205275:Latent [Qualitative Concept]
   795   C0220844:growth [Physiologic Function]
   795   C1441547:Derived [Qualitative Concept]
   795   C1510411:Transforming [Pathologic Function]
   795   C1521761:Factor [Functional Concept]
   795   C1621966:Growth [Organ or Tissue Function]
   795   C2827422:Factor [Conceptual Entity]
   795   C2911660:Growth [Activity]
   795   C3245521:derived [Idea or Concept]
   712 E C1963076:Platelets [Finding]

Phrase: "(huLatTGF-"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "comprises"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700400:Comprise [Activity]

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "plus the latency-associated peptide LAP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Sigma-Aldrich"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "recombinant latent human TGF- (TGF-)"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   919   C1527194:Recombinant Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Transforming Growth Factor
   904   C1515377:Recombinant Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0086418:Human [Human]
   799   C0205275:Latent [Qualitative Concept]
   799   C0220844:growth [Physiologic Function]
   799   C1510411:Transforming [Pathologic Function]
   799   C1514798:recombinant [Organism]
   799   C1521761:Factor [Functional Concept]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]

Phrase: ","

Phrase: "also"

Phrase: "comprising"

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "plus LAP"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332281:Associated [Qualitative Concept]
   779 E C0750490:Associate [Idea or Concept]
   779 E C1706221:Associate [Professional or Occupational Group]
   741   C0205275:Latent [Qualitative Concept]

Phrase: "(R&D Systems"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   743 E C0205373:Systemic [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "added to parasites"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0030498:Parasites [Eukaryote]
   790   C0521066:Parasites. [Functional Concept]
   790   C1524062:Added [Functional Concept]
   756 E C1883712:Add [Functional Concept]

Phrase: "at a final concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 100 ng/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439275:ng/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "incubated for 2 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0011744:h 2 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37C."
Processing 00000000.tx.57: The contents of each well were then centrifuged (13,000 rpm for 60 s) to pellet the parasite material and the supernatants were tested for active TGF- by ELISA. 

Phrase: "The contents of each well"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0456205:Contents [Conceptual Entity]
   760   C1552853:contents [Idea or Concept]
   726 E C0423896:Content [Mental Process]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "centrifuged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "(13,000 rpm for 60"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0582523:rpm [Quantitative Concept]

Phrase: "s) to pellet"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0441436:Pellet [Manufactured Object]
   790   C0993610:Pellet [Biomedical or Dental Material]
   790   C1998480:Pellet [Quantitative Concept]
   790   C2603362:S' [Clinical Attribute]

Phrase: "the parasite material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Material [Substance]

Phrase: "and"

Phrase: "the supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "tested for active TGF-"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   833   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0205177:Active [Functional Concept]
   753   C0220844:growth [Physiologic Function]
   753   C0392366:tested [Intellectual Product]
   753   C1510411:Transforming [Pathologic Function]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]
   719 E C0022885:Test [Laboratory Procedure]
   719 E C0039593:Test [Functional Concept]

Phrase: "by ELISA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014441:ELISA [Laboratory Procedure]
Processing 00000000.tx.58: Recombinant human TSP-1 (rHuTSP-1; Sigma-Aldrich), at a concentration of 50 ng/ml, was used as a positive control. 

Phrase: "Recombinant human TSP-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0147139:Thrombospondin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1336626:THROMBOSPONDIN I [Gene or Genome]
   812   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(rHuTSP-1"

Phrase: "; Sigma-Aldrich"

Phrase: ")"

Phrase: ","

Phrase: "at a concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 50 ng/ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439275:ng/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "was"

Phrase: "used as a positive control."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   806   C1883676:Positive Control [Conceptual Entity]
   760   C0243148:control [Qualitative Concept]
   760   C0439178:% Positive [Quantitative Concept]
   760   C1273517:used [Finding]
   760   C1446409:Positive [Qualitative Concept]
   760   C1514241:Positive [Finding]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C2825490:Positive [Qualitative Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.59: The maximum releasable concentration of active TGF- was determined by acid activation of LatTGF-, as previously described (12). 

Phrase: "The maximum releasable concentration of active TGF-"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   790   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C2347813:Concentration Maximum [Quantitative Concept]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0086045:Concentration [Mental Process]
   742   C0205177:Active [Functional Concept]
   742   C0220844:growth [Physiologic Function]
   742   C0806909:Maximum [Quantitative Concept]
   742   C1446561:Concentration [Quantitative Concept]
   742   C1510411:Transforming [Pathologic Function]
   742   C1521761:Factor [Functional Concept]
   742   C1552615:maximum [Quantitative Concept]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C2826546:MAXIMUM [Quantitative Concept]
   742   C2827422:Factor [Conceptual Entity]
   742   C2911660:Growth [Activity]

Phrase: "was"

Phrase: "determined by acid activation of LatTGF-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0001128:Acid [Chemical]
   748   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0202406:Acid [Laboratory Procedure]
   748   C0205275:Latent [Qualitative Concept]
   748   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1879547:Activation [Activity]

Phrase: ","

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.60: All assays were performed in triplicate. 

Phrase: "All assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed in triplicate."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205174:Triplicate [Quantitative Concept]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.61: TGF- Inhibitors. 

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "Inhibitors."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243077:inhibitors [Chemical Viewed Functionally]
   966 E C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.62: To determine their ability to block TGF- activation, potential inhibitors were added to the LatTGF- at the start of the assay, before addition of the parasites. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "their ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "activation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "potential inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "were"

Phrase: "added to the LatTGF-"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205275:Latent [Qualitative Concept]
   760   C1524062:Added [Functional Concept]
   760   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   726 E C1883712:Add [Functional Concept]

Phrase: "at the start"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Start [Temporal Concept]

Phrase: "of the assay,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "before"

Phrase: "addition of the parasites."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883712:Addition [Functional Concept]
Processing 00000000.tx.63: Mouse monoclonal antibody (clone TSP-B7) to human TSP-1 (antiTSP-1; Sigma-Aldrich) was used at concentrations from 0.01 to 20 g/ml. 

Phrase: "Mouse monoclonal antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   901   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0746619:monoclonal [Finding]

Phrase: "(clone TSP-B7"

Phrase: ")"

Phrase: "to human TSP-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0147139:Thrombospondin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1336626:THROMBOSPONDIN I [Gene or Genome]
   827   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(antiTSP-1"

Phrase: "; Sigma-Aldrich"

Phrase: ")"

Phrase: "was"

Phrase: "used at concentrations"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   790   C0086045:Concentrations [Mental Process]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1446561:Concentration [Quantitative Concept]
   756 E C1947944:Use [Intellectual Product]
   706 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "from 0.01"

Phrase: "to 20 g/ml."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1300565:g/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.64: Affinity-purified polyclonal sheep antibody, 1.5, and mouse monoclonal antibody, 19F7, to P. falciparum TSP-related adhesive protein (PfTRAP) were provided by K. 

Phrase: "Affinity-purified polyclonal sheep antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "1.5,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450316:1/5 [Quantitative Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "mouse monoclonal antibody,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   901   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0746619:monoclonal [Finding]

Phrase: "19F7,"

Phrase: "to P. falciparum TSP-related adhesive protein"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   895   C0082731:P-protein [Amino Acid, Peptide, or Protein,Enzyme]
   895   C1151818:P-protein [Molecular Function]
   799   C0001516:Adhesive [Manufactured Object]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0439849:Related [Qualitative Concept]
   799   C0445223:Related [Finding]
   799   C2982905:Adhesive [Manufactured Object]
   766 E C0163712:Relate [Organic Chemical]
   727 E C0080103:Relation [Family Group]
   727 E C0869014:Relations [Social Behavior]

Phrase: "(PfTRAP"

Phrase: ")"

Phrase: "were"

Phrase: "provided by K."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   790   C1708601:K' [Quantitative Concept]
   790   C1999230:Provided [Activity]
Processing 00000000.tx.65: Robson (University of Oxford, Oxford, United Kingdom) and A. 

Phrase: "Robson"

Phrase: "(University of Oxford,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Oxford,"

Phrase: "United Kingdom"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041700:United Kingdom [Geographic Area]
   861   C1708611:Kingdom [Classification]
   827   C0166872:unite [Biomedical or Dental Material]

Phrase: ")"

Phrase: "and"

Phrase: "A."
Processing 00000000.tx.66: Crisanti (Imperial College, London, United Kingdom), respectively. 

Phrase: "Crisanti"

Phrase: "(Imperial College,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0557806:College [Manufactured Object]

Phrase: "London,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023973:London [Geographic Area]

Phrase: "United Kingdom"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041700:United Kingdom [Geographic Area]
   861   C1708611:Kingdom [Classification]
   827   C0166872:unite [Biomedical or Dental Material]

Phrase: ")"

Phrase: ","

Phrase: "respectively."
Processing 00000000.tx.67: Antibodies were dialyzed against PBS to remove preservatives and diluted to final concentrations of up to 4 g/ml. 

Phrase: "Antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "dialyzed against PBS to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1720830:PBS [Disease or Syndrome]
   770   C1823521:PBS [Gene or Genome]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "preservatives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033086:preservatives [Biomedical or Dental Material]

Phrase: "and"

Phrase: "diluted to final concentrations of"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0086045:Concentrations [Mental Process]
   760   C0205088:Final [Temporal Concept]
   760   C1546485:Final [Idea or Concept]
   726 E C1446561:Concentration [Quantitative Concept]
   726   C1720119:Dilute [Functional Concept]
   726   C1948037:Dilute [Functional Concept]

Phrase: "up to 4 g/ml."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1300565:g/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.68: Dialyzed control antibodies, polyclonal sheep IgG (Sigma-Aldrich) and mouse IgG (R&D Systems), and a monoclonal antibody X509 to P. falciparum merozoite protein 1 (provided by M. Blackman, National Institute for Medical Research, London, United Kingdom), were used as negative controls. 

Phrase: "Dialyzed"

Phrase: "control antibodies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "polyclonal sheep IgG (Sigma-Aldrich"

Phrase: ")"

Phrase: "and"

Phrase: "mouse IgG (R&D Systems"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   804   C0205090:R- [Spatial Concept]
   804   C0684010:R. [Professional or Occupational Group]
   804   C2603358:R' [Clinical Attribute]
   771   C0449913:System [Functional Concept]
   771   C1553451:System [Manufactured Object]
   771   C1704459:System [Medical Device]
   721 E C0205373:Systemic [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "a monoclonal antibody X509 to P. falciparum merozoite protein 1"

Phrase: "("

Phrase: "provided by M. Blackman,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   770   C1999230:Provided [Activity]

Phrase: "National Institute for Medical Research,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   875   C0035172:institute research [Organization]
   840   C0079816:Medical Research [Research Activity]
   840   C1556038:Medical Research [Professional or Occupational Group]
   804   C0021622:institute [Organization]
   804   C0035168:research [Research Activity]
   804   C0205476:Medical [Functional Concept]
   804   C0242481:Research [Research Activity]
   804   C1272753:Institute [Idea or Concept]
   804   C3245503:national [Intellectual Product]

Phrase: "London,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023973:London [Geographic Area]

Phrase: "United Kingdom"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041700:United Kingdom [Geographic Area]
   861   C1708611:Kingdom [Classification]
   827   C0166872:unite [Biomedical or Dental Material]

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "used as negative controls."
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   799   C1639518:% negative control [Quantitative Concept]
   799   C1947986:Negative Control [Conceptual Entity]
   770   C0205160:Negative [Qualitative Concept]
   770   C1273517:used [Finding]
   770   C1513916:Negative [Finding]
   770   C2825415:Negative [Conceptual Entity]
   770   C2825491:Negative [Qualitative Concept]
   737 E C0042153:use [Functional Concept]
   737   C0243148:control [Qualitative Concept]
   737 E C0457083:Use [Functional Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737 E C1947944:Use [Intellectual Product]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.69: Protease inhibitors were obtained from Sigma-Aldrich (benzamidine, E-64, phenanthroline, apstatin, calpain inhibitor, phosphoramidon, bestatin, APMSF, and EDTA) or Calbiochem (metalloproteinase [MMP]2 inhibitor, MMP2/MMP9 inhibitor, and GM1489). 

Phrase: "Protease inhibitors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   966 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1947941:Protease [Enzyme]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "were"

Phrase: "obtained from Sigma-Aldrich"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1301820:Obtained [Functional Concept]
   770   C1719918:Sigma [Intellectual Product]
   737 E C1706701:Obtain [Activity]

Phrase: "(benzamidine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0053140:benzamidine [Organic Chemical,Pharmacologic Substance]

Phrase: "E-64,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0058882:E 64 [Organic Chemical,Pharmacologic Substance]

Phrase: "phenanthroline,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031370:phenanthroline [Organic Chemical]

Phrase: "apstatin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0384979:apstatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "calpain inhibitor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054533:calpain inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "phosphoramidon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "bestatin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0053355:bestatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "APMSF,"

Phrase: "and"

Phrase: "EDTA)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "Calbiochem"

Phrase: "(metalloproteinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "[MMP]2 inhibitor,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C1513016:MMP Inhibitor [Pharmacologic Substance]
   827   C1999216:Inhibitor [Qualitative Concept]
   734   C0172537:MMP-2 [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1334522:MMP2 [Gene or Genome]
   734   C2698024:MMP2 [Laboratory Procedure]

Phrase: "MMP2/MMP9 inhibitor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "GM1489"

Phrase: ")."
Processing 00000000.tx.70: Synthetic Peptides. 

Phrase: "Synthetic Peptides."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C1883254:synthetic [Activity]
Processing 00000000.tx.71: N-acetyl peptides, 834 residues long, representing sequences of PfTRAP and PbTRAP, each with an additional COOH-terminal cysteine, were synthesized by conventional solid phase techniques. 

Phrase: "N-acetyl peptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "834 residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "long,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205166:Long [Qualitative Concept]
  1000   C1706317:Long [Qualitative Concept]

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "sequences of PfTRAP"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   790   C0162326:Sequences [Nucleotide Sequence]
   756 E C0004793:Sequence [Nucleotide Sequence]
   756 E C0162327:Sequence [Nucleotide Sequence]
   756 E C1519249:Sequence [Functional Concept]
   706 E C1548958:Sequential [Idea or Concept]
   706 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "PbTRAP,"

Phrase: "each with an additional COOH-terminal cysteine,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205088:Terminal [Temporal Concept]
   748   C1457900:Each [Quantitative Concept]
   748   C1524062:Additional [Functional Concept]
   748   C1705314:Terminal [Manufactured Object]
   748   C1705315:Terminal [Spatial Concept]

Phrase: "were"

Phrase: "synthesized by conventional solid phase techniques."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0025664:techniques [Intellectual Product]
   753   C0205208:Solid [Qualitative Concept]
   753   C0205390:Phase [Temporal Concept]
   753   C0302909:Solid [Substance]
   753   C0439858:Conventional [Qualitative Concept]
   753   C0449851:Techniques [Functional Concept]
   753   C1378566:Solid [Biomedical or Dental Material]
   753   C1883254:Synthesized [Activity]
Processing 00000000.tx.72: Peptides were purified by RP-HPLC in gradients of CH3CN (Merck) in 0.1% trifluoroacetic acid (Applied Biosystems), lyophilized, reconstituted in PBS, and dialyzed before use. 

Phrase: "Peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "purified by RP-HPLC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0008562:HPLC [Laboratory Procedure]
   770   C1538326:RP [Gene or Genome]
   770   C1998793:Purified [Functional Concept]
   770   C3541325:RP [Idea or Concept]

Phrase: "in gradients"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0812409:gradients [Quantitative Concept]
   966 E C0439182:% gradient [Quantitative Concept]

Phrase: "of CH3CN"

Phrase: "(Merck"

Phrase: ")"

Phrase: "in 0.1% trifluoroacetic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040982:Trifluoroacetic Acid [Organic Chemical]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: "(Applied Biosystems"

Phrase: ")"

Phrase: ","

Phrase: "lyophilized"

Phrase: ","

Phrase: "reconstituted in PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]

Phrase: "and"

Phrase: "dialyzed before use."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0042153:use [Functional Concept]
   790   C0457083:Use [Functional Concept]
   790   C1947944:Use [Intellectual Product]
Processing 00000000.tx.73: Peptide identities were confirmed by matrix-assisted laser desorption time-of-flight mass spectroscopy. 

Phrase: "Peptide identities"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0424215:identities [Mental Process]
   827 E C2003939:Identity [Finding]

Phrase: "were"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "by matrix-assisted laser desorption time-of-flight mass spectroscopy."
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   827   C2348791:Time-of-Flight [Quantitative Concept]
   807   C0037813:Spectroscopy, Mass [Laboratory Procedure]
   791   C0037812:spectroscopy [Laboratory Procedure]
   791   C0040223:Time [Temporal Concept]
   791   C0577559:Mass [Finding]
   791   C1306372:*Mass [Quantitative Concept]
   791   C1555977:Flight [Intellectual Product]
   791   C2610507:flight [Phenomenon or Process]
   791   C2713504:Spectroscopy [Occupation or Discipline]
   791   C2984732:SPECTROSCOPY [Functional Concept]
   791   C3152252:Mass [Quantitative Concept]
   791   C3541383:Time [Temporal Concept]
   735 E C0442043:Temporal [Spatial Concept]
   735 E C2362314:Temporal [Temporal Concept]
   708 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.74: The sequences of the peptides are: PfTRAP-1, VIGPFMKAVCVEVEKTASCGVWDEWSPCSVTCGK; 

Phrase: "The sequences of the peptides"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   764   C0920679:peptide sequence [Amino Acid Sequence]
   760   C0162326:Sequences [Nucleotide Sequence]
   726 E C0004793:Sequence [Nucleotide Sequence]
   726 E C0162327:Sequence [Nucleotide Sequence]
   726 E C1519249:Sequence [Functional Concept]

Phrase: "are"

Phrase: ":"

Phrase: "PfTRAP-1,"

Phrase: "VIGPFMKAVCVEVEKTASCGVWDEWSPCSVTCGK"

Phrase: ";"
Processing 00000000.tx.75: PfTRAP-2, SCGVWDEWSPCSVTCGK; 

Phrase: "PfTRAP-2,"

Phrase: "SCGVWDEWSPCSVTCGK"

Phrase: ";"
Processing 00000000.tx.76: and PbTRAP, KVALCGKWEEWSECSTTCDN. 

Phrase: "and"

Phrase: "PbTRAP,"

Phrase: "KVALCGKWEEWSECSTTCDN."
Processing 00000000.tx.77: The underlined amino acid sequences indicate the region homologous to the TSP-1 TGF-binding motif, GGWSHW. 

Phrase: "The underlined amino acid sequences"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   923   C0002518:Sequences, Amino Acid [Amino Acid Sequence]
   861   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acid [Chemical]
   812   C0162326:Sequences [Nucleotide Sequence]
   812   C0202406:Acid [Laboratory Procedure]
   779 E C0004793:Sequence [Nucleotide Sequence]
   779 E C0162327:Sequence [Nucleotide Sequence]
   779 E C1519249:Sequence [Functional Concept]
   729 E C1548958:Sequential [Idea or Concept]
   729 E C1705294:Sequential [Qualitative Concept]

Phrase: "indicate"

Phrase: "the region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "homologous to the TSP-1 TGF-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1334043:Homologous [Gene or Genome]

Phrase: "binding motif,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514562:Motif [Amino Acid Sequence]

Phrase: "GGWSHW."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0967657:GGWSHW [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.78: TGF- ELISA. 

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "ELISA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014441:ELISA [Laboratory Procedure]
Processing 00000000.tx.79: ELISA assays were conducted as previously described (27) using chicken antihuman TGF--1 as the coating antibody, monoclonal mouse antihTGF-1, antihTGF-2, and anti-hTGF-3 as the detecting antibody, and recombinant human TGF-1 as the standard (all reagents from R&D Systems). 

Phrase: "ELISA assays"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C0014441:ELISA assay [Laboratory Procedure]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "conducted as previously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0004927:Conduct [Individual Behavior]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(27"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "chicken antihuman TGF--"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   884   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0008051:Chicken [Bird]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C0677521:Chicken [Food]
   804   C1365945:CHICKEN [Food]
   804   C1510411:Transforming [Pathologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]

Phrase: "1 as the coating antibody,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C1522408:Coating [Qualitative Concept]
   760   C1704806:Coating [Biomedical or Dental Material]
   760   C2827734:1+ [Quantitative Concept]
   760   C2981698:1+ [Classification]
   726 E C0453946:Coat [Manufactured Object]
   726 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "monoclonal mouse antihTGF-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0025914:Mouse [Mammal]
   812   C0025929:mouse [Mammal]
   812   C0026809:Mouse [Mammal]
   812   C0746619:monoclonal [Finding]

Phrase: "antihTGF-2,"

Phrase: "and"

Phrase: "anti-hTGF-3 as the detecting antibody,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   714   C0442726:detect [Finding]

Phrase: "and"

Phrase: "recombinant human TGF-"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   933   C1527194:Recombinant Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Transforming Growth Factor
   911   C1515377:Recombinant Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   884   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0086418:Human [Human]
   804   C0220844:growth [Physiologic Function]
   804   C1510411:Transforming [Pathologic Function]
   804   C1514798:recombinant [Organism]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]

Phrase: "1 as the standard"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1442989:Standard [Qualitative Concept]
   770   C2827734:1+ [Quantitative Concept]
   770   C2828392:Standard [Intellectual Product]
   770   C2981698:1+ [Classification]

Phrase: "("

Phrase: "all reagents from R&D Systems"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: ")."
Processing 00000000.tx.80: These antibodies detect epitopes that are revealed only in the bioactive form of TGF- but not in the inactive (latent) form of the molecule. 

Phrase: "These antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "epitopes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003316:Epitopes [Immunologic Factor]

Phrase: "that"

Phrase: "are"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "only in the bioactive form of TGF-"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   790   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0205171:Only [Quantitative Concept]
   742   C0220844:growth [Physiologic Function]
   742   C0348078:Form [Qualitative Concept]
   742   C0376315:Form [Manufactured Object]
   742   C1510411:Transforming [Pathologic Function]
   742   C1521761:Factor [Functional Concept]
   742   C1522492:Form [Functional Concept]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C1720467:Only [Intellectual Product]
   742   C2827422:Factor [Conceptual Entity]
   742   C2911660:Growth [Activity]

Phrase: "but"

Phrase: "not in the inactive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205254:Inactive [Qualitative Concept]
   770   C1518422:Not [Functional Concept]

Phrase: "(latent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205275:Latent [Qualitative Concept]

Phrase: ")"

Phrase: "form of the molecule."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C0567416:Molecule [Substance]
   770   C1522492:Form [Functional Concept]
Processing 00000000.tx.81: Thus, the assay measures only bioactive TGF-. 

Phrase: "Thus,"

Phrase: "the assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "measures"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]
  1000   C1879489:Measures [Functional Concept]

Phrase: "only bioactive TGF-"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   884   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0205171:Only [Quantitative Concept]
   804   C0220844:growth [Physiologic Function]
   804   C1510411:Transforming [Pathologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C1720467:Only [Intellectual Product]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]

Phrase: "."
Processing 00000000.tx.82: Supernatants were not acid activated before testing. 

Phrase: "Supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "not acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "activated before testing."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0039593:Testing [Functional Concept]
   790   C0392366:testing [Intellectual Product]
   790   C1879547:Activated [Activity]
   756 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.83: Zymography. 

Phrase: "Zymography."
Processing 00000000.tx.84: 4 x 107 pRBCs were suspended in Tris-glycine SDS sample buffer (0.25 M Tris-Cl, 20% glycerol, 5% SDS, 0.05% bromophenol blue, pH 6.8), sonicated, centrifuged at 10,000 g for 20 min at 4C, and applied to a 10% zymogram gel (Invitrogen). 

Phrase: "4 x 107 pRBCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0014792:rbcs [Cell]

Phrase: "were"

Phrase: "suspended in Tris-glycine SDS sample buffer"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   774   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   748   C0370003:Sample [Substance]
   748   C0522461:Glycine [Plant]
   748   C0814229:TRI [Intellectual Product]
   748   C1553389:suspended [Idea or Concept]
   748   C1553403:suspended [Idea or Concept]
   748   C1705537:Suspended [Functional Concept]
   748   C2347026:Sample [Conceptual Entity]

Phrase: "(0.25 M Tris-Cl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "20% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "5% SDS,"

Phrase: "0.05% bromophenol blue,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006247:Bromophenol Blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C1260957:Blue [Qualitative Concept]

Phrase: "pH 6.8"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "sonicated"

Phrase: ","

Phrase: "centrifuged at 10,000 g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439267:g% [Quantitative Concept]
   726   C0179834:centrifuge [Medical Device]

Phrase: "for 20 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "and"

Phrase: "applied to a 10% zymogram gel"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0185125:Applied [Health Care Activity]
   753   C1382104:Gel [Substance]
   719 E C1632850:Apply [Functional Concept]
   719 E C1879355:Apply [Functional Concept]

Phrase: "(Invitrogen"

Phrase: ")."
Processing 00000000.tx.85: The gel was electrophoresed at 125 V for 90 min and proteins were renatured by incubation of the gel in 25% Triton X-100 in dH2O. 

Phrase: "The gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017243:Gel [Biomedical or Dental Material]
  1000   C1382104:Gel [Substance]

Phrase: "was"

Phrase: "electrophoresed at 125 V"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0013855:electrophorese [Laboratory Procedure]

Phrase: "for 90 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "renatured by incubation of the gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C1382104:Gel [Substance]

Phrase: "in 25% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "in dH2O."
Processing 00000000.tx.86: The renatured gel was incubated in developing buffer (Tris base 1.21 g/l, Tris HCl 6.3 g/l, NaCl 11.7 g/l, CaCl2 0.74 g/liter, Brij 3.5% [wt/vol] in dH2O) for 16 h at 37C and stained with Coomassie blue. 

Phrase: "The renatured gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C1382104:Gel [Substance]

Phrase: "was"

Phrase: "incubated in developing buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "(Tris base 1.21 g/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439294:g l [Quantitative Concept]

Phrase: "Tris HCl 6.3 g/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439294:g l [Quantitative Concept]

Phrase: "NaCl 11.7 g/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   840   C0439294:g l [Quantitative Concept]

Phrase: "CaCl2 0.74 g/liter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0475211:liter [Quantitative Concept]

Phrase: "Brij 3.5%"

Phrase: "[wt/vol] in dH2O"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0449468:VOL [Quantitative Concept]
   770   C0560268:vol% [Quantitative Concept]
   770   C1690016:% vol [Qualitative Concept]

Phrase: ")"

Phrase: "for 16 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 37C"

Phrase: "and"

Phrase: "stained with Coomassie blue."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0056269:Coomassie blue [Organic Chemical,Pharmacologic Substance]
   770   C1260957:Blue [Qualitative Concept]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.87: Gelatin-Agarose Affinity Chromatography. 

Phrase: "Gelatin-Agarose Affinity Chromatography."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   875   C0008552:Chromatography, Agarose [Laboratory Procedure,Research Activity]
   861   C0008551:Chromatography, Affinity [Laboratory Procedure]
   812   C0008550:Chromatography [Laboratory Procedure]
   812   C1510827:Affinity [Natural Phenomenon or Process]
   712 E C0302647:chromatograph [Medical Device]
Processing 00000000.tx.88: P. falciparum schizont-infected erythrocytes (pRBCs) were suspended at a concentration of 4 x 107 pRBCs per ml in 20 mM Tris-HCl, pH 7.5, containing 0.15 M NaCl, 1% Triton X-100, plus protease inhibitors leupeptin, E64, and antipain (all used at 25 g/ml; all from Sigma-Aldrich), and briefly sonicated. 

Phrase: "P. falciparum schizont-infected erythrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0014772:Erythrocytes [Laboratory Procedure]
   804   C0014792:Erythrocytes [Cell]

Phrase: "(pRBCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014792:rbcs [Cell]

Phrase: ")"

Phrase: "were"

Phrase: "suspended at a concentration of 4 x 107 pRBCs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   739   C0014792:rbcs [Cell]
   739   C0086045:Concentration [Mental Process]
   739   C1446561:Concentration [Quantitative Concept]
   739   C1553389:suspended [Idea or Concept]
   739   C1553403:suspended [Idea or Concept]
   739   C1705537:Suspended [Functional Concept]

Phrase: "per ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "in 20 mM Tris-HCl,"

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.15 M NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: "1% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "plus protease inhibitors leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "E64,"

Phrase: "and"

Phrase: "antipain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003403:Antipain [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "("

Phrase: "all"

Phrase: "used at 25 g/ml"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   806   C1300565:g/mL [Quantitative Concept]
   797 E C1637390:mL/g [Quantitative Concept]
   760   C0439267:g% [Quantitative Concept]
   760   C0439526:/mL [Quantitative Concept]
   760   C1273517:used [Finding]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: ";"

Phrase: "all from Sigma-Aldrich"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0444868:All [Quantitative Concept]
   770   C1719918:Sigma [Intellectual Product]
   770   C3539085:All [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "briefly"

Phrase: "sonicated."
Processing 00000000.tx.89: The sonicate was spun down (10,000 g for 20 min at 4C) and 200 l of the supernatant was mixed with an equal volume of gelatin-agarose resin (Sigma-Aldrich) and incubated on ice for 2 h. 

Phrase: "The sonicate"

Phrase: "was"

Phrase: "spun down"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   833   C1446863:Spun [Laboratory Procedure]
   799 E C1415347:SPIN [Gene or Genome]
   799 E C1823107:SPIN [Gene or Genome]

Phrase: "(10,000 g for 20 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0560021:g/min [Quantitative Concept]
   753   C0439267:g% [Quantitative Concept]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "200 l of the supernatant"

Phrase: "was"

Phrase: "mixed with an equal volume of gelatin-agarose resin"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   742   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   742   C0035191:Resin [Biomedical or Dental Material]
   742   C0036681:Agarose [Carbohydrate]
   742   C0205163:Equal [Qualitative Concept]
   742   C0205430:Mixed [Functional Concept]
   742   C0449468:*Volume [Quantitative Concept]
   742   C1145617:Gelatin [Food]
   742   C1549782:Equal [Idea or Concept]
   742   C1690016:% volume [Qualitative Concept]
   742   C1705102:Volume [Intellectual Product]
   742   C2700258:Volume [Laboratory Procedure]
   742   C3160715:Mixed [Finding]
   708 E C1421951:MIX [Gene or Genome]
   708 E C1720722:Mix [Qualitative Concept]

Phrase: "(Sigma-Aldrich"

Phrase: ")"

Phrase: "and"

Phrase: "incubated on ice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020746:Ice [Inorganic Chemical]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 2 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.90: The resin was spun down and washed three times in 50 mM Tris-HCl, pH 7.5, with 0.5 M NaCl, 5 mM CaCl2, 0.05% Brij-35, and 0.02% NaN3 (all from Sigma-Aldrich). 

Phrase: "The resin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035191:Resin [Biomedical or Dental Material]

Phrase: "was"

Phrase: "spun down"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   833   C1446863:Spun [Laboratory Procedure]
   799 E C1415347:SPIN [Gene or Genome]
   799 E C1823107:SPIN [Gene or Genome]

Phrase: "and"

Phrase: "washed three times in 50 mM Tris-HCl,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0040223:times [Temporal Concept]
   744   C1632851:Times [Quantitative Concept]
   711 E C3541383:Time [Temporal Concept]

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "with 0.5 M NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: "5 mM CaCl2,"

Phrase: "0.05% Brij-35,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0107162:Brij 35 [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.02% NaN3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0074721:NaN3 [Hazardous or Poisonous Substance,Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]

Phrase: "("

Phrase: "all from Sigma-Aldrich"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0444868:All [Quantitative Concept]
   770   C1719918:Sigma [Intellectual Product]
   770   C3539085:All [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.91: Bound proteins were released by incubation on ice for 30 min in 100 l 7.5% DMSO in Tris-Brij buffer. 

Phrase: "Bound proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "released by incubation"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0391871:Released [Functional Concept]
   790   C1283071:Released [Functional Concept]
   756 E C0030685:Release [Health Care Activity]
   756 E C0439180:% release [Quantitative Concept]
   756 E C0680255:release [Health Care Activity]
   756 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "on ice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020746:Ice [Inorganic Chemical]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "in 100 l 7.5% DMSO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0012403:DMSO [Organic Chemical,Pharmacologic Substance]

Phrase: "in Tris-Brij buffer."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.92: The supernatant was dialyzed against 50 mM Tris-HCl, pH 7.5, with 5 mM CaCl2 and 0.01% Brij-35, and concentrated using a minidialysis unit (Pierce Chemical Co.). 

Phrase: "The supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "dialyzed against 50 mM Tris-HCl,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   753   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   753   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "with 5 mM CaCl2"

Phrase: "and"

Phrase: "0.01% Brij-35,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0107162:Brij 35 [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "concentrated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1880165:Concentrated [Biomedical or Dental Material]
   966 E C1880310:Concentrate [Manufactured Object]
   966 E C2003864:Concentrate [Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a minidialysis unit"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439148:Unit [Quantitative Concept]
   861   C1519795:Unit [Quantitative Concept]
   861   C1704753:Unit [Manufactured Object]
   861   C1880519:Unit [Quantitative Concept]

Phrase: "(Pierce Chemical Co."

Phrase: ")."
Processing 00000000.tx.93: The supernatant was tested for TGF-activating capacity and for the presence of gelatinases by zymography.  

Phrase: "The supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "tested for TGF-"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   862   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   862   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C0392366:tested [Intellectual Product]
   760   C1510411:Transforming [Pathologic Function]
   760   C1521761:Factor [Functional Concept]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2827422:Factor [Conceptual Entity]
   760   C2911660:Growth [Activity]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]

Phrase: "activating capacity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516240:Capacity [Quantitative Concept]

Phrase: "and for the presence of gelatinases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0206528:Gelatinases [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C1515981:And [Idea or Concept]

Phrase: "by zymography."
Processing 00000000.tx.94: Results Top Abstract Introduction Materials and Methods Results Discussion References  P. falciparum Schizont-infected Erythrocytes Activate rLatTGF- In Vitro. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "P. falciparum Schizont-infected Erythrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0014772:Erythrocytes [Laboratory Procedure]
   804   C0014792:Erythrocytes [Cell]

Phrase: "Activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "rLatTGF-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086418:Human [Human]
   812   C0205275:Latent [Qualitative Concept]
   812   C1514798:recombinant [Organism]
   812   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "In Vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.95: Purified, platelet-derived huLatTFG- and rLatTGF- were incubated with varying concentrations of pRBCs, uRBCs, or pRBC supernatant for 2 h and the release of bioactive TGF- into the medium was assayed by ELISA. 

Phrase: "Purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: ","

Phrase: "platelet-derived huLatTFG-"

Phrase: "and"

Phrase: "rLatTGF-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086418:Human [Human]
   812   C0205275:Latent [Qualitative Concept]
   812   C1514798:recombinant [Organism]
   812   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "incubated with varying concentrations of pRBCs,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0014792:rbcs [Cell]
   748   C0086045:Concentrations [Mental Process]
   748   C1439852:Incubated [Laboratory Procedure]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "uRBCs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014792:rbcs [Cell]

Phrase: "or"

Phrase: "pRBC supernatant for 2 h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1550101:Supernatant [Body Substance]

Phrase: "and"

Phrase: "the release of bioactive TGF-"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   814   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   814   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0599947:release factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0030685:Release [Health Care Activity]
   748   C0220844:growth [Physiologic Function]
   748   C0391871:Release [Functional Concept]
   748   C0439180:% release [Quantitative Concept]
   748   C0680255:release [Health Care Activity]
   748   C1283071:Release [Functional Concept]
   748   C1510411:Transforming [Pathologic Function]
   748   C1521761:Factor [Functional Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C1963578:Release [Therapeutic or Preventive Procedure]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]

Phrase: "into the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "assayed by ELISA."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   841   C0014441:ELISA assay [Laboratory Procedure]
           ELISA
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.96: The huLatTGF- and rLatTGF- were both activated, in a dose-dependent manner, by pRBCs but not by uRBCs (Fig. 1 a). 

Phrase: "The huLatTGF-"

Phrase: "and"

Phrase: "rLatTGF-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086418:Human [Human]
   812   C0205275:Latent [Qualitative Concept]
   812   C1514798:recombinant [Organism]
   812   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "both"

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: ","

Phrase: "in a dose-dependent manner,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1512045:Dose-dependent [Quantitative Concept]

Phrase: "by pRBCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014792:rbcs [Cell]

Phrase: "but"

Phrase: "not by uRBCs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0014792:rbcs [Cell]
   770   C1518422:Not [Functional Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "a"

Phrase: ")."
Processing 00000000.tx.97: However, the rLatTGF- preparation appeared to contain some spontaneously active TGF-, making the effects of specific activators and inhibitors less easy to interpret. 

Phrase: "However,"

Phrase: "the rLatTGF-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0086418:Human [Human]
   804   C0205275:Latent [Qualitative Concept]
   804   C1514798:recombinant [Organism]
   804   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "some spontaneously active TGF-"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   861   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0205177:Active [Functional Concept]
   799   C0205392:Some [Quantitative Concept]
   799   C0220844:growth [Physiologic Function]
   799   C1510411:Transforming [Pathologic Function]
   799   C1521761:Factor [Functional Concept]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   799   C3540770:Some [Intellectual Product]

Phrase: ","

Phrase: "making"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "the effects of specific activators"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "inhibitors less easy to"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0243077:inhibitors [Chemical Viewed Functionally]
   812   C0332219:Easy [Qualitative Concept]
   779 E C1999216:Inhibitor [Qualitative Concept]
   741 E C1331418:Ease [Mental Process]

Phrase: "interpret."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285553:interpret [Functional Concept]
Processing 00000000.tx.98: Thus, platelet-derived huLatTGF- was used in all subsequent assays. 

Phrase: "Thus,"

Phrase: "platelet-derived huLatTGF-"

Phrase: "was"

Phrase: "used in all subsequent assays."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0332282:Subsequent [Temporal Concept]
   760   C1273517:used [Finding]
   726   C0005507:Assay [Laboratory Procedure]
   726 E C0042153:use [Functional Concept]
   726   C0243073:assay [Qualitative Concept]
   726 E C0457083:Use [Functional Concept]
   726   C1510438:Assay [Laboratory Procedure]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.99: Concentrations of active TGF- released by pRBC were of the same order of magnitude as those released by acid activation (mean, SEM 1970  109 pg/ml). 

Phrase: "Concentrations of active TGF-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "released by pRBC"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0391871:Released [Functional Concept]
   790   C1283071:Released [Functional Concept]
   756 E C0030685:Release [Health Care Activity]
   756 E C0439180:% release [Quantitative Concept]
   756 E C0680255:release [Health Care Activity]
   756 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "were of the same order of magnitude"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0445247:Same [Qualitative Concept]
   748   C0449286:magnitude [Quantitative Concept]
   748   C1704240:Magnitude [Quantitative Concept]
   748   C1705175:Order [Intellectual Product]
   748   C1705176:Order [Qualitative Concept]
   748   C1705177:Order [Classification]
   748   C1705178:Order [Activity]
   748   C1882348:Order [Qualitative Concept]

Phrase: "as those"

Phrase: "released by acid activation"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C0391871:Released [Functional Concept]
   770   C1283071:Released [Functional Concept]
   770   C1879547:Activation [Activity]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(mean,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "SEM 1970  109 pg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0439297:pg/mL [Quantitative Concept]
   804   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.100: View larger version (36K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(36K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.101: Activation of huLatTGF- by Plasmodium spp. 

Phrase: "Activation of huLatTGF-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: "by Plasmodium spp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424276:SPP [Gene or Genome]
Processing 00000000.tx.102: (a) HuLatTGF- was incubated for 2 h with P. falciparum schizonts (pRBC) or uRBCs (uRBC) at concentrations of 105, 106, or 107 erythrocytes per ml, or medium alone. 

Phrase: "(a) HuLatTGF-"

Phrase: "was"

Phrase: "incubated for 2 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0011744:h 2 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "with P. falciparum schizonts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0562656:Schizonts [Eukaryote]
   734   C0858318:p falciparum [Disease or Syndrome]

Phrase: "(pRBC)"

Phrase: "or"

Phrase: "uRBCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014792:rbcs [Cell]

Phrase: "(uRBC"

Phrase: ")"

Phrase: "at concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0086045:Concentrations [Mental Process]
   966 E C1446561:Concentration [Quantitative Concept]
   916 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 105,"

Phrase: "106,"

Phrase: "or"

Phrase: "107 erythrocytes per ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0014772:Erythrocytes [Laboratory Procedure]
   770   C0014792:Erythrocytes [Cell]

Phrase: "or"

Phrase: "medium alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Alone [Quantitative Concept]
   861   C0439044:alone [Finding]
   861   C0679994:alone [Group Attribute]
Processing 00000000.tx.103: HuLatTGF-, platelet-derived, latent human TGF-; 

Phrase: "HuLatTGF-,"

Phrase: "platelet-derived,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0005821:Platelet [Cell]
   861   C1441547:Derived [Qualitative Concept]
   861   C3245521:derived [Idea or Concept]
   777 E C1963076:Platelets [Finding]

Phrase: "latent human TGF-"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   884   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0086418:Human [Human]
   804   C0205275:Latent [Qualitative Concept]
   804   C0220844:growth [Physiologic Function]
   804   C1510411:Transforming [Pathologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]

Phrase: ";"
Processing 00000000.tx.104: rLatTGF-, recombinant latent human TGF-. 

Phrase: "rLatTGF-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086418:Human [Human]
   812   C0205275:Latent [Qualitative Concept]
   812   C1514798:recombinant [Organism]
   812   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ","

Phrase: "recombinant latent human TGF-"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   919   C1527194:Recombinant Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Transforming Growth Factor
   904   C1515377:Recombinant Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0086418:Human [Human]
   799   C0205275:Latent [Qualitative Concept]
   799   C0220844:growth [Physiologic Function]
   799   C1510411:Transforming [Pathologic Function]
   799   C1514798:recombinant [Organism]
   799   C1521761:Factor [Functional Concept]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]

Phrase: "."
Processing 00000000.tx.105: (b) HuLatTGF- was incubated with 4 x 1034 x 107 P. falciparum pRBCs/ml, the supernatant from an equivalent number of rupturing schizonts (pRBC supernatant) or equal numbers of uRBCs (uRBC). 

Phrase: "(b) HuLatTGF-"

Phrase: "was"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "with 4 x 1034 x 107 P. falciparum pRBCs/ml,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439526:/mL [Quantitative Concept]

Phrase: "the supernatant from an equivalent number of rupturing schizonts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1550101:Supernatant [Body Substance]

Phrase: "(pRBC supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550101:Supernatant [Body Substance]

Phrase: ")"

Phrase: "or"

Phrase: "equal numbers of uRBCs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "(uRBC"

Phrase: ")."
Processing 00000000.tx.106: (c) HuLatTGF- was incubated with 106 P. falciparum pRBCs/ml, 106 uRBCs/ml, or medium alone in the presence or absence of 50 ng/ml rHuTSP-1. 

Phrase: "(c) HuLatTGF-"

Phrase: "was"

Phrase: "incubated with 106 P. falciparum pRBCs/ml,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0014792:rbcs [Cell]
   744   C0439526:/mL [Quantitative Concept]
   744   C1439852:Incubated [Laboratory Procedure]

Phrase: "106 uRBCs/ml,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439526:/mL [Quantitative Concept]

Phrase: "or"

Phrase: "medium alone in the presence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205171:Alone [Quantitative Concept]
   760   C0439044:alone [Finding]
   760   C0679994:alone [Group Attribute]

Phrase: "or"

Phrase: "absence of 50 ng/ml rHuTSP-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332197:absence [Quantitative Concept]
   748   C1689985:Absence [Anatomical Abnormality]
Processing 00000000.tx.107: (d) HuLatTGF- was activated by acidification or incubated with 106 P. falciparum, P. berghei, or P. yoelii pRBCs or equivalent concentrations of human or mouse uRBCs. 

Phrase: "("

Phrase: "d)"

Phrase: "HuLatTGF-"

Phrase: "was"

Phrase: "activated by acidification"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1522821:acidification [Cell Function]
   790   C1879547:Activated [Activity]
   790   C2987513:Acidification [Phenomenon or Process]
   756 E C1515877:Activate [Functional Concept]

Phrase: "or"

Phrase: "incubated with 106 P. falciparum,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "P. berghei,"

Phrase: "or"

Phrase: "P. yoelii pRBCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0014792:rbcs [Cell]

Phrase: "or"

Phrase: "equivalent concentrations of human"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "or"

Phrase: "mouse uRBCs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0014792:rbcs [Cell]
Processing 00000000.tx.108: In all cases the concentration of bioactive TGF- in cell supernatants was assayed by ELISA. 

Phrase: "In all cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "the concentration of bioactive TGF-"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   814   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   814   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0086045:Concentration [Mental Process]
   748   C0220844:growth [Physiologic Function]
   748   C1446561:Concentration [Quantitative Concept]
   748   C1510411:Transforming [Pathologic Function]
   748   C1521761:Factor [Functional Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]

Phrase: "in cell supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "assayed by ELISA."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   841   C0014441:ELISA assay [Laboratory Procedure]
           ELISA
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.109: Error bars represent SEM of triplicate assays. 

Phrase: "Error bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "SEM of triplicate assays."
Processing 00000000.tx.110: In a, b, and c, acid activation of HuLatTGF- generated 1,970  109 pg/ml (mean  SEM) active TGF-.  

Phrase: "In a,"

Phrase: "b,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "c,"

Phrase: "acid activation of HuLatTGF-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "1,970  109 pg/ml (mean  SEM) active TGF-"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   816   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   816   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   801   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   801   C0439297:pg/mL [Quantitative Concept]
   788   C0018270:'growth' NOS [Organism Function]
   788   C0205177:Active [Functional Concept]
   788   C0220844:growth [Physiologic Function]
   788   C0439526:/mL [Quantitative Concept]
   788   C0444504:Mean [Quantitative Concept]
   788   C1266240:PG [Laboratory Procedure]
   788   C1510411:Transforming [Pathologic Function]
   788   C1521761:Factor [Functional Concept]
   788   C1621966:Growth [Organ or Tissue Function]
   788   C2347634:Mean [Quantitative Concept]
   788   C2348143:Mean [Quantitative Concept]
   788   C2827422:Factor [Conceptual Entity]
   788   C2827734:1+ [Quantitative Concept]
   788   C2911660:Growth [Activity]
   788   C2981698:1+ [Classification]

Phrase: "."
Processing 00000000.tx.111: LatTGF- was activated both by pRBCs and pRBC supernatant (Fig. 1 b), suggesting that the TGF-activating component of the parasite is released at schizont rupture. 

Phrase: "LatTGF-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0205275:Latent [Qualitative Concept]
   861   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "both by pRBCs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0014792:rbcs [Cell]
   770   C0238767:Both [Spatial Concept]
   770   C1706086:Both [Qualitative Concept]

Phrase: "and"

Phrase: "pRBC supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550101:Supernatant [Body Substance]

Phrase: "(Fig. 1 b"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "activating component of the parasite"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449432:Component [Manufactured Object]
   760   C1705248:Component [Conceptual Entity]

Phrase: "is"

Phrase: "released at schizont rupture."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0391871:Released [Functional Concept]
   770   C0562656:Schizont [Eukaryote]
   770   C1283071:Released [Functional Concept]
   770   C1881712:RUPTURE [Phenomenon or Process]
   770   C3203359:Rupture [Injury or Poisoning]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.112: The amount of bioactive TGF- liberated by pRBCs was shown to be similar in magnitude to that liberated by rHuTSP-1 (Fig. 1 c). 

Phrase: "The amount of bioactive TGF-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   814   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   814   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C1265611:Amount [Quantitative Concept]
   748   C1510411:Transforming [Pathologic Function]
   748   C1521761:Factor [Functional Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]

Phrase: "liberated by pRBCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0014792:rbcs [Cell]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "similar in magnitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "to that"

Phrase: "liberated by rHuTSP-1"

Phrase: "(Fig. 1 c)."
Processing 00000000.tx.113: Incubation of LatTGF- with rHuTSP-1 and pRBCs together released only slightly more bioactive TGF- than incubation with either activator alone, suggesting that the mechanisms of activation of LatTGF- by pRBCs and TSP might be similar. 

Phrase: "Incubation of LatTGF-"

Phrase: "with rHuTSP-1"

Phrase: "and"

Phrase: "pRBCs together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0014792:rbcs [Cell]

Phrase: "released"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0391871:Released [Functional Concept]
  1000   C1283071:Released [Functional Concept]
   966 E C0030685:Release [Health Care Activity]
   966 E C0439180:% release [Quantitative Concept]
   966 E C0680255:release [Health Care Activity]
   966 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "only slightly more bioactive TGF-"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   845   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   845   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0018270:'growth' NOS [Organism Function]
   795   C0205171:Only [Quantitative Concept]
   795   C0220844:growth [Physiologic Function]
   795   C0750482:Slightly [Idea or Concept]
   795   C1510411:Transforming [Pathologic Function]
   795   C1521761:Factor [Functional Concept]
   795   C1621966:Growth [Organ or Tissue Function]
   795   C1720467:Only [Intellectual Product]
   795   C2827422:Factor [Conceptual Entity]
   795   C2911660:Growth [Activity]

Phrase: "than incubation"

Phrase: "with either activator"

Phrase: "alone,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the mechanisms of activation of LatTGF-"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205275:Latent [Qualitative Concept]
   748   C0441712:Mechanisms [Functional Concept]
   748   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1879547:Activation [Activity]
   714 E C1706376:Mechanism [Manufactured Object]

Phrase: "by pRBCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014792:rbcs [Cell]

Phrase: "and"

Phrase: "TSP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "might"

Phrase: "be"

Phrase: "similar."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.114: Specific activation of LatTGF- was seen at parasite concentrations as low as 103104 pRBCs/ml (Fig. 1 b), which is three orders of magnitude lower than the parasite densities typically associated with the onset of human clinical malaria, indicating that the effect is seen at physiologically relevant parasite densities. 

Phrase: "Specific activation of LatTGF-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205275:Latent [Qualitative Concept]
   760   C0205369:Specific [Qualitative Concept]
   760   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1552740:specific [Intellectual Product]
   760   C1879547:Activation [Activity]

Phrase: "was"

Phrase: "seen at parasite concentrations"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0030498:Parasite [Eukaryote]
   770   C0086045:Concentrations [Mental Process]
   770   C0205397:Seen [Qualitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1446561:Concentration [Quantitative Concept]
   737 E C1947903:See [Activity]

Phrase: "as low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "as 103104 pRBCs/ml (Fig. 1 b"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "is"

Phrase: "three orders of magnitude"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   770   C3244315:orders [Intellectual Product]
   737 E C1705175:Order [Intellectual Product]
   737 E C1705176:Order [Qualitative Concept]
   737 E C1705177:Order [Classification]
   737 E C1705178:Order [Activity]
   737 E C1882348:Order [Qualitative Concept]

Phrase: "lower than the parasite densities typically"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0441994:Lower [Spatial Concept]
   753   C1548802:Lower [Body Location or Region]
   753   C2003888:Lower [Activity]

Phrase: "associated with the onset of human clinical malaria,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   744   C0024530:Malaria [Disease or Syndrome]
   744   C0086418:Human [Human]
   744   C0205210:Clinical [Qualitative Concept]
   744   C0332162:Onset [Qualitative Concept]
   744   C2984572:Malaria [Functional Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "indicating"

Phrase: "that"

Phrase: "the effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "seen at physiologically relevant parasite densities."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0030498:Parasite [Eukaryote]
   753   C0178587:densities [Quantitative Concept]
   753   C0205397:Seen [Qualitative Concept]
   753   C2347946:Relevant [Qualitative Concept]
   719 E C0042789:see [Organism Function]
   719 E C1947903:See [Activity]
Processing 00000000.tx.115: However, variation was observed between experiments in the amount of TGF- released by a given concentration of pRBCs (varying from 400 to 2,500 pg/ml from 106 pRBCs). 

Phrase: "However,"

Phrase: "variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:Variation [Qualitative Concept]

Phrase: "was"

Phrase: "observed between experiments"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0681814:Experiments [Research Activity]
   790   C1441672:Observed [Functional Concept]
   756 E C1706386:Experiment [Conceptual Entity]
   706 E C1517586:Experimental [Qualitative Concept]

Phrase: "in the amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1265611:Amount [Quantitative Concept]

Phrase: "of TGF-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C0332285:Of [Spatial Concept]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "released by a given concentration of pRBCs"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   744   C0014792:rbcs [Cell]
   744   C0086045:Concentration [Mental Process]
   744   C0391871:Released [Functional Concept]
   744   C1283071:Released [Functional Concept]
   744   C1446561:Concentration [Quantitative Concept]
   711 E C0030685:Release [Health Care Activity]
   711 E C0439180:% release [Quantitative Concept]
   711 E C0680255:release [Health Care Activity]
   711 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: "varying from 400"

Phrase: "to 2,500 pg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439297:pg/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "from 106 pRBCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0014792:rbcs [Cell]

Phrase: ")."
Processing 00000000.tx.116: We believe that this relates to the exact stage of maturity of the schizonts and the extent to which they undergo schizont rupture during the incubation period. 

Phrase: "We"

Phrase: "believe"

Phrase: "that"

Phrase: "this"

Phrase: "relates to the exact stage of maturity of the schizonts"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   739   C0163712:Relate [Organic Chemical]
   739   C0205390:Stage [Temporal Concept]
   739   C0449989:Maturity [Qualitative Concept]
   739   C0562656:Schizonts [Eukaryote]
   739   C0700597:Maturity [Temporal Concept]
   739   C1300072:Stage [Clinical Attribute]
   739   C1306673:Stage [Qualitative Concept]
   739   C2828393:Exact [Qualitative Concept]
   705   C0686886:Mature schizont [Eukaryote]

Phrase: "and"

Phrase: "the extent to which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439792:Extent [Spatial Concept]

Phrase: "they"

Phrase: "undergo"

Phrase: "schizont"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0562656:Schizont [Eukaryote]

Phrase: "rupture during the incubation period."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1320226:Incubation period [Finding]
   760   C0439531:/period [Temporal Concept]
   760   C1881712:RUPTURE [Phenomenon or Process]
   760   C1948053:Period [Temporal Concept]
   760   C3203359:Rupture [Injury or Poisoning]
Processing 00000000.tx.117: Other Plasmodium spp Also Possess TGF-activating Enzymes. 

Phrase: "Other Plasmodium spp Also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1424276:SPP [Gene or Genome]

Phrase: "Possess"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "activating Enzymes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]
Processing 00000000.tx.118: To determine whether TGF- activation was a unique feature of P. falciparum, or whether other Plasmodium spp might also be able to interact with host cytokines, we compared schizont sonicates of P. falciparum with similar preparations of two rodent malaria parasites, P. berghei NK65 and P. yoelii 17XL, for their ability to activate TGF- (Fig. 1 d). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "was"

Phrase: "a unique feature of P. falciparum,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1521970:Feature [Qualitative Concept]
   753   C1706388:Feature [Conceptual Entity]
   753   C2346469:Feature [Qualitative Concept]
   753   C2348519:Feature [Qualitative Concept]

Phrase: "or"

Phrase: "whether"

Phrase: "other Plasmodium spp"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424276:SPP [Gene or Genome]

Phrase: "might"

Phrase: "also"

Phrase: "be"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "interact with host cytokines,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1167395:Host [Organism]
   770   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "we"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "schizont"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0562656:Schizont [Eukaryote]

Phrase: "sonicates of P. falciparum"

Phrase: "with similar preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0455052:Preparation [Health Care Activity]
   827   C1521827:Preparation [Functional Concept]

Phrase: "of two rodent malaria parasites,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   825   C1271614:Malarial parasites [Eukaryote]
   812   C0030498:Parasites [Eukaryote]
   812   C0521066:Parasites. [Functional Concept]

Phrase: "P. berghei NK65"

Phrase: "and"

Phrase: "P. yoelii 17XL,"

Phrase: "for their ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "(Fig. 1 d"

Phrase: ")."
Processing 00000000.tx.119: uRBC sonicate had little or no activating effect. 

Phrase: "uRBC"

Phrase: "sonicate"

Phrase: "had"

Phrase: "little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "or"

Phrase: "no activating effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.120: Both P. berghei pRBC and P. yoelii pRBC sonicates showed very marked TGF-activating effects. 

Phrase: "Both P. berghei pRBC"

Phrase: "and"

Phrase: "P. yoelii pRBC sonicates"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "very"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442824:Very [Qualitative Concept]

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "activating effects."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.121: Levels of TGF- released by the murine parasites were significantly higher than those released by P. falciparum. 

Phrase: "Levels of TGF-"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "released by the murine parasites"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   760   C0026809:Murine [Mammal]
   760   C0030498:Parasites [Eukaryote]
   760   C0391871:Released [Functional Concept]
   760   C0521066:Parasites. [Functional Concept]
   760   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   760   C1283071:Released [Functional Concept]
   726 E C0030685:Release [Health Care Activity]
   726 E C0439180:% release [Quantitative Concept]
   726 E C0680255:release [Health Care Activity]
   726 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "significantly higher than those"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "released by P. falciparum."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0391871:Released [Functional Concept]
   770   C1283071:Released [Functional Concept]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.122: Anti-TSP Antibodies Partially Inhibit the TGF-activating Capacity of P. falciparum. 

Phrase: "Anti-TSP Antibodies Partially"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   875   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "Inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "activating Capacity of P. falciparum."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1516240:Capacity [Quantitative Concept]
Processing 00000000.tx.123: LatTGF- was incubated with 106 P. falciparum pRBCs, 106 uRBCs, or 50 ng/ml rHuTSP-1 in the presence or absence of a neutralizing antibody to human TSP-1 (Fig. 2) . Anti-TSP antibodies inhibited the activation of LatTGF- by both TSP-1 itself and by pRBCs (Fig. 2 a). 

Phrase: "LatTGF-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0205275:Latent [Qualitative Concept]
   861   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "incubated with 106 P. falciparum pRBCs,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0014792:rbcs [Cell]
   748   C1439852:Incubated [Laboratory Procedure]

Phrase: "106 uRBCs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0014792:rbcs [Cell]

Phrase: "or"

Phrase: "50 ng/ml rHuTSP-1 in the presence"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0439275:ng/mL [Quantitative Concept]
   767   C0964553:NG.1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C1334110:NG.1 [Gene or Genome]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C0439526:/mL [Quantitative Concept]

Phrase: "or"

Phrase: "absence of a neutralizing antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "to human TSP-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0147139:Thrombospondin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1336626:THROMBOSPONDIN I [Gene or Genome]
   827   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ") . Anti-TSP antibodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the activation of LatTGF-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205275:Latent [Qualitative Concept]
   760   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1879547:Activation [Activity]

Phrase: "by both TSP-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0147139:Thrombospondin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336626:THROMBOSPONDIN I [Gene or Genome]
   861   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "itself"

Phrase: "and by pRBCs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0014792:rbcs [Cell]
   770   C1515981:And [Idea or Concept]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "a"

Phrase: ")."
Processing 00000000.tx.124: The effects of anti-TSP antibody were dose dependent and at a concentration of 0.25 g/ml, the antiTSP-1 antibody inhibited the effects of pRBC by 70% in comparison to the uRBC control (Fig. 2 b). 

Phrase: "The effects of anti-TSP antibody"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "dose dependent"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1512045:Dose-dependent [Quantitative Concept]
   861   C0178602:Dose [Quantitative Concept]
   861   C0851827:Dependent [Qualitative Concept]
   861   C0869039:Dose [Quantitative Concept]
   861   C1114758:Dose # [Clinical Attribute]
   861   C1701901:Dependent [Qualitative Concept]
   861   C3244310:dependent [Functional Concept]

Phrase: "and at a concentration of 0.25 g/ml,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   764   C1300565:g/mL [Quantitative Concept]
   762 E C1637390:mL/g [Quantitative Concept]
   742   C0086045:Concentration [Mental Process]
   742   C0439267:g% [Quantitative Concept]
   742   C0439526:/mL [Quantitative Concept]
   742   C1446561:Concentration [Quantitative Concept]
   742   C1515981:And [Idea or Concept]

Phrase: "the antiTSP-1 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the effects of pRBC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "by 70%"

Phrase: "in comparison to the uRBC control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 2 b"

Phrase: ")."
Processing 00000000.tx.125: The control antibody did not inhibit TGF- activation. 

Phrase: "The control antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]
Processing 00000000.tx.126: These data suggest that the TGF-activating activity of pRBCs is mediated, in part, by a TSP-related protein that is recognized by anti-TSP antibodies. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "activating activity of pRBCs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: ","

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "by a TSP-related protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "is"

Phrase: "recognized by anti-TSP antibodies."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   797   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   781 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.127: View larger version (20K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.128: Antibodies to human TSP-1 inhibit TGF- activation by pRBCs. 

Phrase: "Antibodies to human TSP-1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "activation by pRBCs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]
Processing 00000000.tx.129: (a) HuLatTGF- was incubated for 2 h with 106/ml P. falciparum pRBCs or uRBCs, or 50 ng/ml TSP-1 in the presence or absence of 20 g/ml neutralizing antiTSP-1 antibody. 

Phrase: "(a) HuLatTGF-"

Phrase: "was"

Phrase: "incubated for 2 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0011744:h 2 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "with 106/ml P. falciparum pRBCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0014792:rbcs [Cell]

Phrase: "or"

Phrase: "uRBCs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014792:rbcs [Cell]

Phrase: "or"

Phrase: "50 ng/ml TSP-1 in the presence"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0147139:Thrombospondin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1336626:THROMBOSPONDIN I [Gene or Genome]
   767   C0964553:NG.1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C1334110:NG.1 [Gene or Genome]
   744   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "absence of 20 g/ml neutralizing antiTSP-1 antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0332197:absence [Quantitative Concept]
   742   C1689985:Absence [Anatomical Abnormality]
Processing 00000000.tx.130: (b) HuLatTGF- was incubated with 106/ml pRBCs or uRBCs in the presence of varying concentrations of neutralizing antiTSP-1 antibody or an isotype-matched control antibody. 

Phrase: "(b) HuLatTGF-"

Phrase: "was"

Phrase: "incubated with 106/ml pRBCs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0014792:rbcs [Cell]
   753   C0439526:/mL [Quantitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "or"

Phrase: "uRBCs in the presence of varying concentrations of neutralizing antiTSP-1 antibody"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   735   C0014792:rbcs [Cell]

Phrase: "or"

Phrase: "an isotype-matched control antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.131: The concentration of bioactive TGF- in cell supernatants was assayed by ELISA. 

Phrase: "The concentration of bioactive TGF-"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   814   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   814   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0086045:Concentration [Mental Process]
   748   C0220844:growth [Physiologic Function]
   748   C1446561:Concentration [Quantitative Concept]
   748   C1510411:Transforming [Pathologic Function]
   748   C1521761:Factor [Functional Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]

Phrase: "in cell supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "assayed by ELISA."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   841   C0014441:ELISA assay [Laboratory Procedure]
           ELISA
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.132: Error bars represent SEM of triplicate assays.  

Phrase: "Error bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "SEM of triplicate assays."
Processing 00000000.tx.133: TGF-activating Molecules of P. falciparum Show Functional Homology to TSP-1. 

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "activating Molecules of P. falciparum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0567416:molecules [Substance]

Phrase: "Show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "Functional Homology to TSP-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1334043:Homology [Gene or Genome]
   760   C2697616:Homology [Qualitative Concept]
Processing 00000000.tx.134: A number of P. falciparum molecules have been identified that share varying levels of homology with HuTSP-1. 

Phrase: "A number of P. falciparum molecules"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "that share varying levels of homology"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "with HuTSP-1."
Processing 00000000.tx.135: Of these, perhaps the best characterized is PfTRAP (28). 

Phrase: "Of these,"

Phrase: "perhaps"

Phrase: "the best characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1880022:Characterized [Activity]

Phrase: "is"

Phrase: "PfTRAP"

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.136: TRAP is expressed in preerythrocytic and erythrocytic stages of the parasite life cycle where it induces both cellular and humoral immune responses (29, 30). 

Phrase: "TRAP"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   812   C0001516:Adhesive [Manufactured Object]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0439849:Related [Qualitative Concept]
   812   C0445223:Related [Finding]
   812   C2982905:Adhesive [Manufactured Object]
   779 E C0163712:Relate [Organic Chemical]
   741 E C0080103:Relation [Family Group]
   741 E C0869014:Relations [Social Behavior]

Phrase: "is"

Phrase: "expressed in preerythrocytic"

Phrase: "and"

Phrase: "erythrocytic stages of the parasite life cycle where"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   793   C0023675:Life Cycle Stages [Temporal Concept]
   782   C0680083:stage of life [Temporal Concept]
           life stages
   744   C1306673:Stages [Qualitative Concept]
   711 E C0205390:Stage [Temporal Concept]
   711 E C1300072:Stage [Clinical Attribute]

Phrase: "it"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "both cellular"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0007634:Cellular [Cell]
  1000   C0178539:Cellular [Functional Concept]
   928 E C1516377:Cellularity [Qualitative Concept]

Phrase: "and"

Phrase: "humoral immune responses"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C1155229:Immune Responses, Humoral [Cell Function]
   983 E C0020967:Humoral Immune Response [Organism Function]
   901   C0301872:immune responses [Organ or Tissue Function]
   827   C0439662:Immune [Functional Concept]
   827   C0871261:responses [Organism Attribute]
   793 E C1704632:Response [Finding]
   793 E C1706817:Response [Intellectual Product]
   793 E C2911692:Response [Mental Process]

Phrase: "(29,"

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.137: PfTRAP shares several regions of homology with TSP-1, including the highly conserved WSPCSVTCG motif, a GXWXXW sequence in which the X's are conservative substitutions for the TGF-binding GGWSHW motif of TSP-1, and a module that facilitates binding to proteoglycans, which are powerful regulators of TGF- activity. 

Phrase: "PfTRAP"

Phrase: "shares"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "several regions of homology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0314644:Homology region [Genetic Function]
   737   C0017446:Region [Geographic Area]
   737   C0205147:Region [Spatial Concept]

Phrase: "with TSP-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0147139:Thrombospondin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336626:THROMBOSPONDIN I [Gene or Genome]
   861   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the highly conserved WSPCSVTCG motif,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1514562:Motif [Amino Acid Sequence]

Phrase: "a GXWXXW sequence in which"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]

Phrase: "the X's"

Phrase: "are"

Phrase: "conservative substitutions for the TGF-"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   814   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   814   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C1510411:Transforming [Pathologic Function]
   748   C1521761:Factor [Functional Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]
   714   C1555721:Substitution [Idea or Concept]
   714   C1706204:Substitution [Activity]

Phrase: "binding GGWSHW motif of TSP-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514562:Motif [Amino Acid Sequence]

Phrase: "and"

Phrase: "a module"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709061:Module [Conceptual Entity]
   900 E C1031041:Modulus [Eukaryote]

Phrase: "that"

Phrase: "facilitates"

Phrase: "binding to proteoglycans,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   841   C1621789:proteoglycan binding [Molecular Function]
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]

Phrase: "which"

Phrase: "are"

Phrase: "powerful regulators of TGF-"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   833   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1817513:growth regulator [Cell Function]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0182953:regulators [Medical Device]
   753   C0220844:growth [Physiologic Function]
   753   C1510411:Transforming [Pathologic Function]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]
   719 E C1704734:Regulator [Medical Device]
   719 E C1704735:Regulator [Conceptual Entity]

Phrase: "activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.138: Therefore, we wondered whether PfTRAP might mediate activation of LatTGF-. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "wondered"

Phrase: "whether"

Phrase: "PfTRAP"

Phrase: "might"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "activation of LatTGF-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "."
Processing 00000000.tx.139: LatTGF- was incubated with pRBCs or uRBCs in the presence or absence of varying concentrations of two different anti-TRAP antibodies or isotype-matched control antibodies. 

Phrase: "LatTGF-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0205275:Latent [Qualitative Concept]
   861   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "incubated with pRBCs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0014792:rbcs [Cell]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "or"

Phrase: "uRBCs in the presence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0014792:rbcs [Cell]

Phrase: "or"

Phrase: "absence of varying concentrations of two different anti-TRAP antibodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   735   C0332197:absence [Quantitative Concept]
   735   C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "isotype-matched control antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.140: The first, a sheep polyclonal IgG anti-TRAP1.5, was raised against the NH2-terminal half of the TRAP molecule, upstream of the TSP-like domain (31). 

Phrase: "The first,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "a sheep polyclonal IgG anti-TRAP1.5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0036945:Sheep [Mammal]
   799   C1123019:Sheep [Mammal]
   799   C1420952:TRAP1 [Gene or Genome]
   799   C1424583:TRAP-1 [Gene or Genome]

Phrase: "was"

Phrase: "raised against the NH2-terminal half"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0002508:NH2 [Organic Chemical]
   753   C0025033:NH2 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   753   C0205088:Terminal [Temporal Concept]
   753   C0442818:Raised [Quantitative Concept]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]
   753   C2825407:Half [Quantitative Concept]

Phrase: "of the TRAP molecule,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0567416:Molecule [Substance]
   733 E C1521991:Molecular [Qualitative Concept]

Phrase: "upstream of the TSP-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "like domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.141: The other, a murine IgG monoclonal antibody 19F7, recognizes an epitope in the extreme C terminus of the TRAP molecule (31). 

Phrase: "The"

Phrase: "other,"

Phrase: "a murine IgG monoclonal antibody 19F7,"

Phrase: "recognizes"

Phrase: "an epitope in the extreme C terminus of the TRAP molecule"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0003316:Epitope [Immunologic Factor]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.142: The polyclonal anti-TRAP1.5 inhibited pRBC-induced activation of TGF- by 60% at a concentration of 4 g/ml, whereas monoclonal antibody 19F7 completely inhibited TGF- activation at a similar concentration (Fig. 3 a). 

Phrase: "The polyclonal anti-TRAP1.5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1420952:TRAP1 [Gene or Genome]
   812   C1424583:TRAP-1 [Gene or Genome]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "pRBC-induced activation of TGF-"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   814   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   814   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C2249824:activation of growth [Organism Function]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0205263:Induced [Functional Concept]
   748   C0220844:growth [Physiologic Function]
   748   C1510411:Transforming [Pathologic Function]
   748   C1521761:Factor [Functional Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C1879547:Activation [Activity]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]

Phrase: "by 60%"

Phrase: "at a concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 4 g/ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1300565:g/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "whereas"

Phrase: "monoclonal antibody 19F7 completely"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "activation at a similar concentration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "a"

Phrase: ")."
Processing 00000000.tx.143: Neither the isotype-matched control antibodies nor an irrelevant malaria-specific monoclonal antibody (monoclonal antibody X509, which binds to P. falciparum merozoite surface protein 1; unpublished data) had any effect on TGF- activation. 

Phrase: "Neither"

Phrase: "the isotype-matched control antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "nor"

Phrase: "an irrelevant malaria-specific monoclonal antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C0443723:Malaria antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   853   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C0746619:monoclonal [Finding]

Phrase: "(monoclonal antibody X509,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "which"

Phrase: "binds to P. falciparum merozoite surface protein 1"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0169904:Merozoite Surface Protein 1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0025252:surface protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205148:Surface [Spatial Concept]
   744   C0444659:Merozoite [Eukaryote]
   744   C1145667:Bind [Activity]
   744   C1167622:bind [Molecular Function]

Phrase: "; unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")"

Phrase: "had"

Phrase: "any effect on TGF-"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   833   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1280500:Effect [Qualitative Concept]
   753   C1510411:Transforming [Pathologic Function]
   753   C1521761:Factor [Functional Concept]
   753   C1552551:Any [Qualitative Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2348382:Effect [Qualitative Concept]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]
   753   C3272371:ANY [Intellectual Product]

Phrase: "activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]
Processing 00000000.tx.144: View larger version (44K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(44K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.145: Plasmodium TRAP is involved in the activation of TGF- by pRBCs. 

Phrase: "Plasmodium TRAP"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   804   C0001516:Adhesive [Manufactured Object]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0439849:Related [Qualitative Concept]
   804   C0445223:Related [Finding]
   804   C2982905:Adhesive [Manufactured Object]
   771 E C0163712:Relate [Organic Chemical]
   733 E C0080103:Relation [Family Group]
   733 E C0869014:Relations [Social Behavior]

Phrase: "is"

Phrase: "involved in the activation of TGF-"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   800   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   800   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C2249824:activation of growth [Organism Function]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0220844:growth [Physiologic Function]
   744   C1314939:Involved [Functional Concept]
   744   C1510411:Transforming [Pathologic Function]
   744   C1521761:Factor [Functional Concept]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C1879547:Activation [Activity]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]

Phrase: "by pRBCs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014792:rbcs [Cell]
Processing 00000000.tx.146: (a) HuLatTGF- was incubated with 106/ml P. falciparum pRBCs or uRBCs in the presence of varying concentrations of anti-TRAP antibodies 1.5 and 19F7, or with isotype-matched control mouse (mIgG) or sheep (sIgG) antibodies. 

Phrase: "(a) HuLatTGF-"

Phrase: "was"

Phrase: "incubated with 106/ml P. falciparum pRBCs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0014792:rbcs [Cell]
   744   C0439526:/mL [Quantitative Concept]
   744   C1439852:Incubated [Laboratory Procedure]

Phrase: "or"

Phrase: "uRBCs in the presence of varying concentrations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0014792:rbcs [Cell]

Phrase: "of anti-TRAP antibodies 1.5"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   866   C1456376:thrombospondin-5 [Gene or Genome]
   854   C0147139:Thrombospondin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   854   C1336626:thrombospondin 1 [Gene or Genome]
   854   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   837 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   791   C0001516:Adhesive [Manufactured Object]
   791   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   791   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0332285:Of [Spatial Concept]
   791   C0439849:Related [Qualitative Concept]
   791   C0445223:Related [Finding]
   791   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   791   C2982905:Adhesive [Manufactured Object]
   758 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   758 E C0163712:Relate [Organic Chemical]

Phrase: "and"

Phrase: "19F7,"

Phrase: "or with isotype-matched control mouse"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   753   C0021017:Isotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C0150103:matched [Research Activity]
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1708943:Matched [Qualitative Concept]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "(mIgG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1332821:MIG [Gene or Genome]
  1000   C1707170:MIG [Gene or Genome]

Phrase: ")"

Phrase: "or"

Phrase: "sheep"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036945:Sheep [Mammal]
  1000   C1123019:Sheep [Mammal]

Phrase: "(sIgG"

Phrase: ")"

Phrase: "antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.147: (b) Synthetic peptides, at concentrations of 0.25.0 g/ml, were added to in vitro TGF- activation assays in the presence of PfSL at a concentration of 2 x 106 parasites/ml. 

Phrase: "(b) Synthetic peptides,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0070338:b peptides [Amino Acid, Peptide, or Protein]
   867   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   827   C1883254:synthetic [Activity]

Phrase: "at concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0086045:Concentrations [Mental Process]
   966 E C1446561:Concentration [Quantitative Concept]
   916 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 0.25.0 g/ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C1300565:g/mL [Quantitative Concept]
   804   C0439526:/mL [Quantitative Concept]

Phrase: "were"

Phrase: "added to in vitro TGF-"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   814   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   814   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0021135:In Vitro [Intellectual Product]
   778   C1533691:in vitro [Qualitative Concept]
           vitro
   778   C2827718:In Vitro [Functional Concept]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C1510411:Transforming [Pathologic Function]
   748   C1521761:Factor [Functional Concept]
   748   C1524062:Added [Functional Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]
   714 E C1883712:Add [Functional Concept]

Phrase: "activation assays in the presence of PfSL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   706   C0005507:Assay [Laboratory Procedure]
   706   C0243073:assay [Qualitative Concept]
   706   C1510438:Assay [Laboratory Procedure]

Phrase: "at a concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 2 x 106 parasites/ml."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.148: (c) Activation of LatTGF- was compared for Pb WT pRBCs (Pb WT) and for PbTRAP knockout (Pb TRAP ko). 

Phrase: "(c) Activation of LatTGF-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205275:Latent [Qualitative Concept]
   760   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1553033:[c] [Quantitative Concept]
   760   C1879547:Activation [Activity]

Phrase: "was"

Phrase: "compared for Pb WT pRBCs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0014792:rbcs [Cell]
   753   C1707455:Compared [Activity]
   753   C2700323:WT [Fish]

Phrase: "(Pb"

Phrase: "WT)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700323:WT [Fish]

Phrase: "and for PbTRAP knockout"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0560617:knock out [Injury or Poisoning]
   770   C1515981:And [Idea or Concept]
   770   C1522225:Knock-out [Experimental Model of Disease]

Phrase: "(Pb TRAP ko"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0560617:knock out [Injury or Poisoning]
   861   C1522225:Knock-out [Experimental Model of Disease]

Phrase: ")."
Processing 00000000.tx.149: (d) Outbred CD1 mice (n = 6 per group) were infected with either wild-type or TRAP knockout P. berghei pRBCs (104 pRBCs per mouse) on day 0 and parasitemia was monitored by microscopy. 

Phrase: "("

Phrase: "d)"

Phrase: "Outbred CD1 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(n = 6 per group"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   819   C0441848:Group N [Intellectual Product]
   770   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441833:Group [Idea or Concept]
   770   C0441922:N+ [Intellectual Product]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1553036:[n] [Quantitative Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: ")"

Phrase: "were"

Phrase: "infected with either wild-type"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0439663:Infected [Functional Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "TRAP knockout P. berghei pRBCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0014792:rbcs [Cell]

Phrase: "(104 pRBCs per mouse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0014792:rbcs [Cell]

Phrase: ")"

Phrase: "on day 0"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "and"

Phrase: "parasitemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242723:Parasitemia [Disease or Syndrome]

Phrase: "was"

Phrase: "monitored by microscopy."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0026018:Microscopy [Laboratory Procedure]
   756   C0030695:monitor [Health Care Activity]
   756   C0150369:monitor [Health Care Activity]
   756   C0181904:Monitor [Medical Device]
   756   C0596972:Monitor [Medical Device]
   756   C1521743:Monitor [Professional or Occupational Group]
   756   C1704646:Monitor [Manufactured Object]
   718 E C0205288:Microscopic [Qualitative Concept]
Processing 00000000.tx.150: Mice were humanely killed when parasitemia reached 80%. 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "humanely"

Phrase: "killed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:killed [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]

Phrase: "when"

Phrase: "parasitemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242723:Parasitemia [Disease or Syndrome]

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "80%."
Processing 00000000.tx.151: , P. berghei wild-type; 

Phrase: ", P. berghei"

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.152: , Pb TRAP ko (five mice); 

Phrase: ", Pb TRAP ko"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0560617:knock out [Injury or Poisoning]
   861   C1522225:Knock-out [Experimental Model of Disease]

Phrase: "(five mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.153: , Pb TRAP ko (one mouse). 

Phrase: ", Pb TRAP ko"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0560617:knock out [Injury or Poisoning]
   861   C1522225:Knock-out [Experimental Model of Disease]

Phrase: "(one mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]

Phrase: ")."
Processing 00000000.tx.154: Infections in all mice became patent on day 3 after inoculation. 

Phrase: "Infections in all mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0009450:Infections [Disease or Syndrome]

Phrase: "became"

Phrase: "patent on day 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030650:patent [Intellectual Product]
   770   C0175566:Patent [Spatial Concept]

Phrase: "after inoculation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042196:Inoculation [Therapeutic or Preventive Procedure]
  1000   C2987620:Inoculation [Therapeutic or Preventive Procedure]
Processing 00000000.tx.155: The concentration of bioactive TGF- in cell supernatants was assayed by ELISA. 

Phrase: "The concentration of bioactive TGF-"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   814   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   814   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0086045:Concentration [Mental Process]
   748   C0220844:growth [Physiologic Function]
   748   C1446561:Concentration [Quantitative Concept]
   748   C1510411:Transforming [Pathologic Function]
   748   C1521761:Factor [Functional Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]

Phrase: "in cell supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "assayed by ELISA."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   841   C0014441:ELISA assay [Laboratory Procedure]
           ELISA
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.156: Error bars represent SEM of triplicate assays. 

Phrase: "Error bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "SEM of triplicate assays."
Processing 00000000.tx.157: Acid activation of HuLatTGF- generated 2,040  120 pg/ml (mean  SEM) active TGF-.  

Phrase: "Acid activation of HuLatTGF-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "2,040  120 pg/ml (mean  SEM) active TGF-"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   816   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   816   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   801   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   801   C0439297:pg/mL [Quantitative Concept]
   788   C0018270:'growth' NOS [Organism Function]
   788   C0205177:Active [Functional Concept]
   788   C0220844:growth [Physiologic Function]
   788   C0439526:/mL [Quantitative Concept]
   788   C0444504:Mean [Quantitative Concept]
   788   C0740116:+2 [Quantitative Concept]
   788   C1266240:PG [Laboratory Procedure]
   788   C1510411:Transforming [Pathologic Function]
   788   C1521761:Factor [Functional Concept]
   788   C1621966:Growth [Organ or Tissue Function]
   788   C2347634:Mean [Quantitative Concept]
   788   C2348143:Mean [Quantitative Concept]
   788   C2827422:Factor [Conceptual Entity]
   788   C2827735:2+ [Quantitative Concept]
   788   C2911660:Growth [Activity]
   788   C2981700:2+ [Classification]

Phrase: "."
Processing 00000000.tx.158: The inhibition of pRBC-mediated activation of LatTGF- by antibodies to both human TSP-1 (Fig. 2) and PfTRAP (Fig. 3 a) indicated that PfTRAP might be a functional homologue of TSP-1 with respect to TGF- activation. 

Phrase: "The inhibition of pRBC-mediated activation of LatTGF-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   762   C0870784:latent inhibition [Mental Process]
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0086597:mediated [Social Behavior]
   742   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   742   C0205275:Latent [Qualitative Concept]
   742   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C1879547:Activation [Activity]
   742   C3463820:Inhibition [Activity]

Phrase: "by antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "to both human TSP-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0147139:Thrombospondin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1336626:THROMBOSPONDIN I [Gene or Genome]
   827   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "and"

Phrase: "PfTRAP"

Phrase: "(Fig. 3 a)"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that PfTRAP"

Phrase: "might"

Phrase: "be"

Phrase: "a functional homologue of TSP-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1334043:Homologue [Gene or Genome]

Phrase: "with respect to TGF-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   861   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0220844:growth [Physiologic Function]
   799   C0679133:respect [Social Behavior]
   799   C1510411:Transforming [Pathologic Function]
   799   C1521761:Factor [Functional Concept]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]

Phrase: "activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]
Processing 00000000.tx.159: Both PfTRAP and PbTRAP contain sequences with homology to the GGWSHW TGF-binding domain of TSP-1. 

Phrase: "Both PfTRAP"

Phrase: "and"

Phrase: "PbTRAP"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "sequences with homology"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
   841   C0162775:Sequence Homology [Quantitative Concept]
   791 E C0162774:Sequence Homolog [Molecular Sequence]
   790   C0162326:Sequences [Nucleotide Sequence]
   756 E C0004793:Sequence [Nucleotide Sequence]
   756 E C0162327:Sequence [Nucleotide Sequence]
   756 E C1519249:Sequence [Functional Concept]
   706 E C1548958:Sequential [Idea or Concept]
   706 E C1705294:Sequential [Qualitative Concept]

Phrase: "to the GGWSHW TGF-"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   861   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0220844:growth [Physiologic Function]
   799   C0967657:GGWSHW [Amino Acid, Peptide, or Protein]
   799   C1510411:Transforming [Pathologic Function]
   799   C1521761:Factor [Functional Concept]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C1883351:To [Qualitative Concept]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]

Phrase: "binding domain of TSP-1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.160: The PfTRAP sequence is GVWDEW and the PbTRAP sequence is GKWEEW. 

Phrase: "The PfTRAP sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "is"

Phrase: "GVWDEW"

Phrase: "and"

Phrase: "the PbTRAP sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "is"

Phrase: "GKWEEW."
Processing 00000000.tx.161: Therefore, we tested the ability of synthetic peptides representing these sequences to activate LatTGF- in vitro. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the ability of synthetic peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "these sequences to"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "LatTGF-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0205275:Latent [Qualitative Concept]
   861   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.162: HPLC-purified and dialyzed peptides were diluted in PBS plus 0.5% BSA and added to LatTGF- at concentrations from 0.2 to 5.0 g/ml in the presence or absence of pRBC. 

Phrase: "HPLC-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008562:HPLC [Laboratory Procedure]

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "and"

Phrase: "dialyzed"

Phrase: "peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "diluted in PBS plus 0.5% BSA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0444499:0/5 [Quantitative Concept]
   748   C0332287:Plus [Qualitative Concept]
   748   C1720830:PBS [Disease or Syndrome]
   748   C1823521:PBS [Gene or Genome]
   714   C1720119:Dilute [Functional Concept]
   714   C1948037:Dilute [Functional Concept]

Phrase: "and"

Phrase: "added to LatTGF-"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0205275:Latent [Qualitative Concept]
   770   C1524062:Added [Functional Concept]
   770   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737 E C1883712:Add [Functional Concept]

Phrase: "at concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0086045:Concentrations [Mental Process]
   966 E C1446561:Concentration [Quantitative Concept]
   916 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "from 0.2"

Phrase: "to 5.0 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1300565:g/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of pRBC."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]
Processing 00000000.tx.163: In the absence of PfSL, none of the peptides showed any significant TGF-activating capacity (not depicted). 

Phrase: "In the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of PfSL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1881488:Lysate [Physical Object]

Phrase: "none of the peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   770   C0456148:None [Quantitative Concept]
   770   C0549184:None [Quantitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "any significant TGF-"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   884   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C0237881:significant [Quantitative Concept]
   804   C0750502:Significant [Idea or Concept]
   804   C1510411:Transforming [Pathologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1546944:Significant [Qualitative Concept]
   804   C1552551:Any [Qualitative Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   804   C3272371:ANY [Intellectual Product]

Phrase: "activating capacity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516240:Capacity [Quantitative Concept]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "depicted"

Phrase: ")."
Processing 00000000.tx.164: However, the PfTRAP-2 and PbTRAP peptides were able to inhibit PfSL-mediated activation of LatTGF- in a dose-dependent manner. 

Phrase: "However,"

Phrase: "the PfTRAP-2"

Phrase: "and"

Phrase: "PbTRAP peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "PfSL-mediated activation of LatTGF-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0858318:p falciparum [Disease or Syndrome]
   742   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0086597:mediated [Social Behavior]
   742   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   742   C0205275:Latent [Qualitative Concept]
   742   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0562656:Schizont [Eukaryote]
   742   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1879547:Activation [Activity]
   742   C1881488:Lysate [Physical Object]
   742   C2603361:P' [Clinical Attribute]

Phrase: "in a dose-dependent manner."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1512045:Dose-dependent [Quantitative Concept]
Processing 00000000.tx.165: The longer PfTRAP-1 peptide also inhibited TGF- activation but the effect was not dose dependent at the range of concentrations tested (Fig. 3 b). 

Phrase: "The longer PfTRAP-1 peptide also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "but"

Phrase: "the effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "not dose dependent at the range of concentrations"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C1512045:Dose-dependent [Quantitative Concept]
   744   C0178602:Dose [Quantitative Concept]
   744   C0851827:Dependent [Qualitative Concept]
   744   C0869039:Dose [Quantitative Concept]
   744   C1114758:Dose # [Clinical Attribute]
   744   C1701901:Dependent [Qualitative Concept]
   744   C3244310:dependent [Functional Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "(Fig. 3 b"

Phrase: ")."
Processing 00000000.tx.166: A control preparation, comprising the flow through from the HPLC column, had no effect on PfSL-mediated TGF- activation (not depicted). 

Phrase: "A control preparation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0455052:Preparation [Health Care Activity]
   861   C1521827:Preparation [Functional Concept]

Phrase: "comprising"

Phrase: "the flow through from the HPLC column,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0806140:Flow [Natural Phenomenon or Process]

Phrase: "had"

Phrase: "no effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "on PfSL-mediated TGF-"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   827   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   807   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0018270:'growth' NOS [Organism Function]
   791   C0086597:mediated [Social Behavior]
   791   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   791   C0220844:growth [Physiologic Function]
   791   C0562656:Schizont [Eukaryote]
   791   C1510411:Transforming [Pathologic Function]
   791   C1521761:Factor [Functional Concept]
   791   C1621966:Growth [Organ or Tissue Function]
   791   C1720176:On [Functional Concept]
   791   C1720294:On [Intellectual Product]
   791   C1881488:Lysate [Physical Object]
   791   C2827422:Factor [Conceptual Entity]
   791   C2911660:Growth [Activity]

Phrase: "activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "depicted"

Phrase: ")."
Processing 00000000.tx.167: These data suggest that the synthetic peptides are able to bind to relevant sequences in LatTGF- and, although not able to directly activate it, may block the access of PfSL-derived molecules, strongly supporting the notion that TGF- activation by PfSL is mediated by TSP-like molecules. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the synthetic peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C1883254:synthetic [Activity]

Phrase: "are"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "bind to relevant sequences"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0162326:Sequences [Nucleotide Sequence]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
   770   C2347946:Relevant [Qualitative Concept]
   737 E C0004793:Sequence [Nucleotide Sequence]
   737 E C0162327:Sequence [Nucleotide Sequence]
   737 E C1519249:Sequence [Functional Concept]

Phrase: "in LatTGF-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0150312:In [Quantitative Concept]
   827   C0205275:Latent [Qualitative Concept]
   827   C0332285:In [Spatial Concept]
   827   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: ","

Phrase: "although"

Phrase: "not able to directly"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0085732:Able [Organism Attribute]
   812   C1299581:Able [Finding]
   812   C1518422:Not [Functional Concept]
   812   C1947931:Directly [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "it,"

Phrase: "may"

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the access of PfSL-derived molecules,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0444454:Access [Spatial Concept]
   742   C1554204:access [Idea or Concept]

Phrase: "strongly"

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "the notion"

Phrase: "that TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "activation by PfSL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "mediated by TSP-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "like molecules."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:molecules [Substance]
   916 E C1521991:Molecular [Qualitative Concept]
Processing 00000000.tx.168: As a final confirmation that TRAP mediates in vitro activation of LatTGF-, we compared the ability of Pb WT and TRAP-deficient P. berghei (Pb TRAP ko) to activate TGF- (Fig. 3 c). 

Phrase: "As a final confirmation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0521091:confirmation [Qualitative Concept]
   861   C0750484:Confirmation [Idea or Concept]

Phrase: "that TRAP"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   812   C0001516:Adhesive [Manufactured Object]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0439849:Related [Qualitative Concept]
   812   C0445223:Related [Finding]
   812   C2982905:Adhesive [Manufactured Object]
   779 E C0163712:Relate [Organic Chemical]
   741 E C0080103:Relation [Family Group]
   741 E C0869014:Relations [Social Behavior]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "in vitro activation of LatTGF-"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0021135:In Vitro [Intellectual Product]
   790   C1533691:in vitro [Qualitative Concept]
           vitro
   790   C2827718:In Vitro [Functional Concept]
   753   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205275:Latent [Qualitative Concept]
   753   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1879547:Activation [Activity]

Phrase: ","

Phrase: "we"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "the ability of Pb WT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "and"

Phrase: "TRAP-deficient P. berghei"

Phrase: "(Pb TRAP ko"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0560617:knock out [Injury or Poisoning]
   861   C1522225:Knock-out [Experimental Model of Disease]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "(Fig. 3 c)."
Processing 00000000.tx.169: Pb WT pRBCs very efficiently activated LatTGF-, as seen previously, whereas activation was markedly lower for Pb TRAP ko pRBC. 

Phrase: "Pb WT pRBCs very efficiently"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0014792:rbcs [Cell]
   799   C0442824:Very [Qualitative Concept]
   799   C2700323:WT [Fish]

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "LatTGF-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0205275:Latent [Qualitative Concept]
   861   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ","

Phrase: "as"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "previously,"

Phrase: "whereas"

Phrase: "activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "was"

Phrase: "markedly lower for Pb TRAP ko pRBC."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0441994:Lower [Spatial Concept]
   753   C1548802:Lower [Body Location or Region]
   753   C2003888:Lower [Activity]
Processing 00000000.tx.170: Similar results were obtained for pRBC lysates (not shown here but apparent in Fig. 5 d). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained for pRBC lysates"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]
   737   C1881488:Lysate [Physical Object]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "here"

Phrase: "but"

Phrase: "apparent in Fig. 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0750489:apparent [Idea or Concept]

Phrase: "d)."
Processing 00000000.tx.171: As we have recently shown (17) that rapid induction of bioactive TGF- very early in a blood stage malaria infection suppresses production of the protective cytokine IFN- and leads to a highly virulent infection, we considered that the failure of Pb TRAP ko parasites to activate TGF- might lead to an attenuated phenotype in vivo. 

Phrase: "As"

Phrase: "we"

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "(17"

Phrase: ")"

Phrase: "that rapid induction of bioactive TGF-"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   800   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   800   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0205263:Induction [Functional Concept]
   744   C0220844:growth [Physiologic Function]
   744   C0439831:Rapid [Qualitative Concept]
   744   C0857127:induction [Therapeutic or Preventive Procedure]
   744   C1510411:Transforming [Pathologic Function]
   744   C1521761:Factor [Functional Concept]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]

Phrase: "very early in a blood stage malaria infection"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   767   C1517886:Early Stage [Classification]
   767   C2363430:Early stage [Temporal Concept]
   744   C0005767:Blood [Tissue]
   744   C0005768:blood [Body Substance]
   744   C0009450:Infection, NOS [Disease or Syndrome]
   744   C0024530:Malaria [Disease or Syndrome]
   744   C0205390:Stage [Temporal Concept]
   744   C0229664:Blood [Body Substance]
   744   C0442824:Very [Qualitative Concept]
   744   C1279919:Early [Temporal Concept]
   744   C1300072:Stage [Clinical Attribute]
   744   C1306673:Stage [Qualitative Concept]
   744   C2984572:Malaria [Functional Concept]

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "production of the protective cytokine IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1327413:cytokine production [Organism Function]
   753   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "leads to a highly virulent infection,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0009450:Infection, NOS [Disease or Syndrome]
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0181586:leads [Medical Device]
   753   C0205250:Highly [Qualitative Concept]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1520022:Virulent [Qualitative Concept]
   753   C1522538:Lead [Functional Concept]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "we"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "that"

Phrase: "the failure of Pb TRAP ko parasites to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0231174:Failure [Functional Concept]
   748   C0680095:failure [Individual Behavior]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "might"

Phrase: "lead to an attenuated phenotype"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0031437:Phenotype [Organism Attribute]
   760   C0332161:Attenuated [Qualitative Concept]
   760   C0599946:Attenuated [Activity]
   760   C1285572:Phenotype [Laboratory Procedure]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.172: Infections with Pb WT and Pb TRAP ko parasites were compared in outbred (CD1) and inbred (C57/Bl6) mice. 

Phrase: "Infections with Pb WT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0009450:Infections [Disease or Syndrome]

Phrase: "and"

Phrase: "Pb TRAP ko parasites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030498:Parasites [Eukaryote]
   827   C0521066:Parasites. [Functional Concept]

Phrase: "were"

Phrase: "compared in outbred"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "(CD1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1413207:CD1 [Gene or Genome]
  1000   C3273701:CD1 [Gene or Genome]
  1000   C3541222:CD1 [Laboratory Procedure]

Phrase: ")"

Phrase: "and"

Phrase: "inbred"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512692:Inbred [Organism]

Phrase: "(C57/Bl6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450600:BL6 [Body Location or Region]

Phrase: ")"

Phrase: "mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.173: Although the inherent growth capacity of both wild-type and knockout lines was similar, as evidenced by the time from inoculation to patency and the exponential growth of both lines in the 3 d before death, PbTRAP ko infections were markedly attenuated in comparison to Pb WT infections with parasitemia being kept under control for the first 10 d after infection. 

Phrase: "Although"

Phrase: "the inherent growth capacity of both wild-type"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1516240:Capacity [Quantitative Concept]

Phrase: "and"

Phrase: "knockout lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "was"

Phrase: "similar,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348205:Similar [Qualitative Concept]

Phrase: "as"

Phrase: "evidenced by the time"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0040223:Time [Temporal Concept]
   770   C3541383:Time [Temporal Concept]
   737   C0332120:Evidence [Functional Concept]
   715 E C0442043:Temporal [Spatial Concept]
   715 E C2362314:Temporal [Temporal Concept]

Phrase: "from inoculation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042196:Inoculation [Therapeutic or Preventive Procedure]
  1000   C2987620:Inoculation [Therapeutic or Preventive Procedure]

Phrase: "to patency"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0175566:Patency [Spatial Concept]
   928 E C0030650:patent [Intellectual Product]

Phrase: "and"

Phrase: "the exponential growth of both lines"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2911660:Growth [Activity]

Phrase: "in the 3 d"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0450363:3-D [Spatial Concept]
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "before death,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]

Phrase: "PbTRAP ko infections"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0009450:Infections [Disease or Syndrome]
   743 E C0439663:Infected [Functional Concept]
   711 E C0030657:infectivity [Qualitative Concept]

Phrase: "were"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "attenuated in comparison to Pb WT infections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0009450:Infections [Disease or Syndrome]
   748   C0332161:Attenuated [Qualitative Concept]
   748   C0599946:Attenuated [Activity]
   748   C1707455:Comparison [Activity]
   748   C2700323:WT [Fish]

Phrase: "with parasitemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242723:Parasitemia [Disease or Syndrome]

Phrase: "being"

Phrase: "kept under control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
   756   C0333118:Keep [Functional Concept]

Phrase: "for the first 10 d"

Phrase: "after infection."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0009450:Infection, NOS [Disease or Syndrome]
   928 E C0439663:Infected [Functional Concept]
   888 E C0030657:infectivity [Qualitative Concept]
Processing 00000000.tx.174: Identical infection patterns were observed for CD1 mice (Fig. 3 d) and C57/BL6 mice (not depicted) and were reproducible over a number of passages. 

Phrase: "Identical infection patterns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449774:Patterns [Spatial Concept]

Phrase: "were"

Phrase: "observed for CD1 mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C1413207:CD1 [Gene or Genome]
   770   C1441672:Observed [Functional Concept]
   770   C3273701:CD1 [Gene or Genome]
   770   C3541222:CD1 [Laboratory Procedure]

Phrase: "(Fig. 3 d"

Phrase: ")"

Phrase: "and"

Phrase: "C57/BL6 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "depicted"

Phrase: ")"

Phrase: "and"

Phrase: "were"

Phrase: "reproducible over a number of passages."
Processing 00000000.tx.175: P. falciparum Proteases Also Activate Human TGF-. 

Phrase: "P. falciparum Proteases Also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C1947941:Proteases [Enzyme]

Phrase: "Activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "Human TGF-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0086418:Human [Human]
   812   C0220844:growth [Physiologic Function]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "."
Processing 00000000.tx.176: As TGF- can also be activated by host proteases (18), we used the TGF- activation assay to determine whether parasite proteases were involved in activation of LatTGF-. 

Phrase: "As"

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "can"

Phrase: "also"

Phrase: "be"

Phrase: "activated by host proteases"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C1167395:Host [Organism]
   770   C1879547:Activated [Activity]
   770   C1947941:Proteases [Enzyme]
   737 E C1515877:Activate [Functional Concept]

Phrase: "(18"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "parasite proteases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Proteases [Enzyme]

Phrase: "were"

Phrase: "involved in activation of LatTGF-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205275:Latent [Qualitative Concept]
   753   C1314939:Involved [Functional Concept]
   753   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1879547:Activation [Activity]

Phrase: "."
Processing 00000000.tx.177: After screening at various concentrations, a selection of protease inhibitors were compared at a single (optimal) concentration for their ability to inhibit the activation of rLatTGF- by P. falciparum pRBCs (Fig. 4 a). 

Phrase: "After screening"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0220908:Screening [Health Care Activity]
  1000   C0220909:screening [Functional Concept]
  1000   C1698960:screening [Intellectual Product]
  1000   C1710031:Screening [Diagnostic Procedure]
  1000   C1710477:SCREENING [Research Activity]

Phrase: "at various concentrations,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "a selection of protease inhibitors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036576:selection [Genetic Function]

Phrase: "were"

Phrase: "compared at a single"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0037179:Single [Population Group]
   770   C0087136:single [Finding]
   770   C0205171:Single [Quantitative Concept]
   770   C1707455:Compared [Activity]

Phrase: "(optimal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2698651:Optimal [Qualitative Concept]

Phrase: ")"

Phrase: "concentration for their ability to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0424098:Concentration ability [Finding]
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the activation of rLatTGF-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0086418:Human [Human]
   748   C0205275:Latent [Qualitative Concept]
   748   C1514798:recombinant [Organism]
   748   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1879547:Activation [Activity]

Phrase: "by P. falciparum pRBCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0014792:rbcs [Cell]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "a"

Phrase: ")."
Processing 00000000.tx.178: In all cases, pRBCs alone induced bioactive TGF- levels of >1,000 pg/ml, whereas the uRBCs did not increase TGF- levels above the medium control. 

Phrase: "In all cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "pRBCs alone induced bioactive TGF-"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   835   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   835   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0014792:rbcs [Cell]
   793   C0018270:'growth' NOS [Organism Function]
   793   C0205171:Alone [Quantitative Concept]
   793   C0205263:Induced [Functional Concept]
   793   C0220844:growth [Physiologic Function]
   793   C0439044:alone [Finding]
   793   C0679994:alone [Group Attribute]
   793   C1510411:Transforming [Pathologic Function]
   793   C1521761:Factor [Functional Concept]
   793   C1621966:Growth [Organ or Tissue Function]
   793   C2827422:Factor [Conceptual Entity]
   793   C2911660:Growth [Activity]

Phrase: "levels of >1,000 pg/ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439297:pg/mL [Quantitative Concept]
   799   C0439526:/mL [Quantitative Concept]

Phrase: "whereas"

Phrase: "the uRBCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014792:rbcs [Cell]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "levels above the medium control."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.179: In the absence of pRBCs none of the inhibitors had any effect on TGF- activation. 

Phrase: "In the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of pRBCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014792:rbcs [Cell]

Phrase: "none of the inhibitors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0243077:inhibitors [Chemical Viewed Functionally]
   770   C0456148:None [Quantitative Concept]
   770   C0549184:None [Quantitative Concept]
   737 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "had"

Phrase: "any effect on TGF-"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   833   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1280500:Effect [Qualitative Concept]
   753   C1510411:Transforming [Pathologic Function]
   753   C1521761:Factor [Functional Concept]
   753   C1552551:Any [Qualitative Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2348382:Effect [Qualitative Concept]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]
   753   C3272371:ANY [Intellectual Product]

Phrase: "activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]
Processing 00000000.tx.180: Two of the enzyme inhibitors, E-64, a cysteine protease inhibitor, and the calpain inhibitor, had no effect on TGF- activation by pRBCs. 

Phrase: "Two of the enzyme inhibitors,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205448:Two [Quantitative Concept]

Phrase: "E-64,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0058882:E 64 [Organic Chemical,Pharmacologic Substance]

Phrase: "a cysteine protease inhibitor,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0033607:Protease Inhibitor [Biologically Active Substance,Pharmacologic Substance]
   901   C0758959:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0769345:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   901   C2717970:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   901   C3536890:Protease Inhibitor [Pharmacologic Substance]
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C1947941:Protease [Enzyme]
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "the calpain inhibitor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054533:calpain inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "had"

Phrase: "no effect on TGF-"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   833   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1301751:No effect [Qualitative Concept]
   783   C0445119:No growth [Finding]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1280500:Effect [Qualitative Concept]
   753   C1298908:no [Idea or Concept]
   753   C1510411:Transforming [Pathologic Function]
   753   C1521761:Factor [Functional Concept]
   753   C1549444:No [Idea or Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2348382:Effect [Qualitative Concept]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]

Phrase: "activation by pRBCs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]
Processing 00000000.tx.181: Benzamidine and APMSF, both serine protease inhibitors, partially inhibited pRBC-induced TGF- activation (by 50 and 35%, respectively). 

Phrase: "Benzamidine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0053140:benzamidine [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "APMSF,"

Phrase: "both serine protease inhibitors,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0036733:Serine Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   901   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   901   C0036734:serine protease [Amino Acid, Peptide, or Protein,Enzyme]
   901   C2717971:Serine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   867 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   827   C1947941:Protease [Enzyme]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "partially"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "pRBC-induced TGF-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   884   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0205263:Induced [Functional Concept]
   804   C0220844:growth [Physiologic Function]
   804   C1510411:Transforming [Pathologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]

Phrase: "activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "("

Phrase: "by 50"

Phrase: "and"

Phrase: "35%,"

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.182: However, TGF- activation was completely or partially blocked by o-phenanthroline, phosphoramidon, EDTA, and bestatin, all of which are MMP inhibitors. 

Phrase: "However,"

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "or"

Phrase: "partially"

Phrase: "blocked by o-phenanthroline,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0028778:Blocked [Pathologic Function]
   770   C0031370:phenanthroline [Organic Chemical]
   770   C0332206:Blocked [Functional Concept]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "phosphoramidon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "bestatin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0053355:bestatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "all of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0444868:All [Quantitative Concept]
   790   C3539085:All [Idea or Concept]

Phrase: "are"

Phrase: "MMP inhibitors."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1513016:MMP Inhibitors [Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.183: Apstatin, a membrane aminopeptidase inhibitor, also completely blocked TGF- activation by pRBC. 

Phrase: "Apstatin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0384979:apstatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "a membrane aminopeptidase inhibitor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: "also completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205197:Completely [Qualitative Concept]

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "activation by pRBC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]
Processing 00000000.tx.184: View larger version (37K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(37K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.185: P. falciparum proteases activate LatTGF- in vitro. 

Phrase: "P. falciparum proteases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C1947941:Proteases [Enzyme]
   734   C0858318:p falciparum [Disease or Syndrome]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "LatTGF-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0205275:Latent [Qualitative Concept]
   861   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.186: HuLatTGF- was incubated with PfSL (equivalent to 106 pRBCs/ml) in the presence or absence of protease inhibitors. 

Phrase: "HuLatTGF-"

Phrase: "was"

Phrase: "incubated with PfSL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0562656:Schizont [Eukaryote]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1881488:Lysate [Physical Object]

Phrase: "(equivalent to 106 pRBCs/ml)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205163:Equivalent [Qualitative Concept]
   753   C0439185:equivalent [Quantitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of protease inhibitors."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]
Processing 00000000.tx.187: The concentration of bioactive TGF- in cell supernatants was assayed by ELISA. 

Phrase: "The concentration of bioactive TGF-"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   814   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   814   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0086045:Concentration [Mental Process]
   748   C0220844:growth [Physiologic Function]
   748   C1446561:Concentration [Quantitative Concept]
   748   C1510411:Transforming [Pathologic Function]
   748   C1521761:Factor [Functional Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]

Phrase: "in cell supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "assayed by ELISA."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   841   C0014441:ELISA assay [Laboratory Procedure]
           ELISA
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.188: Error bars represent SEM of triplicate assays. 

Phrase: "Error bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "SEM of triplicate assays."
Processing 00000000.tx.189: (a) Protease inhibitors were tested at a single concentration: 2 mM benzamidine, 1 M E-64, 5 M o-phenanthroline, 5 M apstatin, 1 M calpain inhibitor, 5 M phosphoramidon, 5 M bestatin, 20 M APMSF, and 2.5 mM EDTA. 

Phrase: "(a) Protease inhibitors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   867 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   827   C1947941:Protease [Enzyme]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "were"

Phrase: "tested at a single concentration"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0037179:Single [Population Group]
   760   C0086045:Concentration [Mental Process]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]
   760   C0392366:tested [Intellectual Product]
   760   C1446561:Concentration [Quantitative Concept]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]

Phrase: ":"

Phrase: "2 mM benzamidine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0053140:benzamidine [Organic Chemical,Pharmacologic Substance]

Phrase: "1 M E-64,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "5 M o-phenanthroline,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0031370:phenanthroline [Organic Chemical]

Phrase: "5 M apstatin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0384979:apstatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "1 M calpain inhibitor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054533:calpain inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1999216:Inhibitor [Qualitative Concept]

Phrase: "5 M phosphoramidon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "5 M bestatin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0053355:bestatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "20 M APMSF,"

Phrase: "and"

Phrase: "2.5 mM EDTA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.190: (b) Protease inhibitors were each tested at three concentrations; 

Phrase: "(b) Protease inhibitors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   867 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   827   C1947941:Protease [Enzyme]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "were"

Phrase: "each"

Phrase: "tested at three concentrations"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0086045:Concentrations [Mental Process]
   770   C0205449:Three [Quantitative Concept]
   770   C0392366:tested [Intellectual Product]
   737 E C0022885:Test [Laboratory Procedure]
   737 E C0039593:Test [Functional Concept]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.191: GM1489 (0.02, 0.2, and 2.0 mg/ml), o-phenanthroline (0.1, 0.5, and 1.0 M), MMP2 inhibitor (0.8, 2.0, and 4.0 mg/ml), and MMP2/MMP9 inhibitor (0.025, 0.25, and 2.5 mg/ml). 

Phrase: "GM1489"

Phrase: "(0.02,"

Phrase: "0.2,"

Phrase: "and"

Phrase: "2.0 mg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439294:mg ml [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "o-phenanthroline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0087870:o-phenanthroline [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   861   C0031370:phenanthroline [Organic Chemical]

Phrase: "(0.1,"

Phrase: "0.5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "and"

Phrase: "1.0"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "M)"

Phrase: ","

Phrase: "MMP2 inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(0.8,"

Phrase: "2.0,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "4.0 mg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439294:mg ml [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "MMP2/MMP9 inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(0.025,"

Phrase: "0.25,"

Phrase: "and"

Phrase: "2.5 mg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439294:mg ml [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.192: Acid activation of TGF- was used as a positive control and uRBCs and medium alone were used as negative controls. 

Phrase: "Acid activation of TGF-"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   833   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   820   C2249824:activation of growth [Organism Function]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0001128:Acid [Chemical]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0220844:growth [Physiologic Function]
   753   C1510411:Transforming [Pathologic Function]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C1879547:Activation [Activity]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]

Phrase: "was"

Phrase: "used as a positive control"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   806   C1883676:Positive Control [Conceptual Entity]
   760   C0243148:control [Qualitative Concept]
   760   C0439178:% Positive [Quantitative Concept]
   760   C1273517:used [Finding]
   760   C1446409:Positive [Qualitative Concept]
   760   C1514241:Positive [Finding]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C2825490:Positive [Qualitative Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "uRBCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014792:rbcs [Cell]

Phrase: "and"

Phrase: "medium alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Alone [Quantitative Concept]
   861   C0439044:alone [Finding]
   861   C0679994:alone [Group Attribute]

Phrase: "were"

Phrase: "used as negative controls."
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   799   C1639518:% negative control [Quantitative Concept]
   799   C1947986:Negative Control [Conceptual Entity]
   770   C0205160:Negative [Qualitative Concept]
   770   C1273517:used [Finding]
   770   C1513916:Negative [Finding]
   770   C2825415:Negative [Conceptual Entity]
   770   C2825491:Negative [Qualitative Concept]
   737 E C0042153:use [Functional Concept]
   737   C0243148:control [Qualitative Concept]
   737 E C0457083:Use [Functional Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737 E C1947944:Use [Intellectual Product]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.193: In these experiments, acid activation of HuLatTGF- generated 2,143  122 pg/ml (mean  SEM) active TGF-.  

Phrase: "In these experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "acid activation of HuLatTGF-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "2,143  122 pg/ml (mean  SEM) active TGF-"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   816   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   816   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   801   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   801   C0439297:pg/mL [Quantitative Concept]
   788   C0018270:'growth' NOS [Organism Function]
   788   C0205177:Active [Functional Concept]
   788   C0220844:growth [Physiologic Function]
   788   C0439526:/mL [Quantitative Concept]
   788   C0444504:Mean [Quantitative Concept]
   788   C0740116:+2 [Quantitative Concept]
   788   C1266240:PG [Laboratory Procedure]
   788   C1510411:Transforming [Pathologic Function]
   788   C1521761:Factor [Functional Concept]
   788   C1621966:Growth [Organ or Tissue Function]
   788   C2347634:Mean [Quantitative Concept]
   788   C2348143:Mean [Quantitative Concept]
   788   C2827422:Factor [Conceptual Entity]
   788   C2827735:2+ [Quantitative Concept]
   788   C2911660:Growth [Activity]
   788   C2981700:2+ [Classification]

Phrase: "."
Processing 00000000.tx.194: The inhibitory activity of o-phenanthroline was dose-dependent, with a concentration of 1M reducing levels of active TGF- to levels seen with uRBC (Fig. 4b). 

Phrase: "The inhibitory activity of o-phenanthroline"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "dose-dependent,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1512045:Dose-dependent [Quantitative Concept]
   861   C0178602:Dose [Quantitative Concept]
   861   C0851827:Dependent [Qualitative Concept]
   861   C0869039:Dose [Quantitative Concept]
   861   C1114758:Dose # [Clinical Attribute]
   861   C1701901:Dependent [Qualitative Concept]
   861   C3244310:dependent [Functional Concept]

Phrase: "with a concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 1M reducing levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "of active TGF-"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   884   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0205177:Active [Functional Concept]
   804   C0220844:growth [Physiologic Function]
   804   C0332285:Of [Spatial Concept]
   804   C1510411:Transforming [Pathologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]

Phrase: "to levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "seen with uRBC"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "(Fig. 4b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.195: Three additional MMP inhibitors were tested for their ability to block pRBC-induced TGF- activation. 

Phrase: "Three additional MMP inhibitors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1513016:MMP Inhibitors [Pharmacologic Substance]
   812   C0243077:inhibitors [Chemical Viewed Functionally]
   779 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "were"

Phrase: "tested for their ability to"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   781   C0003647:ability test [Diagnostic Procedure]
   760   C0085732:Ability [Organism Attribute]
   760   C0392366:tested [Intellectual Product]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "pRBC-induced TGF-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   884   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0205263:Induced [Functional Concept]
   804   C0220844:growth [Physiologic Function]
   804   C1510411:Transforming [Pathologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]

Phrase: "activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]
Processing 00000000.tx.196: An MMP-2 inhibitor (MMP-2Pi) had modest effects on TGF- activation but a dual MMP-2/MMP-9 inhibitor (MMP2/9i) and GM1489 (a broad spectrum MMP inhibitor) completely blocked TGF- activation at concentrations of 2.5 g/ml and 2.0 g/ml respectively; 

Phrase: "An MMP-2 inhibitor (MMP-2Pi)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C1513016:MMP Inhibitor [Pharmacologic Substance]
   827   C1999216:Inhibitor [Qualitative Concept]
   734   C0172537:MMP-2 [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1334522:MMP2 [Gene or Genome]
   734   C2698024:MMP2 [Laboratory Procedure]

Phrase: "had"

Phrase: "modest effects on TGF-"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   833   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1280500:effects [Qualitative Concept]
   753   C1510411:Transforming [Pathologic Function]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "but"

Phrase: "a dual MMP-2/MMP-9 inhibitor (MMP2/9i)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   876   C1513016:MMP Inhibitor [Pharmacologic Substance]
   799   C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "GM1489"

Phrase: "("

Phrase: "a broad spectrum MMP inhibitor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1513016:MMP Inhibitor [Pharmacologic Substance]
   812   C1999216:Inhibitor [Qualitative Concept]

Phrase: ")"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "activation at concentrations of 2.5 g/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "2.0 g/ml respectively"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C1300565:g/mL [Quantitative Concept]
   804   C0439526:/mL [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.197: 50% inhibition was observed at concentrations of 0.025 g/ml and 0.2 g/ml respectively. 

Phrase: "50% inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "was"

Phrase: "observed at concentrations of 0.025 g/ml"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C1300565:g/mL [Quantitative Concept]
   767 E C1637390:mL/g [Quantitative Concept]
   744   C0086045:Concentrations [Mental Process]
   744   C0439267:g% [Quantitative Concept]
   744   C0439526:/mL [Quantitative Concept]
   744   C1441672:Observed [Functional Concept]
   711 E C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "0.2 g/ml respectively."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C1300565:g/mL [Quantitative Concept]
   804   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.198: These data indicate that MMPs are required for P. falciparum-mediated activation of LatTGF-. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that MMPs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0623362:MMPs [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C0919336:MMP [Gene or Genome]

Phrase: "are"

Phrase: "required for P. falciparum-mediated activation of LatTGF-"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0086597:mediated [Social Behavior]
   742   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   742   C0205275:Latent [Qualitative Concept]
   742   C1514873:Required [Functional Concept]
   742   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1879547:Activation [Activity]

Phrase: "."
Processing 00000000.tx.199: TGF-activating Proteases of P. falciparum Bind to Gelatin and Have Gelatinase Activity. 

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "activating Proteases of P. falciparum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C1947941:Proteases [Enzyme]

Phrase: "Bind to Gelatin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   790   C1145617:Gelatin [Food]
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]

Phrase: "and"

Phrase: "Have"

Phrase: "Gelatinase Activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.200: One feature of MMPs is that they bind to, and cleave, gelatin. 

Phrase: "One feature of MMPs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1521970:Feature [Qualitative Concept]
   770   C1706388:Feature [Conceptual Entity]
   770   C2346469:Feature [Qualitative Concept]
   770   C2348519:Feature [Qualitative Concept]

Phrase: "is"

Phrase: "that"

Phrase: "they"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "to,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "and"

Phrase: "cleave"

Phrase: ","

Phrase: "gelatin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
  1000   C1145617:Gelatin [Food]
Processing 00000000.tx.201: Zymography of PfSL confirmed the presence of gelatinase activity in infected but not uninfected red cells (Fig. 5 a). 

Phrase: "Zymography of PfSL"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the presence of gelatinase activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in infected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439663:Infected [Functional Concept]

Phrase: "but"

Phrase: "not uninfected red cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0014792:Red cells [Cell]
   812   C0007634:Cells [Cell]
   812   C0332575:Red [Finding]
   812   C1260956:Red [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "a"

Phrase: ")."
Processing 00000000.tx.202: Two clear bands were seen, one of which had a molecular weight of 55 kD. 

Phrase: "Two clear bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0175723:Bands [Medical Device]
   793 E C0439645:Band [Spatial Concept]
   793 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: ","

Phrase: "one of which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205447:One [Quantitative Concept]

Phrase: "had"

Phrase: "a molecular weight of 55 kD."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0026385:Molecular Weight [Quantitative Concept]
   753   C0005910:weight [Organism Attribute]
   753   C0043100:Weight [Quantitative Concept]
   753   C1305866:weight [Diagnostic Procedure]
   753   C1521991:Molecular [Qualitative Concept]
   753   C1705104:Weight [Idea or Concept]
Processing 00000000.tx.203: This may be the P. falciparum equivalent of a heat shock protein with MMP activity described for Plasmodium vivax (32). 

Phrase: "This"

Phrase: "may"

Phrase: "be"

Phrase: "the P. falciparum equivalent of a heat shock protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205163:Equivalent [Qualitative Concept]
   742   C0439185:equivalent [Quantitative Concept]

Phrase: "with MMP activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "described for Plasmodium vivax"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0032154:Plasmodium vivax [Eukaryote]
   770   C0032148:Plasmodium [Eukaryote]
   770   C1552738:described [Idea or Concept]
   770   C3541306:Plasmodium [Laboratory Procedure]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.204: A similar sized band was detected for P. berghei (Fig. 5 b, lanes 1 and 2). 

Phrase: "A similar sized band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0175723:Band [Medical Device]
   827   C0439645:Band [Spatial Concept]
   827   C1521913:band [Cell Component]

Phrase: "was"

Phrase: "detected for P. berghei"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 5 b,"

Phrase: "lanes 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.205: Lysates of P. falciparum and P. berghei pRBCs were affinity purified on gelatin-agarose and eluates were tested for their ability to activate LatTGF- in vitro. 

Phrase: "Lysates of P. falciparum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1881488:Lysate [Physical Object]

Phrase: "and"

Phrase: "P. berghei pRBCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0014792:rbcs [Cell]

Phrase: "were"

Phrase: "affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "purified on gelatin-agarose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   770   C0036681:Agarose [Carbohydrate]
   770   C1145617:Gelatin [Food]
   770   C1998793:Purified [Functional Concept]

Phrase: "and"

Phrase: "eluates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0301870:Eluate [Body Substance]
   966   C1272724:Eluate [Substance]

Phrase: "were"

Phrase: "tested for their ability to"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   781   C0003647:ability test [Diagnostic Procedure]
   760   C0085732:Ability [Organism Attribute]
   760   C0392366:tested [Intellectual Product]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "LatTGF-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0205275:Latent [Qualitative Concept]
   861   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.206: For P. berghei, the gelatin-purified material was enriched in the 55-kD gelatinase activity and, although less active than the crude lysate, this material retained significant TGF-activating activity (Fig. 5 c). 

Phrase: "For P. berghei,"

Phrase: "the gelatin-purified material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0520510:Material [Substance]

Phrase: "was"

Phrase: "enriched in the 55-kD gelatinase activity"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0026691:KD [Disease or Syndrome]
   748   C0205177:Activity [Functional Concept]
   748   C0206528:Gelatinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0359583:enriched [Food]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C0450382:55 [Intellectual Product]
   748   C1561536:*Activity [Idea or Concept]
   748   C1705240:KD [Gene or Genome]
   748   C1839259:KD [Disease or Syndrome]

Phrase: "and"

Phrase: ","

Phrase: "although"

Phrase: "less active than the crude lysate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205177:Active [Functional Concept]

Phrase: "this material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Material [Substance]

Phrase: "retained"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retained [Functional Concept]

Phrase: "significant TGF-"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C0237881:significant [Quantitative Concept]
   812   C0750502:Significant [Idea or Concept]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1546944:Significant [Qualitative Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "activating activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(Fig. 5 c)."
Processing 00000000.tx.207: Similar results were obtained with P. falciparum lysate. 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained with P. falciparum lysate."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C1301820:Obtained [Functional Concept]
   760   C1881488:Lysate [Physical Object]
   726 E C1706701:Obtain [Activity]
Processing 00000000.tx.208: View larger version (49K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(49K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.209: TGF-activating moieties of P. falciparum bind to gelatin and display gelatinase activity. 

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "activating moieties of P. falciparum"

Phrase: "bind to gelatin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   790   C1145617:Gelatin [Food]
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]

Phrase: "and"

Phrase: "display gelatinase activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.210: (a) Lysates of 4 x 107/ml P. falciparum pRBCs or uRBCs were electrophoresed on a 10% zymogram gel. 

Phrase: "(a) Lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "of 4 x 107/ml P. falciparum pRBCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0014792:rbcs [Cell]

Phrase: "or"

Phrase: "uRBCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014792:rbcs [Cell]

Phrase: "were"

Phrase: "electrophoresed on a 10% zymogram gel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C1382104:Gel [Substance]
   719   C0013855:electrophorese [Laboratory Procedure]
Processing 00000000.tx.211: The gel was incubated overnight at 37C and stained with Coomassie blue. 

Phrase: "The gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017243:Gel [Biomedical or Dental Material]
  1000   C1382104:Gel [Substance]

Phrase: "was"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "overnight at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439583:Overnight [Temporal Concept]

Phrase: "and"

Phrase: "stained with Coomassie blue."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0056269:Coomassie blue [Organic Chemical,Pharmacologic Substance]
   770   C1260957:Blue [Qualitative Concept]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.212: (b) Lysates of P. falciparum pRBCs and P. berghei pRBCs (lanes 1 and 3) or affinity-purified pRBC lysates (eluates released from gelatin-agarose resin by incubation with DMSO/Tris Brij; lanes 2 and 4) and control preparations of mouse or human uRBCs (lanes 5 and 6) were electrophoresed on a 10% zymogram gel. 

Phrase: "(b) Lysates of P. falciparum pRBCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1881488:Lysate [Physical Object]

Phrase: "and"

Phrase: "P. berghei pRBCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0014792:rbcs [Cell]

Phrase: "(lanes 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "or"

Phrase: "affinity-purified pRBC lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1881488:Lysate [Physical Object]

Phrase: "(eluates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0301870:Eluate [Body Substance]
   966   C1272724:Eluate [Substance]

Phrase: "released from gelatin-agarose resin"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   760   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   760   C0035191:Resin [Biomedical or Dental Material]
   760   C0036681:Agarose [Carbohydrate]
   760   C0391871:Released [Functional Concept]
   760   C1145617:Gelatin [Food]
   760   C1283071:Released [Functional Concept]
   726 E C0030685:Release [Health Care Activity]
   726 E C0439180:% release [Quantitative Concept]
   726 E C0680255:release [Health Care Activity]
   726 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "by incubation"

Phrase: "with DMSO/Tris Brij"

Phrase: "; lanes 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "4"

Phrase: ")"

Phrase: "and"

Phrase: "control preparations of mouse"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0455052:Preparation [Health Care Activity]
   737   C1521827:Preparation [Functional Concept]

Phrase: "or"

Phrase: "human uRBCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0014792:rbcs [Cell]

Phrase: "(lanes 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "6"

Phrase: ")"

Phrase: "were"

Phrase: "electrophoresed on a 10% zymogram gel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C1382104:Gel [Substance]
   719   C0013855:electrophorese [Laboratory Procedure]
Processing 00000000.tx.213: The gel was incubated overnight at 37C and stained with Coomassie blue. 

Phrase: "The gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017243:Gel [Biomedical or Dental Material]
  1000   C1382104:Gel [Substance]

Phrase: "was"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "overnight at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439583:Overnight [Temporal Concept]

Phrase: "and"

Phrase: "stained with Coomassie blue."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0056269:Coomassie blue [Organic Chemical,Pharmacologic Substance]
   770   C1260957:Blue [Qualitative Concept]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.214: (c) Gelatin-purified lysates of P. falciparum or P. berghei pRBCs were compared with crude lysates for their TGF-activating activity by ELISA. 

Phrase: "(c) Gelatin-purified lysates of P. falciparum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1881488:Lysate [Physical Object]

Phrase: "or"

Phrase: "P. berghei pRBCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0014792:rbcs [Cell]

Phrase: "were"

Phrase: "compared with crude lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1707455:Compared [Activity]
   737   C1881488:Lysate [Physical Object]

Phrase: "for their TGF-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   884   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C0521125:For [Qualitative Concept]
   804   C1510411:Transforming [Pathologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]

Phrase: "activating activity by ELISA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.215: Error bars represent SEM of triplicate assays. 

Phrase: "Error bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "SEM of triplicate assays."
Processing 00000000.tx.216: (d) Gelatin-purified lysates of wild-type (Pb WT) and TRAP knockout (Pb TRAP ko) P. berghei pRBCs were compared with crude lysates for their TGF-activating activity by ELISA. 

Phrase: "("

Phrase: "d)"

Phrase: "Gelatin-purified lysates of wild-type"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1881488:Lysate [Physical Object]

Phrase: "(Pb"

Phrase: "WT)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700323:WT [Fish]

Phrase: "and"

Phrase: "TRAP knockout"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0560617:knock out [Injury or Poisoning]
   804   C1522225:Knock-out [Experimental Model of Disease]

Phrase: "(Pb TRAP ko"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0560617:knock out [Injury or Poisoning]
   861   C1522225:Knock-out [Experimental Model of Disease]

Phrase: ")"

Phrase: "P. berghei pRBCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0014792:rbcs [Cell]

Phrase: "were"

Phrase: "compared with crude lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1707455:Compared [Activity]
   737   C1881488:Lysate [Physical Object]

Phrase: "for their TGF-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   884   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C0521125:For [Qualitative Concept]
   804   C1510411:Transforming [Pathologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]

Phrase: "activating activity by ELISA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.217: Assay of lysates alone confirms that pRBC lysates do not contain TGF-like components. 

Phrase: "Assay of lysates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0005507:Assay [Laboratory Procedure]
   790   C0243073:assay [Qualitative Concept]
   790   C1510438:Assay [Laboratory Procedure]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "confirms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that pRBC lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "like components."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449432:Components [Manufactured Object]
   966 E C1705248:Component [Conceptual Entity]
Processing 00000000.tx.218: Error bars represent SEM of triplicate assays.  

Phrase: "Error bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "SEM of triplicate assays."
Processing 00000000.tx.219: Interestingly, gelatin-agarosepurified and eluted material from Pb TRAP ko parasites was significantly less able to activate TGF- than material from Pb WT parasites (Fig. 5 d), suggesting that the gelatin-binding components of the parasite lysate are physically associated with TRAP.  

Phrase: "Interestingly,"

Phrase: "gelatin-agarosepurified"

Phrase: "and"

Phrase: "eluted material from Pb TRAP ko parasites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0520510:Material [Substance]

Phrase: "was"

Phrase: "significantly less able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0085732:Able [Organism Attribute]
   812   C1299581:Able [Finding]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "than material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Material [Substance]

Phrase: "from Pb WT parasites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030498:Parasites [Eukaryote]
   827   C0521066:Parasites. [Functional Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "d)"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the gelatin-binding components of the parasite lysate"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0449432:Components [Manufactured Object]
   711 E C1705248:Component [Conceptual Entity]

Phrase: "are"

Phrase: "physically"

Phrase: "associated with TRAP."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0001516:Adhesive [Manufactured Object]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439849:Related [Qualitative Concept]
   753   C0445223:Related [Finding]
   753   C2982905:Adhesive [Manufactured Object]
   719 E C0163712:Relate [Organic Chemical]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.220: Discussion Top Abstract Introduction Materials and Methods Results Discussion References  Members of the TGF- family are highly conserved throughout evolution and play essential roles in growth and development in multicellular organisms, including metazoan parasites. 

Phrase: "Discussion Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Members of the TGF-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0680022:members [Population Group]
   719 E C2698041:Member [Professional or Occupational Group]

Phrase: "family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Family [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   928 E C0241888:Familial [Functional Concept]

Phrase: "are"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "conserved throughout evolution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0015219:Evolution [Genetic Function]

Phrase: "and"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "essential roles in growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "development in multicellular organisms,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   854   C1817464:multicellular organismal development [Organ or Tissue Function]
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "metazoan parasites."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C2713498:Metazoan parasite [Eukaryote]
   861   C0030498:Parasites [Eukaryote]
   861   C0521066:Parasites. [Functional Concept]
Processing 00000000.tx.221: Thus, for example, TGF- or TGF- receptor homologues have been identified in filarial nematodes (33, 34) and components of the TGF- signaling pathway are functionally conserved in schistosomes (3537). 

Phrase: "Thus,"

Phrase: "for example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "or"

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "receptor homologues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1334043:Homologue [Gene or Genome]

Phrase: "have"

Phrase: "been"

Phrase: "identified in filarial nematodes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C0486786:Filaria identified [Laboratory or Test Result]
   770   C0027581:nematodes [Eukaryote]
   770   C0205396:Identified [Qualitative Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
   770   C1621857:Filarial [Eukaryote]
   770   C1704319:Nematodes [Eukaryote]
   770   C1947962:Nematodes [Eukaryote]

Phrase: "(33,"

Phrase: "34"

Phrase: ")"

Phrase: "and"

Phrase: "components of the TGF-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0449432:Components [Manufactured Object]
   719 E C1705248:Component [Conceptual Entity]

Phrase: "signaling pathway"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0037083:signaling pathway [Cell Function]
  1000   C0086982:Signaling Pathway [Molecular Function]
   983 E C0037080:Signal Pathway [Molecular Function]
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "are"

Phrase: "functionally"

Phrase: "conserved in schistosomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0036315:schistosomes [Eukaryote]
   756 E C0036321:Schistosome, NOS [Eukaryote]
   706 E C0521080:Schistosomal [Functional Concept]

Phrase: "(3537"

Phrase: ")."
Processing 00000000.tx.222: The role of TGF- family molecules in growth or development of unicellular parasites is less clear but, given the established role of TGF- in regulating immune responses to protozoa (for review see reference 11), modulation of host TGF- signaling pathways might be an effective survival strategy. 

Phrase: "The role of TGF-"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0035820:Role [Social Behavior]
   753   C0220844:growth [Physiologic Function]
   753   C1510411:Transforming [Pathologic Function]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C1705810:Role [Conceptual Entity]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]

Phrase: "family molecules in growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2911660:Growth [Activity]

Phrase: "or"

Phrase: "development of unicellular parasites"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]

Phrase: "is"

Phrase: "less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "but"

Phrase: ","

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the established role of TGF-"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   814   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   814   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0035820:Role [Social Behavior]
   748   C0220844:growth [Physiologic Function]
   748   C0443211:Established [Qualitative Concept]
   748   C1272684:Established [Qualitative Concept]
   748   C1510411:Transforming [Pathologic Function]
   748   C1521761:Factor [Functional Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C1705810:Role [Conceptual Entity]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]

Phrase: "in"

Phrase: "regulating"

Phrase: "immune responses to protozoa"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   898   C1155327:response to protozoa [Cell Function]
   833   C0301872:immune responses [Organ or Tissue Function]
   770   C0439662:Immune [Functional Concept]
   770   C0871261:responses [Organism Attribute]
   737 E C1704632:Response [Finding]
   737 E C1706817:Response [Intellectual Product]
   737 E C2911692:Response [Mental Process]

Phrase: "("

Phrase: "for review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "reference 11"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514811:Reference [Idea or Concept]
   861   C1706462:Reference [Conceptual Entity]

Phrase: ")"

Phrase: ","

Phrase: "modulation of host TGF-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0443264:Modulation [Spatial Concept]

Phrase: "signaling pathways"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   983   C0037080:Signal Pathways [Molecular Function]
   983   C0037083:signaling pathway [Cell Function]
   983   C0086982:Signaling Pathway [Molecular Function]
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]

Phrase: "might"

Phrase: "be"

Phrase: "an effective survival strategy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0679199:strategy [Mental Process]
Processing 00000000.tx.223: For example, the intracellular protozoan Trypanosoma cruzi induces expression of TGF- and requires functional expression of TGF- receptors to invade the host cell (38, 39). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "the intracellular protozoan Trypanosoma cruzi"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041221:Trypanosoma cruzi [Eukaryote]
   812   C0041215:Trypanosoma [Eukaryote]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "expression of TGF-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "requires"

Phrase: "functional expression of TGF-"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   833   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0205245:Functional [Functional Concept]
   753   C0220844:growth [Physiologic Function]
   753   C0542341:Functional [Functional Concept]
   753   C1510411:Transforming [Pathologic Function]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2700217:Functional [Conceptual Entity]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]

Phrase: "receptors to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "invade"

Phrase: "the host cell"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1819995:Host Cell [Cell Component]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "(38,"

Phrase: "39"

Phrase: ")."
Processing 00000000.tx.224: The extracellular protozoan, Trypanosoma brucei, also induces expression of TGF- mRNA (40). 

Phrase: "The extracellular protozoan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033739:Protozoan [Eukaryote]

Phrase: "Trypanosoma brucei,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041217:Trypanosoma brucei [Eukaryote]
   861   C0041215:Trypanosoma [Eukaryote]

Phrase: "also"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "expression of TGF-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "mRNA (40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.225: The data presented here indicate that malaria parasites have adopted an alternative strategy to modulate the effects of TGF-: directly activating constitutively produced LatTGF- to its bioactive form. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here"

Phrase: "indicate"

Phrase: "that malaria parasites"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C1271614:Malarial parasites [Eukaryote]
   861   C0030498:Parasites [Eukaryote]
   861   C0521066:Parasites. [Functional Concept]

Phrase: "have"

Phrase: "adopted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0425382:Adopted [Finding]

Phrase: "an alternative strategy to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0679199:strategy [Mental Process]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the effects of TGF-"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   833   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1280500:effects [Qualitative Concept]
   753   C1510411:Transforming [Pathologic Function]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: ":"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "activating"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:activating [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "constitutively"

Phrase: "produced"

Phrase: "LatTGF-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0205275:Latent [Qualitative Concept]
   861   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "to its bioactive form."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]
Processing 00000000.tx.226: Extracellular processing of LatTGF- is a major control point in regulation of TGF- function as the signal peptide that targets the mature protein for secretion is encoded within the LAP (41). 

Phrase: "Extracellular processing of LatTGF-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205275:Latent [Qualitative Concept]
   760   C0521119:Extracellular [Cell Component]
   760   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709694:Processing [Activity]

Phrase: "is"

Phrase: "a major control point in regulation of TGF-"
Meta Candidates (Total=26; Excluded=0; Pruned=0; Remaining=26)
   782   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   782   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   777   C1160191:regulation of growth [Organism Function]
           growth regulation
   760   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   757   C0683951:control factor [Quantitative Concept]
   757   C0960756:factor A [Organic Chemical]
   757   C2924612:A point [Body Location or Region]
   739   C0018270:'growth' NOS [Organism Function]
   739   C0205164:Major [Qualitative Concept]
   739   C0220844:growth [Physiologic Function]
   739   C0243148:control [Qualitative Concept]
   739   C0851285:Regulation [Governmental or Regulatory Activity]
   739   C1327622:Regulation [Biologic Function]
   739   C1510411:Transforming [Pathologic Function]
   739   C1521761:Factor [Functional Concept]
   739   C1550141:Control [Substance]
   739   C1552961:Point [Quantitative Concept]
   739   C1621966:Growth [Organ or Tissue Function]
   739   C1882979:Control [Conceptual Entity]
   739   C2347617:point [Quantitative Concept]
   739   C2587213:Control [Functional Concept]
   739   C2827422:Factor [Conceptual Entity]
   739   C2911660:Growth [Activity]
   739   C3274648:Control [Qualitative Concept]

Phrase: "function as the signal peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "that"

Phrase: "targets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "the mature protein for secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1159339:Protein Secretion [Cell Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "encoded within the LAP"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0332281:Associated [Qualitative Concept]
   753   C0679058:encoded [Mental Process]
   753   C2700640:Encoded [Activity]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.227: Consequently, overexpression of the entire TGF- gene has minimal consequences but overexpression of a functional version of the molecule leads to pathology (42). 

Phrase: "Consequently,"

Phrase: "overexpression of the entire TGF-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1512282:Growth Factor Overexpression [Laboratory or Test Result]
   748   C1514559:Overexpression [Genetic Function]

Phrase: "gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "has"

Phrase: "minimal consequences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0686907:consequences [Functional Concept]

Phrase: "but"

Phrase: "overexpression of a functional version of the molecule"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1514559:Overexpression [Genetic Function]

Phrase: "leads to pathology"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C0030664:Pathology [Biomedical Occupation or Discipline]
   790   C0181586:leads [Medical Device]
   790   C0205469:pathology [Functional Concept]
   790   C0677042:pathology [Pathologic Function]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]
   718 E C1521733:Pathologic [Functional Concept]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.228: The ability of malaria parasites to directly activate LatTGF- has potentially important implications. 

Phrase: "The ability of malaria parasites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "to directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "LatTGF-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0205275:Latent [Qualitative Concept]
   861   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "potentially important implications."
Processing 00000000.tx.229: If parasite-derived molecules are able to activate TGF- in vivo, this may contribute to limiting the extent of immunopathology (7, 12) that might be advantageous for the parasite in that it may ensure that the host survives long enough to transmit the infection. 

Phrase: "If"

Phrase: "parasite-derived molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "are"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "this"

Phrase: "may"

Phrase: "contribute to limiting"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0439801:limiting [Functional Concept]
   790   C1880177:Contribute [Activity]
   756 E C1549649:Limit [Idea or Concept]
   756 E C2349209:Limit [Conceptual Entity]

Phrase: "the extent of immunopathology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439792:Extent [Spatial Concept]

Phrase: "(7,"

Phrase: "12"

Phrase: ")"

Phrase: "that"

Phrase: "might"

Phrase: "be"

Phrase: "advantageous for the parasite"

Phrase: "in"

Phrase: "that"

Phrase: "it"

Phrase: "may"

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "that"

Phrase: "the host"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1167395:Host [Organism]

Phrase: "survives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0310255:SURVIVE [Pharmacologic Substance]

Phrase: "long enough to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205166:Long [Qualitative Concept]
   827   C1706317:Long [Qualitative Concept]

Phrase: "transmit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332289:transmit [Functional Concept]

Phrase: "the infection."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0009450:Infection, NOS [Disease or Syndrome]
   928 E C0439663:Infected [Functional Concept]
   888 E C0030657:infectivity [Qualitative Concept]
Processing 00000000.tx.230: If so, vaccines need to be designed such that they do not interfere with this endogenous pathway of immune modulation. 

Phrase: "If"

Phrase: "so,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "vaccines"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042210:Vaccines [Immunologic Factor,Pharmacologic Substance]
   966 E C1552558:Vaccine [Intellectual Product]

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "such"

Phrase: "that"

Phrase: "they"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "interfere with this endogenous pathway of immune modulation."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0678889:immune modulation [Organism Function]
   744   C0205227:Endogenous [Functional Concept]
   744   C0439662:Immune [Functional Concept]
   744   C0443264:Modulation [Spatial Concept]
   744   C0521102:Interfere [Qualitative Concept]
   744   C1704259:Pathway [Molecular Function]
   744   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.231: More generally, identification of immunomodulatory parasite products may open up new avenues for chemotherapy. 

Phrase: "More generally,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "identification of immunomodulatory parasite products"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1261145:Parasite identification [Laboratory Procedure]
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "may"

Phrase: "open up new avenues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0175566:Open [Spatial Concept]
   770   C0205314:New [Temporal Concept]

Phrase: "for chemotherapy."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0013216:Chemotherapy [Therapeutic or Preventive Procedure]
  1000   C0013217:chemotherapy [Functional Concept]
  1000   C0392920:Chemotherapy [Therapeutic or Preventive Procedure]
Processing 00000000.tx.232: Alternatively, very rapid induction (within 24 h) of high levels of bioactive TGF-, as is seen in C57/BL6 mice infected with P. yoelii 17XL (17), may switch off the early inflammatory cytokine response that is essential for controlling parasite replication, leading to enhanced parasite virulence (43). 

Phrase: "Alternatively,"

Phrase: "very rapid induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205263:Induction [Functional Concept]
   827   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: "within 24 h)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "of high levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of bioactive TGF-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   884   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C0332285:Of [Spatial Concept]
   804   C1510411:Transforming [Pathologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]

Phrase: ","

Phrase: "as is"

Phrase: "seen in C57/BL6 mice"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0205397:Seen [Qualitative Concept]
   760   C0450600:BL6 [Body Location or Region]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: "infected with P. yoelii 17XL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439663:Infected [Functional Concept]

Phrase: "(17"

Phrase: ")"

Phrase: ","

Phrase: "may"

Phrase: "switch off the early inflammatory cytokine response"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   774   C1155266:Inflammatory Response [Pathologic Function]
   748   C0079189:cytokine [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0333348:Inflammatory [Functional Concept]
   748   C0871261:Response [Organism Attribute]
   748   C1279919:Early [Temporal Concept]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C1707719:Switch [Manufactured Object]
   748   C2911692:Response [Mental Process]

Phrase: "that"

Phrase: "is"

Phrase: "essential for controlling parasite replication,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205224:Essential [Qualitative Concept]

Phrase: "leading to enhanced parasite virulence"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   760   C0030498:Parasite [Eukaryote]
   760   C0042765:Virulence [Biologic Function]
   760   C0220936:virulence [Qualitative Concept]
   760   C0332152:Leading [Temporal Concept]
   760   C1522538:Leading [Functional Concept]
   760   C2349975:Enhanced [Activity]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.233: This hypothesis is supported by our observation that TRAP-deficient P. berghei, which does not possess endogenous TGF-activating capacity, is initially controlled much more effectively by the host than is the wild-type parasite. 

Phrase: "This hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "is"

Phrase: "supported by our observation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0302523:Observation [Research Activity]
   770   C0700325:observation [Health Care Activity]
   770   C1521721:Supported [Conceptual Entity]
   770   C1964257:Observation [Diagnostic Procedure]
   737 E C0183683:Support [Medical Device]

Phrase: "that TRAP-deficient P. berghei,"

Phrase: "which"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "possess"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "endogenous TGF-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0205227:Endogenous [Functional Concept]
   812   C0220844:growth [Physiologic Function]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "activating capacity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516240:Capacity [Quantitative Concept]

Phrase: "is"

Phrase: "initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "controlled"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C2587213:Controlled [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]

Phrase: "much more effectively by the host"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1167395:Host [Organism]

Phrase: "than"

Phrase: "is"

Phrase: "the wild-type parasite."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030498:Parasite [Eukaryote]
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.234: This cannot be attributed to any inherent defect in the replication of TRAP-deficient parasites as the time from inoculation of subpatent numbers of TRAP-deficient, infected erythrocytes to patency in the blood is identical for TRAP knockout and Pb WT (this study and 25) and, once the infection is established, TRAP knockout parasites are capable of exponential growth. 

Phrase: "This"

Phrase: "cannot"

Phrase: "be"

Phrase: "attributed to any inherent defect"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C1457869:Defect [Functional Concept]
   760   C1861101:DEFECT [Disease or Syndrome]
   726   C0449234:Attribute [Idea or Concept]
   726   C1704772:Attribute [Conceptual Entity]
   726   C1882133:Attribute [Qualitative Concept]

Phrase: "in the replication"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0598312:Replication [Genetic Function]
  1000   C1883725:replication [Qualitative Concept]
   928 E C0205173:Replicate [Functional Concept]
   928 E C0205341:Replicate [Functional Concept]

Phrase: "of TRAP-deficient parasites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0030498:Parasites [Eukaryote]
   799   C0521066:Parasites. [Functional Concept]

Phrase: "as the time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "from inoculation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042196:Inoculation [Therapeutic or Preventive Procedure]
  1000   C2987620:Inoculation [Therapeutic or Preventive Procedure]

Phrase: "of subpatent numbers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "of TRAP-deficient, infected erythrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0014772:Erythrocytes [Laboratory Procedure]
   795   C0014792:Erythrocytes [Cell]

Phrase: "to patency"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0175566:Patency [Spatial Concept]
   928 E C0030650:patent [Intellectual Product]

Phrase: "in the blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "is"

Phrase: "identical for TRAP knockout"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205280:Identical [Qualitative Concept]

Phrase: "and"

Phrase: "Pb"

Phrase: "WT ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700323:WT [Fish]

Phrase: "this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "25"

Phrase: ")"

Phrase: "and"

Phrase: ","

Phrase: "once"

Phrase: "the infection"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0009450:Infection, NOS [Disease or Syndrome]
   928 E C0439663:Infected [Functional Concept]
   888 E C0030657:infectivity [Qualitative Concept]

Phrase: "is"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: ","

Phrase: "TRAP knockout parasites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0030498:Parasites [Eukaryote]
   799   C0521066:Parasites. [Functional Concept]

Phrase: "are"

Phrase: "capable of exponential growth."
Processing 00000000.tx.235: Rather, we believe that in the early phase of infection TRAP knockout parasites fail to activate endogenous TGF-, allowing induction of a partially protective proinflammatory (IFN-) cytokine response (17). 

Phrase: "Rather,"

Phrase: "we"

Phrase: "believe"

Phrase: "that in the early phase of infection TRAP knockout parasites"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   735   C0001516:Adhesive [Manufactured Object]
   735   C0009450:Infection, NOS [Disease or Syndrome]
   735   C0030498:Parasites [Eukaryote]
   735   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   735   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   735   C0205390:Phase [Temporal Concept]
   735   C0439849:Related [Qualitative Concept]
   735   C0445223:Related [Finding]
   735   C0521066:Parasites. [Functional Concept]
   735   C0560617:knock out [Injury or Poisoning]
   735   C1279919:Early [Temporal Concept]
   735   C1522225:Knock-out [Experimental Model of Disease]
   735   C2982905:Adhesive [Manufactured Object]
   702 E C0163712:Relate [Organic Chemical]

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "endogenous TGF-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0205227:Endogenous [Functional Concept]
   812   C0220844:growth [Physiologic Function]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: ","

Phrase: "allowing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowing [Social Behavior]

Phrase: "induction of a partially protective proinflammatory"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205263:Induction [Functional Concept]
   753   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "(IFN-) cytokine response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.236: The significance of TGF- activation for survival of protozoan parasites has also recently been demonstrated for Leishmania. 

Phrase: "The significance of TGF-"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C0237881:Significance [Quantitative Concept]
   753   C0750502:Significance [Idea or Concept]
   753   C1510411:Transforming [Pathologic Function]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]

Phrase: "activation for survival of protozoan parasites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "has"

Phrase: "also recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "demonstrated for Leishmania."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0023270:Leishmania [Eukaryote]
   790   C1095819:Leishmania [Eukaryote]
Processing 00000000.tx.237: Leishmania spp are potent inducers of TGF- (44) and it has recently been reported that cathepsin Blike cysteine proteases of Leishmania donovani and Leishmania chagasi can activate rLatTGF- and that induction and activation of TGF- is causally linked to enhanced parasite survival within the macrophage (45, 46). 

Phrase: "Leishmania spp"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424276:SPP [Gene or Genome]

Phrase: "are"

Phrase: "potent inducers of TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1510411:Transforming [Pathologic Function]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]

Phrase: "(44"

Phrase: ")"

Phrase: "and"

Phrase: "it"

Phrase: "has"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that cathepsin Blike cysteine proteases of Leishmania donovani"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C2717970:Cysteine Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   754 E C0758959:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   754 E C0769345:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   744   C1947941:Proteases [Enzyme]

Phrase: "and"

Phrase: "Leishmania chagasi"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0446195:Leishmania chagasi [Eukaryote]
   861   C0023270:Leishmania [Eukaryote]
   861   C1095819:Leishmania [Eukaryote]

Phrase: "can"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "rLatTGF-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086418:Human [Human]
   812   C0205275:Latent [Qualitative Concept]
   812   C1514798:recombinant [Organism]
   812   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "that induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "activation of TGF-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C2249824:activation of growth [Organism Function]
   760   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "causally"

Phrase: "linked to enhanced parasite survival"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030498:Parasite [Eukaryote]
   760   C0038952:Survival [Activity]
   760   C0220921:survival [Functional Concept]
   760   C2349975:Enhanced [Activity]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]

Phrase: "within the macrophage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024432:macrophage [Cell]

Phrase: "(45,"

Phrase: "46"

Phrase: ")."
Processing 00000000.tx.238: In a very different hostpathogen interaction, that of influenza virus infection, viral neuraminidase has been shown to activate TGF-, leading to apoptosis of virus-infected cells and suppression of T cell activation (47, 48). 

Phrase: "In a very different hostpathogen interaction,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1704675:Interaction [Functional Concept]

Phrase: "that of influenza virus infection,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0029341:Influenza virus [Virus]
   806   C0042769:virus infection [Disease or Syndrome]
   760   C0009450:Infection, NOS [Disease or Syndrome]
   760   C0021400:Influenza [Disease or Syndrome]
   760   C0021403:INFLUENZA [Immunologic Factor,Pharmacologic Substance]
   760   C0042776:Virus [Virus]
   760   C0319157:virus [Virus]

Phrase: "viral neuraminidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027803:Neuraminidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: ","

Phrase: "leading to apoptosis of virus-infected cells"
Meta Candidates (Total=17; Excluded=7; Pruned=0; Remaining=10)
   897   C1159845:apoptosis of virus-infected cells [Cell Function]
           virus-infected cell apoptosis
   748   C0007634:Cells [Cell]
   748   C0042776:Virus [Virus]
   748   C0162638:Apoptosis [Cell Function]
   748   C0319157:virus [Virus]
   748   C0332152:Leading [Temporal Concept]
   748   C0439663:Infected [Functional Concept]
   748   C1522538:Leading [Functional Concept]
   748   C3282337:Cells [Cell]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1269647:Cell [Cell]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "suppression of T cell activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0221103:Suppression [Pathologic Function]
   760   C0301625:Suppression [Organism Function]
   760   C0439181:% suppression [Quantitative Concept]
   760   C0728721:suppression [Mental Process]

Phrase: "(47,"

Phrase: "48"

Phrase: ")."
Processing 00000000.tx.239: In this study we have shown that soluble components of P. falciparum, P. berghei, and P. yoelii pRBCs are directly able to activate both native (platelet-derived) and rLatTGF-. 

Phrase: "In this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that soluble components of P. falciparum,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0449432:Components [Manufactured Object]
   719 E C1705248:Component [Conceptual Entity]

Phrase: "P. berghei,"

Phrase: "and"

Phrase: "P. yoelii pRBCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0014792:rbcs [Cell]

Phrase: "are"

Phrase: "directly able to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]
   827   C1947931:Directly [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "both native"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0302891:Native [Functional Concept]

Phrase: "(platelet-derived"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0005821:Platelet [Cell]
   861   C1441547:Derived [Qualitative Concept]
   861   C3245521:derived [Idea or Concept]
   777 E C1963076:Platelets [Finding]

Phrase: ")"

Phrase: "and"

Phrase: "rLatTGF-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086418:Human [Human]
   812   C0205275:Latent [Qualitative Concept]
   812   C1514798:recombinant [Organism]
   812   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "."
Processing 00000000.tx.240: The activating capacity of P. berghei pRBCs was always noticeably higher than that of P. falciparum pRBCs, suggesting that there are interspecies differences in the ability of malaria parasites to activate TGF-. 

Phrase: "The activating capacity of P. berghei pRBCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1516240:Capacity [Quantitative Concept]

Phrase: "was"

Phrase: "always noticeably higher than that of P. falciparum pRBCs,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   706   C0205250:High [Qualitative Concept]
   706   C1299351:High [Qualitative Concept]
   706   C2700149:HIGH [Intellectual Product]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that there"

Phrase: "are"

Phrase: "interspecies differences in the ability of malaria parasites to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   708   C1705241:*Difference [Quantitative Concept]
   708   C1705242:Difference [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "."
Processing 00000000.tx.241: It remains to be seen whether these differences correlate with virulence. 

Phrase: "It"

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "whether"

Phrase: "these differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "correlate with virulence."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0042765:Virulence [Biologic Function]
   790   C0220936:virulence [Qualitative Concept]
   718 E C1520022:Virulent [Qualitative Concept]
Processing 00000000.tx.242: TGF- activation involves two distinct parasite-derived molecules, a homologue of TSP-1 and an MMP. 

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "involves"

Phrase: "two distinct parasite-derived molecules,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0567416:molecules [Substance]
   721 E C1521991:Molecular [Qualitative Concept]

Phrase: "a homologue of TSP-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1334043:Homologue [Gene or Genome]

Phrase: "and"

Phrase: "an MMP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0919336:MMP [Gene or Genome]
Processing 00000000.tx.243: This suggests that the ability of malaria parasites to activate TGF- has evolved separately from that of Leishmania spp (45, 46). 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the ability of malaria parasites to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "has"

Phrase: "evolved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332253:evolved [Functional Concept]

Phrase: "separately from that of Leishmania spp (45,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0023270:Leishmania [Eukaryote]
   748   C1095819:Leishmania [Eukaryote]
   748   C1424276:SPP [Gene or Genome]

Phrase: "46"

Phrase: ")."
Processing 00000000.tx.244: Activation of the LatTGF- complex can be blocked with antibodies to human TSP-1 and to PfTRAP and TRAP-deficient parasites are significantly impaired in their ability to activate LatTGF-, suggesting that TRAP may mimic the activity of TSP-1. 

Phrase: "Activation of the LatTGF-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "can"

Phrase: "be"

Phrase: "blocked with antibodies"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   824   C0282682:antibody block [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   790   C0028778:Blocked [Pathologic Function]
   790   C0332206:Blocked [Functional Concept]
   790   C2983591:BLOCKED [Research Activity]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   756 E C1533157:Block [Substance]
   756 E C1706084:Block [Geographic Area]
   756 E C2828370:Block [Quantitative Concept]

Phrase: "to human TSP-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0147139:Thrombospondin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1336626:THROMBOSPONDIN I [Gene or Genome]
   827   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and to PfTRAP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "and"

Phrase: "TRAP-deficient parasites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0030498:Parasites [Eukaryote]
   799   C0521066:Parasites. [Functional Concept]

Phrase: "are"

Phrase: "significantly"

Phrase: "impaired in their ability to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0085732:Ability [Organism Attribute]
   760   C0221099:Impaired [Functional Concept]
   760   C0684336:Impaired [Pathologic Function]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "LatTGF-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0205275:Latent [Qualitative Concept]
   861   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that TRAP"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   812   C0001516:Adhesive [Manufactured Object]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0439849:Related [Qualitative Concept]
   812   C0445223:Related [Finding]
   812   C2982905:Adhesive [Manufactured Object]
   779 E C0163712:Relate [Organic Chemical]
   741 E C0080103:Relation [Family Group]
   741 E C0869014:Relations [Social Behavior]

Phrase: "may"

Phrase: "mimic"

Phrase: "the activity of TSP-1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.245: Region II of PfTRAP shows strong homology with the type 1 (properdin-like) repeats of human TSP-1 in which the TGF- binding site has been localized (22) and is flanked by conserved cysteine residues, suggesting that the secondary structure around this sequence is also conserved (28). 

Phrase: "Region II of PfTRAP"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "strong homology with the type 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1334043:Homology [Gene or Genome]
   753   C2697616:Homology [Qualitative Concept]

Phrase: "(properdin-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033452:Properdin [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1418482:PROPERDIN [Gene or Genome]

Phrase: "like"

Phrase: ")"

Phrase: "repeats of human TSP-1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0147139:Thrombospondin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1336626:THROMBOSPONDIN I [Gene or Genome]
   760   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0086418:Human [Human]
   760   C0205341:Repeat [Functional Concept]
   760   C1547730:Repeat [Temporal Concept]
   760   C1705914:Repeat [Conceptual Entity]

Phrase: "in which"

Phrase: "the TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "binding site"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0005456:Binding Site [Receptor]
  1000   C0682969:Binding Site [Amino Acid Sequence]
   861   C0205145:Site [Spatial Concept]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "has"

Phrase: "been"

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "(22"

Phrase: ")"

Phrase: "and"

Phrase: "is"

Phrase: "flanked by conserved cysteine residues,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   726   C0230171:Flank [Body Location or Region]
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the secondary structure around this sequence"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0162807:Secondary Structure [Spatial Concept]
   753   C0027627:secondary [Neoplastic Process]
   753   C0175668:Secondary [Temporal Concept]
   753   C0205436:Secondary [Quantitative Concept]
   753   C0678594:Structure [Spatial Concept]

Phrase: "is"

Phrase: "also"

Phrase: "conserved"

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.246: TRAP or TRAP-related molecules thus have the potential to modulate TGF- activity in a number of different ways. 

Phrase: "TRAP"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   812   C0001516:Adhesive [Manufactured Object]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0439849:Related [Qualitative Concept]
   812   C0445223:Related [Finding]
   812   C2982905:Adhesive [Manufactured Object]
   779 E C0163712:Relate [Organic Chemical]
   741 E C0080103:Relation [Family Group]
   741 E C0869014:Relations [Social Behavior]

Phrase: "or"

Phrase: "TRAP-related molecules thus"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C0567416:molecules [Substance]
   712 E C1521991:Molecular [Qualitative Concept]

Phrase: "have"

Phrase: "the potential to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3245505:Potential [Qualitative Concept]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "activity in a number of different ways."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.247: A monoclonal antibody recognizing an epitope in the COOH-terminal region of PfTRAP was highly effective at low concentrations of inhibiting TGF- activation and a polyclonal serum recognizing the NH2-terminal half of the molecule was also able to inhibit. 

Phrase: "A monoclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0746619:monoclonal [Finding]

Phrase: "recognizing"

Phrase: "an epitope in the COOH-terminal region of PfTRAP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0003316:Epitope [Immunologic Factor]

Phrase: "was"

Phrase: "highly effective at low concentrations of inhibiting TGF-"
Meta Candidates (Total=21; Excluded=1; Pruned=0; Remaining=20)
   782   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   782   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0018270:'growth' NOS [Organism Function]
   739   C0086045:Concentrations [Mental Process]
   739   C0205250:Highly [Qualitative Concept]
   739   C0205251:low [Qualitative Concept]
   739   C0220844:growth [Physiologic Function]
   739   C1280519:effective [Qualitative Concept]
   739   C1299352:Low [Qualitative Concept]
   739   C1510411:Transforming [Pathologic Function]
   739   C1521761:Factor [Functional Concept]
   739   C1550472:low [Idea or Concept]
   739   C1621966:Growth [Organ or Tissue Function]
   739   C1704419:Effective [Qualitative Concept]
   739   C2827422:Factor [Conceptual Entity]
   739   C2911660:Growth [Activity]
   739   C3463820:Inhibiting [Activity]
   722   C0151686:GROWTH RETARDED [Pathologic Function]
   722   C0333951:GROWTH ARRESTS [Pathologic Function]
   706 E C1446561:Concentration [Quantitative Concept]

Phrase: "activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "a polyclonal serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "recognizing"

Phrase: "the NH2-terminal half of the molecule"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2825407:Half [Quantitative Concept]

Phrase: "was"

Phrase: "also able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]

Phrase: "inhibit."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]
Processing 00000000.tx.248: The effects of anti-TRAP antibodies were confirmed by showing that PfTRAP and PbTRAP peptide homologues of the GGWSHW TGF- orientation/binding domain of TSP also inhibited TGF- activation. 

Phrase: "The effects of anti-TRAP antibodies"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   762   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   745 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0001516:Adhesive [Manufactured Object]
   742   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0439849:Related [Qualitative Concept]
   742   C0445223:Related [Finding]
   742   C1280500:effects [Qualitative Concept]
   742   C2982905:Adhesive [Manufactured Object]
   708 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   708 E C0163712:Relate [Organic Chemical]
   708 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "confirmed by showing"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0750484:Confirmed [Idea or Concept]
   756 E C1456348:Confirm [Qualitative Concept]
   756   C1547282:Show [Intellectual Product]

Phrase: "that PfTRAP"

Phrase: "and"

Phrase: "PbTRAP peptide homologues of the GGWSHW TGF-"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   742   C0220844:growth [Physiologic Function]
   742   C0967657:GGWSHW [Amino Acid, Peptide, or Protein]
   742   C1510411:Transforming [Pathologic Function]
   742   C1521761:Factor [Functional Concept]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C2827422:Factor [Conceptual Entity]
   742   C2911660:Growth [Activity]
   708   C1334043:Homologue [Gene or Genome]

Phrase: "orientation/binding domain of TSP also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]
Processing 00000000.tx.249: This suggests that TRAP may bind TGF- but, in the absence of a (K)RFK-like cleavage motif (22), is unable to cause full activation of the latent molecule. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that TRAP"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   812   C0001516:Adhesive [Manufactured Object]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0439849:Related [Qualitative Concept]
   812   C0445223:Related [Finding]
   812   C2982905:Adhesive [Manufactured Object]
   779 E C0163712:Relate [Organic Chemical]
   741 E C0080103:Relation [Family Group]
   741 E C0869014:Relations [Social Behavior]

Phrase: "may"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "but"

Phrase: ","

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of a (K)RFK-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1538827:RFK [Gene or Genome]

Phrase: "like cleavage motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514562:Motif [Amino Acid Sequence]

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "is"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "full activation of the latent molecule."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]
Processing 00000000.tx.250: Thus, TRAP is necessary but not sufficient for TGF- activation by malaria parasites and this study indicates an essential role for MMPs in addition to TRAP or other TSP homologues. 

Phrase: "Thus,"

Phrase: "TRAP"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   812   C0001516:Adhesive [Manufactured Object]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0439849:Related [Qualitative Concept]
   812   C0445223:Related [Finding]
   812   C2982905:Adhesive [Manufactured Object]
   779 E C0163712:Relate [Organic Chemical]
   741 E C0080103:Relation [Family Group]
   741 E C0869014:Relations [Social Behavior]

Phrase: "is"

Phrase: "necessary"

Phrase: "but"

Phrase: "not sufficient for TGF-"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0205410:Sufficient [Qualitative Concept]
   753   C0220844:growth [Physiologic Function]
   753   C1510411:Transforming [Pathologic Function]
   753   C1518422:Not [Functional Concept]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]

Phrase: "activation by malaria parasites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "indicates"

Phrase: "an essential role for MMPs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in addition to TRAP"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   812   C0001516:Adhesive [Manufactured Object]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0439849:Related [Qualitative Concept]
   812   C0445223:Related [Finding]
   812   C2982905:Adhesive [Manufactured Object]
   779 E C0163712:Relate [Organic Chemical]
   741 E C0080103:Relation [Family Group]
   741 E C0869014:Relations [Social Behavior]

Phrase: "or"

Phrase: "other TSP homologues."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1334043:Homologue [Gene or Genome]
Processing 00000000.tx.251: Indeed, recent reports suggest that TSP alone does not activate TGF- but depends on the presence of other factors (49, 50) and a recent study has shown that human MMP-2 (gelatinase A) binds to TSP (51). 

Phrase: "Indeed,"

Phrase: "recent reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that TSP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "but"

Phrase: "depends on the presence of other factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0725813:depend [Medical Device]
   714   C1521761:Factor [Functional Concept]
   714   C2827422:Factor [Conceptual Entity]

Phrase: "(49,"

Phrase: "50"

Phrase: ")"

Phrase: "and"

Phrase: "a recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "has"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that human MMP-2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0172537:MMP-2 [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1334522:MMP2 [Gene or Genome]
   901   C2698024:MMP2 [Laboratory Procedure]
   827   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0919336:MMP [Gene or Genome]

Phrase: "(gelatinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206528:Gelatinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "A)"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "to TSP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(51"

Phrase: ")."
Processing 00000000.tx.252: The role of TRAP, rather than other Plasmodium-derived TSP-like molecules, in TGF- activation was confirmed by experiments with transgenic, TRAP-deficient P. berghei. 

Phrase: "The role of TRAP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "rather than"

Phrase: "other Plasmodium-derived TSP-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "like molecules,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:molecules [Substance]
   916 E C1521991:Molecular [Qualitative Concept]

Phrase: "in TGF-"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0150312:In [Quantitative Concept]
   812   C0220844:growth [Physiologic Function]
   812   C0332285:In [Spatial Concept]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "was"

Phrase: "confirmed by experiments"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0681814:Experiments [Research Activity]
   790   C0750484:Confirmed [Idea or Concept]
   756 E C1456348:Confirm [Qualitative Concept]
   756 E C1706386:Experiment [Conceptual Entity]
   706 E C1517586:Experimental [Qualitative Concept]

Phrase: "with transgenic, TRAP-deficient P. berghei."
Processing 00000000.tx.253: Although TRAP is primarily expressed in sporozoite stages of the parasite, there are reports of expression of TRAP or TRAP-like proteins in blood stages of P. falciparum (52) and recent data indicate that the PbTRAP promoter is leaky with low levels of promoter activity continuing in blood stage parasites (Mnard, R., personal communication). 

Phrase: "Although"

Phrase: "TRAP"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   812   C0001516:Adhesive [Manufactured Object]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0439849:Related [Qualitative Concept]
   812   C0445223:Related [Finding]
   812   C2982905:Adhesive [Manufactured Object]
   779 E C0163712:Relate [Organic Chemical]
   741 E C0080103:Relation [Family Group]
   741 E C0869014:Relations [Social Behavior]

Phrase: "is"

Phrase: "primarily"

Phrase: "expressed in sporozoite stages of the parasite,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   748   C0030498:Parasite [Eukaryote]
   748   C0562648:Sporozoite [Eukaryote]
   748   C1306673:Stages [Qualitative Concept]
   714 E C0205390:Stage [Temporal Concept]
   714 E C1300072:Stage [Clinical Attribute]

Phrase: "there"

Phrase: "are"

Phrase: "reports of expression of TRAP"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0684224:Reports [Intellectual Product]
   744   C0700287:reports [Health Care Activity]
   711 E C3273238:Report [Intellectual Product]

Phrase: "or"

Phrase: "TRAP-"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   812   C0001516:Adhesive [Manufactured Object]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0439849:Related [Qualitative Concept]
   812   C0445223:Related [Finding]
   812   C2982905:Adhesive [Manufactured Object]
   779 E C0163712:Relate [Organic Chemical]
   741 E C0080103:Relation [Family Group]
   741 E C0869014:Relations [Social Behavior]

Phrase: "like proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "stages of P. falciparum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205390:Stage [Temporal Concept]
   770   C1300072:Stage [Clinical Attribute]
   770   C1306673:Stage [Qualitative Concept]

Phrase: "(52"

Phrase: ")"

Phrase: "and"

Phrase: "recent data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that"

Phrase: "the PbTRAP promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "leaky with low levels of promoter activity continuing"

Phrase: "in blood stage parasites"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0562633:blood parasites [Eukaryote]
   827   C0030498:Parasites [Eukaryote]
   827   C0521066:Parasites. [Functional Concept]

Phrase: "(Mnard,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "personal communication"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086792:Personal Communication [Social Behavior]
   861   C0009452:Communication [Social Behavior]

Phrase: ")."
Processing 00000000.tx.254: It is possible that differences between Plasmodium species in levels of TRAP expression by erythrocytic stages might explain the differences that we have observed in their TGF-activating capacity. 

Phrase: "It"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that differences between Plasmodium species"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0178849:species difference [Biologic Function]
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "in levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "of TRAP expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C1171362:protein expression [Genetic Function]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "by erythrocytic stages"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1306673:Stages [Qualitative Concept]
   827 E C0205390:Stage [Temporal Concept]
   827 E C1300072:Stage [Clinical Attribute]

Phrase: "might"

Phrase: "explain"

Phrase: "the differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "that"

Phrase: "we"

Phrase: "have"

Phrase: "observed in their TGF-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1441672:Observed [Functional Concept]
   753   C1510411:Transforming [Pathologic Function]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]

Phrase: "activating capacity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516240:Capacity [Quantitative Concept]
Processing 00000000.tx.255: The proteinase inhibition experiments indicate that MMP-like components of malaria parasites contribute to TGF- activation. 

Phrase: "The proteinase inhibition experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "indicate"

Phrase: "that MMP-like components of malaria parasites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0919336:MMP [Gene or Genome]

Phrase: "contribute to TGF-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   862   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   862   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C1510411:Transforming [Pathologic Function]
   760   C1521761:Factor [Functional Concept]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C1880177:Contribute [Activity]
   760   C2827422:Factor [Conceptual Entity]
   760   C2911660:Growth [Activity]

Phrase: "activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]
Processing 00000000.tx.256: Specifically, we have shown a role for a gelatinase B/MMP-9like but not an MMP-2like moiety. 

Phrase: "Specifically,"

Phrase: "we"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a role for a gelatinase B/MMP-9like"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "an MMP-2like moiety."
Processing 00000000.tx.257: We have shown by zymography that both P. falciparum and P. berghei contain gelatinases. 

Phrase: "We"

Phrase: "have"

Phrase: "shown by zymography"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "both P. falciparum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0858318:p falciparum [Disease or Syndrome]

Phrase: "and"

Phrase: "P. berghei"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "gelatinases."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206528:Gelatinases [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.258: One of these may correspond to the 55-kD heat shock protein of P. vivax that has previously been shown to display MMP activity (32). 

Phrase: "One of these"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205447:One [Quantitative Concept]

Phrase: "may"

Phrase: "correspond to the 55-kD heat shock protein of P. vivax"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   775   C0018850:Heat-Shock Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0282498:Heat Shock [Physiologic Function]
   754   C0007507:Protein 55 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   738   C0018837:Heat [Natural Phenomenon or Process]
   738   C0026691:KD [Disease or Syndrome]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0036974:Shock [Pathologic Function]
   738   C0450382:55 [Intellectual Product]
   738   C1705240:KD [Gene or Genome]
   738   C1839259:KD [Disease or Syndrome]

Phrase: "that"

Phrase: "has"

Phrase: "previously"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "MMP activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.259: Gelatinase activity can be enriched by adsorption of parasite extracts with gelatin-agarose and the enriched material, after elution from gelatin-agarose, retains the ability to activate TGF-. 

Phrase: "Gelatinase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "can"

Phrase: "be"

Phrase: "enriched by adsorption of parasite"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0001674:Adsorption [Laboratory Procedure]
   760   C0030498:Parasite [Eukaryote]
   760   C0359583:enriched [Food]

Phrase: "extracts with gelatin-agarose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   770   C0036681:Agarose [Carbohydrate]
   770   C1145617:Gelatin [Food]
   770   C2828366:Extract [Substance]

Phrase: "and"

Phrase: "the enriched material,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Material [Substance]

Phrase: "after"

Phrase: "elution from gelatin-agarose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1441565:Elution [Laboratory Procedure]

Phrase: "retains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "the ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "."
Processing 00000000.tx.260: Thus, parasite-derived MMPs and TSP-1like molecules can activate LatTGF-, however the precise mechanism remains to be resolved. 

Phrase: "Thus,"

Phrase: "parasite-derived MMPs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0623362:MMPs [Amino Acid, Peptide, or Protein,Enzyme]
   793 E C0919336:MMP [Gene or Genome]

Phrase: "and"

Phrase: "TSP-1like molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "can"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "LatTGF-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0205275:Latent [Qualitative Concept]
   861   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ","

Phrase: "however"

Phrase: "the precise mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "resolved."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514893:Resolved [Idea or Concept]
  1000   C2699488:Resolved [Conceptual Entity]
Processing 00000000.tx.261: There are a number of related models that might explain our findings. 

Phrase: "There"

Phrase: "are"

Phrase: "a number of related models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C3274659:Model Number [Intellectual Product]
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "that"

Phrase: "might"

Phrase: "explain"

Phrase: "our findings."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]
Processing 00000000.tx.262: In the first model, parasite-derived proteases cleave TSP-like molecules (such as TRAP) from the surface membrane of the parasite. 

Phrase: "In the first model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "parasite-derived proteases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C1947941:Proteases [Enzyme]

Phrase: "cleave"

Phrase: "TSP-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "like molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:molecules [Substance]
   916 E C1521991:Molecular [Qualitative Concept]

Phrase: "("

Phrase: "such as TRAP"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   812   C0001516:Adhesive [Manufactured Object]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0439849:Related [Qualitative Concept]
   812   C0445223:Related [Finding]
   812   C2982905:Adhesive [Manufactured Object]
   779 E C0163712:Relate [Organic Chemical]
   741 E C0080103:Relation [Family Group]
   741 E C0869014:Relations [Social Behavior]

Phrase: ")"

Phrase: "from the surface membrane"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0025255:Membrane [Tissue]
   861   C0205148:Surface [Spatial Concept]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "of the parasite."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030498:Parasite [Eukaryote]
Processing 00000000.tx.263: These TSP-like molecules are now free to interact with soluble TGF- and activate it. 

Phrase: "These TSP-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "like molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:molecules [Substance]
   916 E C1521991:Molecular [Qualitative Concept]

Phrase: "are"

Phrase: "now free to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1948052:Now [Temporal Concept]
   827   C1996904:Free [Qualitative Concept]

Phrase: "interact with soluble TGF-"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1510411:Transforming [Pathologic Function]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C1749467:soluble [Cell Component]
   753   C1948047:Soluble [Qualitative Concept]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "it."
Processing 00000000.tx.264: In support of this model, the parasite-derived protease MPP1 of Toxoplasma gondii cleaves a number of membrane-associated micronemal proteins of T. gondii including TgMIC2 (53), a functional homologue of Plasmodium TRAP (54). 

Phrase: "In support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "of this model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "the parasite-derived protease MPP1 of Toxoplasma gondii"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1334525:MPP1 [Gene or Genome]
   744   C1417240:MPP1 [Gene or Genome]

Phrase: "cleaves"

Phrase: "a number of membrane-associated micronemal proteins of T. gondii"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0237753:*Number [Quantitative Concept]
   739   C0449788:Number [Quantitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "TgMIC2"

Phrase: "(53"

Phrase: ")"

Phrase: ","

Phrase: "a functional homologue of Plasmodium TRAP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1334043:Homologue [Gene or Genome]

Phrase: "(54"

Phrase: ")."
Processing 00000000.tx.265: Cleavage takes place within the transmembrane domain leading to release of soluble protein (53, 55). 

Phrase: "Cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010813:cleavage [Cell Function]
  1000   C0596311:Cleavage [Phenomenon or Process]
  1000   C1330957:cleavage [Cell Function]

Phrase: "takes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "place within the transmembrane domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0442504:Place [Spatial Concept]
   760   C1704765:Place [Functional Concept]
   760   C1882509:Place [Activity]
   760   C3496241:place [Disease or Syndrome]

Phrase: "leading"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332152:Leading [Temporal Concept]
  1000   C1522538:Leading [Functional Concept]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "release of soluble protein (53,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0030685:Release [Health Care Activity]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1749467:soluble [Cell Component]
   760   C1948047:Soluble [Qualitative Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.266: One class of enzymes that is able to cleave polypeptides within cell membranes are the site 2 zinc MMPs (56). 

Phrase: "One class of enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456387:Class [Intellectual Product]
   770   C1705943:Class [Classification]

Phrase: "that"

Phrase: "is"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "cleave"

Phrase: "polypeptides within cell membranes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]

Phrase: "are"

Phrase: "the site 2 zinc MMPs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0623362:MMPs [Amino Acid, Peptide, or Protein,Enzyme]
   779 E C0919336:MMP [Gene or Genome]

Phrase: "(56"

Phrase: ")."
Processing 00000000.tx.267: The transmembrane cleavage motif is highly conserved in micronemal proteins of apicomplexa, including PfTRAP, PbTRAP, and circumsporozoite TRAP-related protein, and PbTRAP can be cleaved by T. gondii proteases (55), suggesting that the proteolytic enzyme is functionally conserved. 

Phrase: "The transmembrane cleavage motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514562:Motif [Amino Acid Sequence]

Phrase: "is"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "conserved in micronemal proteins of apicomplexa,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0085316:Apicomplexa [Eukaryote]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "PfTRAP,"

Phrase: "PbTRAP,"

Phrase: "and"

Phrase: "circumsporozoite TRAP-related protein,"

Phrase: "and"

Phrase: "PbTRAP"

Phrase: "can"

Phrase: "be"

Phrase: "cleaved by T. gondii proteases"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0205242:Cleaved [Spatial Concept]
   760   C0333853:Cleaved [Cell]
   760   C1947941:Proteases [Enzyme]

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the proteolytic enzyme"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0030940:Proteolytic enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1947941:Proteolytic Enzyme [Enzyme]
           proteolytic
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   861   C0597304:Proteolytic [Molecular Function]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "is"

Phrase: "functionally"

Phrase: "conserved."
Processing 00000000.tx.268: T. gondii MPP1 is constitutively active on the parasite surface (55), suggesting that the homologous enzyme in Plasmodium might be expressed on merozoites and come into contact with plasma proteins at schizont rupture. 

Phrase: "T. gondii MPP1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1334525:MPP1 [Gene or Genome]
   827   C1417240:MPP1 [Gene or Genome]

Phrase: "is"

Phrase: "constitutively active on the parasite surface"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205177:Active [Functional Concept]

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the homologous enzyme in Plasmodium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0014442:Enzyme [Enzyme,Organic Chemical]

Phrase: "might"

Phrase: "be"

Phrase: "expressed on merozoites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0444659:Merozoites [Eukaryote]

Phrase: "and"

Phrase: "come into contact"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332158:contact [Functional Concept]
   790   C0337611:Contact [Population Group]
   790   C1705415:Contact [Idea or Concept]

Phrase: "with plasma proteins"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0032120:Plasma Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C0036825:Plasma Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0032105:Plasma [Body Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "at schizont rupture."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1881712:RUPTURE [Phenomenon or Process]
   861   C3203359:Rupture [Injury or Poisoning]
Processing 00000000.tx.269: Alternatively, a two step activation process has been described for TGF- in epithelial tissues that involves the binding of the integrin v8 to the RGD motif of LAP followed by cleavage of LAP by a membrane-type 1-MMP (MT1-MMP; reference 57). 

Phrase: "Alternatively,"

Phrase: "a two step activation process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1184743:Process [Body Part, Organ, or Organ Component]
   812   C1522240:Process [Phenomenon or Process]

Phrase: "has"

Phrase: "been"

Phrase: "described for TGF-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   862   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   862   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C1510411:Transforming [Pathologic Function]
   760   C1521761:Factor [Functional Concept]
   760   C1552738:described [Idea or Concept]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2827422:Factor [Conceptual Entity]
   760   C2911660:Growth [Activity]

Phrase: "in epithelial tissues"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0014609:epithelial tissues [Tissue]
   900 E C0221908:Epithelial [Qualitative Concept]
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "that"

Phrase: "involves"

Phrase: "the binding of the integrin v8"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1149503:Integrin Binding [Molecular Function]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "to the RGD motif"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052350:RGD Motif [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1514562:Motif [Amino Acid Sequence]

Phrase: "of LAP"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332281:Associated [Qualitative Concept]
   793 E C0750490:Associate [Idea or Concept]
   793 E C1706221:Associate [Professional or Occupational Group]
   755   C0205275:Latent [Qualitative Concept]

Phrase: "followed by cleavage of LAP"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   778   C0332283:Followed by [Temporal Concept]
           followed
   774   C0597304:Protein Cleavage [Molecular Function]
   748   C0010813:cleavage [Cell Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0332281:Associated [Qualitative Concept]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]
   714 E C1719822:Follow [Intellectual Product]

Phrase: "by a membrane-type 1-MMP (MT1-MMP"

Phrase: "; reference 57"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514811:Reference [Idea or Concept]
   861   C1706462:Reference [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.270: By analogy, PfTRAP or a related protein could bind to LAP via the GXWXXW domain, allowing a parasite-encoded matrix MMP to then cleave the latency protein. 

Phrase: "By analogy,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0679213:analogy [Idea or Concept]
   900 E C0243071:Analog [Chemical Viewed Structurally]

Phrase: "PfTRAP"

Phrase: "or"

Phrase: "a related protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "could"

Phrase: "bind to LAP"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332281:Associated [Qualitative Concept]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "via the GXWXXW domain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "allowing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowing [Social Behavior]

Phrase: "a parasite-encoded matrix MMP to then"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0919336:MMP [Gene or Genome]

Phrase: "cleave"

Phrase: "the latency protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.271: In a third model, binding and cleavage of LatTGF- could be mediated by a single bifunctional molecule such as a member of the disintegrin and MMP domain TSP type-1 zinc MMP family of enzymes (58), which are characterized by the presence of a variable number of TSP type-1 repeats upstream of MMP and disintegrin-like domains. 

Phrase: "In a third model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "cleavage of LatTGF-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]

Phrase: "could"

Phrase: "be"

Phrase: "mediated by a single bifunctional molecule"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0872367:single molecule [Substance]
   753   C0037179:Single [Population Group]
   753   C0086597:mediated [Social Behavior]
   753   C0087136:single [Finding]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0205171:Single [Quantitative Concept]
   753   C0567416:Molecule [Substance]

Phrase: "such as a member"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0680022:member [Population Group]
  1000   C2698041:Member [Professional or Occupational Group]

Phrase: "of the disintegrin"

Phrase: "and"

Phrase: "MMP domain TSP type-1 zinc MMP family of enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0015576:Family [Family Group]
   739   C1704727:Family [Conceptual Entity]

Phrase: "(58"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "are"

Phrase: "characterized by the presence of a variable number of TSP type-1 repeats"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   750   C0441729:Type 1 [Classification]
   749   C0147139:Thrombospondin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   749   C1336626:thrombospondin 1 [Gene or Genome]
   749   C1882124:Number Type [Conceptual Entity]
   735   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   735   C0205341:repeats [Functional Concept]
   735   C0237753:*Number [Quantitative Concept]
   735   C0332307:Type [Qualitative Concept]
   735   C0392148:Presence [Therapeutic or Preventive Procedure]
   735   C0439828:Variable [Qualitative Concept]
   735   C0449788:Number [Quantitative Concept]
   735   C1547052:*Type [Quantitative Concept]
   735   C1705914:Repeats [Conceptual Entity]
   735   C1880022:Characterized [Activity]
   702 E C1547730:Repeat [Temporal Concept]

Phrase: "upstream of MMP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0919336:MMP [Gene or Genome]

Phrase: "and"

Phrase: "disintegrin-like domains."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   896   C1511990:Disintegrin Domain [Amino Acid Sequence]
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.272: Several P. falciparum proteins appear to contain both MMP domains and TSP type-1 repeats. 

Phrase: "Several P. falciparum proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "both MMP domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "TSP type-1 repeats."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   875   C0147139:Thrombospondin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C1336626:thrombospondin 1 [Gene or Genome]
   861   C0441729:Type 1 [Classification]
   812   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0205341:repeats [Functional Concept]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]
   812   C1705914:Repeats [Conceptual Entity]
   779 E C1547730:Repeat [Temporal Concept]
Processing 00000000.tx.273: These include TRAP itself, the circumsporozoite protein, and circumsporozoite TRAP-related protein. 

Phrase: "These"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "TRAP"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   812   C0001516:Adhesive [Manufactured Object]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0439849:Related [Qualitative Concept]
   812   C0445223:Related [Finding]
   812   C2982905:Adhesive [Manufactured Object]
   779 E C0163712:Relate [Organic Chemical]
   741 E C0080103:Relation [Family Group]
   741 E C0869014:Relations [Social Behavior]

Phrase: "itself,"

Phrase: "the circumsporozoite protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0055782:circumsporozoite protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "circumsporozoite TRAP-related protein."
Processing 00000000.tx.274: The observation that gelatin-purified material from wild-type parasites retains TGF-activating capacity whereas that of Pb TRAP ko pRBC has very little TGF-activating capacity, suggesting that the TRAP and MMP moieties are linked in some way, tends to support this latter model of TGF- activation. 

Phrase: "The observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that gelatin-purified material from wild-type parasites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0520510:Material [Substance]

Phrase: "retains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "activating capacity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516240:Capacity [Quantitative Concept]

Phrase: "whereas"

Phrase: "that of Pb TRAP ko pRBC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0560617:knock out [Injury or Poisoning]
   760   C1522225:Knock-out [Experimental Model of Disease]

Phrase: "has"

Phrase: "very little TGF-"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   884   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
   804   C0220844:growth [Physiologic Function]
   804   C0442824:Very [Qualitative Concept]
   804   C0700321:Little [Quantitative Concept]
   804   C1510411:Transforming [Pathologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2700395:Little [Quantitative Concept]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]

Phrase: "activating capacity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516240:Capacity [Quantitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the TRAP"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   812   C0001516:Adhesive [Manufactured Object]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0439849:Related [Qualitative Concept]
   812   C0445223:Related [Finding]
   812   C2982905:Adhesive [Manufactured Object]
   779 E C0163712:Relate [Organic Chemical]
   741 E C0080103:Relation [Family Group]
   741 E C0869014:Relations [Social Behavior]

Phrase: "and"

Phrase: "MMP moieties"

Phrase: "are"

Phrase: "linked in some way,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "tends"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "this latter model of TGF-"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   814   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   814   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C1080058:This [Eukaryote]
   748   C1510411:Transforming [Pathologic Function]
   748   C1521761:Factor [Functional Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]
   748   C3161035:Model [Intellectual Product]

Phrase: "activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]
Processing 00000000.tx.275: In summary, we have described an entirely novel mechanism of pathogen-mediated TGF- activation. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "we"

Phrase: "have"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "an entirely novel mechanism of pathogen-mediated TGF-"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   782   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   782   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0018270:'growth' NOS [Organism Function]
   739   C0086597:mediated [Social Behavior]
   739   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   739   C0205314:Novel [Temporal Concept]
   739   C0220844:growth [Physiologic Function]
   739   C0441712:Mechanism [Functional Concept]
   739   C0450254:Pathogen [Organism]
   739   C0679622:novel [Intellectual Product]
   739   C1510411:Transforming [Pathologic Function]
   739   C1521761:Factor [Functional Concept]
   739   C1621966:Growth [Organ or Tissue Function]
   739   C1706376:Mechanism [Manufactured Object]
   739   C2827422:Factor [Conceptual Entity]
   739   C2911660:Growth [Activity]

Phrase: "activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]
Processing 00000000.tx.276: In contrast to the mechanisms described for other pathogens, our data indicate that activation of TGF- by malaria parasites is similar to endogenous TGF- activation in the mammalian host, suggesting either conservation of TGF-activating mechanisms or convergent evolution. 

Phrase: "In contrast to the mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "described for other pathogens,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552738:described [Idea or Concept]
   737   C0450254:Pathogen [Organism]

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that activation of TGF-"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   820   C2249824:activation of growth [Organism Function]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1510411:Transforming [Pathologic Function]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C1879547:Activation [Activity]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]

Phrase: "by malaria parasites"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C1271614:Malarial parasites [Eukaryote]
   861   C0030498:Parasites [Eukaryote]
   861   C0521066:Parasites. [Functional Concept]

Phrase: "is"

Phrase: "similar to endogenous TGF-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "activation in the mammalian host,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "either conservation of TGF-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1510411:Transforming [Pathologic Function]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2347858:Conservation [Qualitative Concept]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]

Phrase: "activating mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "or"

Phrase: "convergent evolution."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0015219:Evolution [Genetic Function]
   789   C0443193:Convergence [Spatial Concept]
   789   C1446614:Convergence [Finding]
   789   C2700387:Convergence [Activity]
Processing 00000000.tx.277: The conservation within apicomplexan protozoa of the key molecular motifs required for TGF- activation suggests that these data might be relevant to other infections, including toxoplasmosis. 

Phrase: "The conservation within apicomplexan protozoa of the key molecular motifs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C2347858:Conservation [Qualitative Concept]

Phrase: "required for TGF-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   862   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   862   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C1510411:Transforming [Pathologic Function]
   760   C1514873:Required [Functional Concept]
   760   C1521761:Factor [Functional Concept]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2827422:Factor [Conceptual Entity]
   760   C2911660:Growth [Activity]

Phrase: "activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "might"

Phrase: "be"

Phrase: "relevant to other infections,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2347946:Relevant [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "toxoplasmosis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040558:Toxoplasmosis [Disease or Syndrome]
Processing 00000000.tx.278: Furthermore, the fact that many different classes of pathogens (viruses, protozoa, and helminths) have independently evolved mechanisms by which to modulate the TGF- pathway suggests that regulation of TGF- activity might be a crucial component of pathogen virulence. 

Phrase: "Furthermore,"

Phrase: "the fact"

Phrase: "that"

Phrase: "many different classes of pathogens"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0684000:class differences [Finding]
   760   C0456387:Class [Intellectual Product]
   760   C1705943:Class [Classification]

Phrase: "(viruses,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042776:Viruses [Virus]
  1000   C0521026:viruses [Functional Concept]
   966 E C0319157:virus [Virus]

Phrase: "protozoa,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033739:Protozoa [Eukaryote]
  1000   C1562573:protozoa [Functional Concept]

Phrase: "and"

Phrase: "helminths"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018893:Helminths [Eukaryote]
  1000   C0220846:helminths [Functional Concept]

Phrase: ")"

Phrase: "have"

Phrase: "independently evolved mechanisms by which to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0441712:Mechanisms [Functional Concept]
   719 E C1706376:Mechanism [Manufactured Object]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathway [Molecular Function]
  1000   C1705987:Pathway [Conceptual Entity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that regulation of TGF-"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   833   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   820   C1160191:regulation of growth [Organism Function]
           growth regulation
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]
   753   C1510411:Transforming [Pathologic Function]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]

Phrase: "activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "might"

Phrase: "be"

Phrase: "a crucial component of pathogen virulence."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449432:Component [Manufactured Object]
   753   C1705248:Component [Conceptual Entity]
Processing 00000000.tx.279: We have recently demonstrated that differences in virulence between strains of the rodent parasite P. yoelii are due to differential induction of bioactive TGF- (17). 

Phrase: "We"

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "demonstrated"

Phrase: "that differences in virulence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "between strains"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0080194:Strains [Injury or Poisoning]
  1000   C0456178:strains [Intellectual Product]
   966 E C1518614:Strain [Organism]
   966 E C2987481:Strain [Mental Process]

Phrase: "of the rodent parasite P. yoelii"

Phrase: "are due to differential induction of bioactive TGF-"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   782   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   782   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0678226:Due to [Functional Concept]
           due
   757   C2752783:differential growth [Organism Function]
   739   C0018270:'growth' NOS [Organism Function]
   739   C0205263:Induction [Functional Concept]
   739   C0220844:growth [Physiologic Function]
   739   C0443199:Differential [Qualitative Concept]
   739   C0857127:induction [Therapeutic or Preventive Procedure]
   739   C1510411:Transforming [Pathologic Function]
   739   C1521761:Factor [Functional Concept]
   739   C1551058:Are [Quantitative Concept]
   739   C1621966:Growth [Organ or Tissue Function]
   739   C1705242:Differential [Qualitative Concept]
   739   C2827422:Factor [Conceptual Entity]
   739   C2911660:Growth [Activity]
   739   C3146286:Due [Idea or Concept]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.280: It remains to be seen whether differences in virulence between other parasite species might also be explained by their relative ability to regulate TGF- activity.  

Phrase: "It"

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "whether"

Phrase: "differences in virulence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "between other parasite species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "might"

Phrase: "also"

Phrase: "be"

Phrase: "explained by their relative ability to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0080103:Relative [Family Group]
   753   C0085732:Ability [Organism Attribute]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: "regulate"

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.281: Acknowledgments  We thank Kathryn Robson and Andrea Crisanti for providing anti-TRAP monoclonal antibodies, Robert Mnard and Victor Nussenzweig for facilitating access to P. berghei transgenic parasites, Mike Blackman for providing antimerozoite protein 1 monoclonal antibody X509, Claire Swales for mycoplasma testing of parasite cultures, Maggie Long for peptide synthesis, Ted Tarelli for matrix-assisted laser desorption time-of-flight mass spectroscopy analysis, and Paul Kaye for reviewing the manuscript. 

Phrase: "Acknowledgments"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Kathryn Robson"

Phrase: "and"

Phrase: "Andrea Crisanti for providing anti-TRAP monoclonal antibodies,"
Meta Candidates (Total=18; Excluded=5; Pruned=0; Remaining=13)
   756   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   756   C1317659:Protein.monoclonal [Laboratory or Test Result]
   754 E C0443737:Monoclonal protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754 E C0700271:monoclonal protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   738   C0001516:Adhesive [Manufactured Object]
   738   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0439849:Related [Qualitative Concept]
   738   C0445223:Related [Finding]
   738   C0746619:monoclonal [Finding]
   738   C2982905:Adhesive [Manufactured Object]
   737 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   737   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   704 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   704 E C0163712:Relate [Organic Chemical]
   704   C1999230:Provide [Activity]

Phrase: "Robert Mnard"

Phrase: "and"

Phrase: "Victor Nussenzweig for facilitating access"

Phrase: "to P. berghei transgenic parasites,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030498:Parasites [Eukaryote]
   812   C0521066:Parasites. [Functional Concept]

Phrase: "Mike Blackman for providing antimerozoite protein 1 monoclonal antibody X509,"

Phrase: "Claire Swales for mycoplasma testing of parasite cultures,"

Phrase: "Maggie"

Phrase: "Long for peptide synthesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205166:Long [Qualitative Concept]
   770   C1706317:Long [Qualitative Concept]

Phrase: "Ted Tarelli"

Phrase: "for matrix-assisted laser desorption time-of-flight mass spectroscopy analysis,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   850   C1718396:Time of analysis [Temporal Concept]
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "Paul Kaye for reviewing"

Phrase: "the manuscript."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600659:Manuscript [Intellectual Product,Manufactured Object]
Processing 00000000.tx.282: We also thank Mike Blackman, David Baker, Robert Mnard, and Victor Nussenzweig for useful discussions and guidance. 

Phrase: "We also"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Mike Blackman,"

Phrase: "David Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0238749:Baker [Professional or Occupational Group]

Phrase: "Robert Mnard,"

Phrase: "and"

Phrase: "Victor Nussenzweig for useful discussions"

Phrase: "and"

Phrase: "guidance."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150600:Guidance [Health Care Activity]
  1000   C1959633:Guidance [Clinical Attribute]
Processing 00000000.tx.283: This study was funded by the Wellcome Trust (grant no. 058069). 

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "funded by the Wellcome Trust"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0016820:funded [Quantitative Concept]
   760   C0237935:Trust [Individual Behavior]
   760   C3245466:trust [Idea or Concept]

Phrase: "(grant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018173:Grant [Quantitative Concept]
  1000   C1548284:Grant [Idea or Concept]

Phrase: "no. 058069"

Phrase: ")."
Processing 00000000.tx.284: Submitted: May 1, 2003 Accepted: October 15, 2003  Footnotes  A.A. 

Phrase: "Submitted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515023:Submitted [Functional Concept]

Phrase: ":"

Phrase: "May 1,"

Phrase: "2003"

Phrase: "Accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: ":"

Phrase: "October 15,"

Phrase: "2003  Footnotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2825232:Footnote [Intellectual Product]

Phrase: "A."

Phrase: "A."
Processing 00000000.tx.285: Sultan's present address is Department of Immunology and Infectious Diseases, Harvard School of Public Health, 665 Huntington Avenue, Boston, MA 02115. 

Phrase: "Sultan's present address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0376649:Address [Intellectual Product]
   827   C1442065:Address [Spatial Concept]

Phrase: "is"

Phrase: "Department of Immunology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Infectious Diseases,"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
  1000   C0009450:Infectious Diseases [Disease or Syndrome]
           Infection, NOS
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]
   768 E C0030657:infectivity [Qualitative Concept]
   761 E C0439663:Infected [Functional Concept]

Phrase: "Harvard School of Public Health,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   844   C0036382:School, Public Health [Health Care Related Organization,Manufactured Object]
   797   C0036370:School Health [Health Care Activity]
   797   C0557800:Public school [Manufactured Object,Organization]
   760   C0036375:School [Manufactured Object,Organization]

Phrase: "665 Huntington Avenue,"

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA 02115."
Processing 00000000.tx.286: Abbreviations used in this paper: huLatTGF-, latent human TGF-; 

Phrase: "Abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used in this paper"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0030351:Paper [Manufactured Object]
   770   C1273517:used [Finding]
   770   C1547566:Paper [Idea or Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: ":"

Phrase: "huLatTGF-,"

Phrase: "latent human TGF-"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   884   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0086418:Human [Human]
   804   C0205275:Latent [Qualitative Concept]
   804   C0220844:growth [Physiologic Function]
   804   C1510411:Transforming [Pathologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]

Phrase: ";"
Processing 00000000.tx.287: LAP, latency-associated protein; 

Phrase: "LAP,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332281:Associated [Qualitative Concept]
   793 E C0750490:Associate [Idea or Concept]
   793 E C1706221:Associate [Professional or Occupational Group]
   755   C0205275:Latent [Qualitative Concept]

Phrase: "latency-associated protein"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332281:Associated [Qualitative Concept]
   793 E C0750490:Associate [Idea or Concept]
   793 E C1706221:Associate [Professional or Occupational Group]
   755   C0205275:Latent [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.288: LatTGF-, latent TGF-; 

Phrase: "LatTGF-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0205275:Latent [Qualitative Concept]
   861   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ","

Phrase: "latent TGF-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0205275:Latent [Qualitative Concept]
   812   C0220844:growth [Physiologic Function]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: ";"
Processing 00000000.tx.289: MMP, metalloproteinase; 

Phrase: "MMP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0919336:MMP [Gene or Genome]

Phrase: "metalloproteinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.290: PbTRAP, P. berghei thrombospondin-related adhesive protein; 

Phrase: "PbTRAP,"

Phrase: "P. berghei thrombospondin-related adhesive protein"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   895   C0082731:P-protein [Amino Acid, Peptide, or Protein,Enzyme]
   895   C1151818:P-protein [Molecular Function]
   799   C0001516:Adhesive [Manufactured Object]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0439849:Related [Qualitative Concept]
   799   C0445223:Related [Finding]
   799   C2982905:Adhesive [Manufactured Object]
   766 E C0163712:Relate [Organic Chemical]
   727 E C0080103:Relation [Family Group]
   727 E C0869014:Relations [Social Behavior]

Phrase: ";"
Processing 00000000.tx.291: Pb TRAP ko, PbTRAP knockout; 

Phrase: "Pb TRAP ko,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0560617:knock out [Injury or Poisoning]
   861   C1522225:Knock-out [Experimental Model of Disease]

Phrase: "PbTRAP knockout"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0560617:knock out [Injury or Poisoning]
   861   C1522225:Knock-out [Experimental Model of Disease]

Phrase: ";"
Processing 00000000.tx.292: Pb WT, wild-type P. berghei; 

Phrase: "Pb WT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2700323:WT [Fish]

Phrase: "wild-type P. berghei"

Phrase: ";"
Processing 00000000.tx.293: PfSL, P. falciparum schizont lysate; 

Phrase: "PfSL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1881488:Lysate [Physical Object]

Phrase: "P. falciparum schizont lysate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1881488:Lysate [Physical Object]

Phrase: ";"
Processing 00000000.tx.294: PfTRAP, P. falciparum thrombospondin-related adhesive protein; 

Phrase: "PfTRAP,"

Phrase: "P. falciparum thrombospondin-related adhesive protein"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   895   C0082731:P-protein [Amino Acid, Peptide, or Protein,Enzyme]
   895   C1151818:P-protein [Molecular Function]
   799   C0001516:Adhesive [Manufactured Object]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0439849:Related [Qualitative Concept]
   799   C0445223:Related [Finding]
   799   C2982905:Adhesive [Manufactured Object]
   766 E C0163712:Relate [Organic Chemical]
   727 E C0080103:Relation [Family Group]
   727 E C0869014:Relations [Social Behavior]

Phrase: ";"
Processing 00000000.tx.295: pRBC, parasitized RBC; 

Phrase: "pRBC,"

Phrase: "parasitized RBC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014792:RBC [Cell]

Phrase: ";"
Processing 00000000.tx.296: rHuTSP-1, recombinant human thrombospondin 1; 

Phrase: "rHuTSP-1,"

Phrase: "recombinant human thrombospondin 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0147139:Thrombospondin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1336626:THROMBOSPONDIN I [Gene or Genome]
   812   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.297: rLatTGF-, recombinant latent human TGF-; 

Phrase: "rLatTGF-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086418:Human [Human]
   812   C0205275:Latent [Qualitative Concept]
   812   C1514798:recombinant [Organism]
   812   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ","

Phrase: "recombinant latent human TGF-"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   919   C1527194:Recombinant Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Transforming Growth Factor
   904   C1515377:Recombinant Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0086418:Human [Human]
   799   C0205275:Latent [Qualitative Concept]
   799   C0220844:growth [Physiologic Function]
   799   C1510411:Transforming [Pathologic Function]
   799   C1514798:recombinant [Organism]
   799   C1521761:Factor [Functional Concept]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]

Phrase: ";"
Processing 00000000.tx.298: TSP, thrombospondin; 

Phrase: "TSP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "thrombospondin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.299: uRBC, uninfected RBC.  

Phrase: "uRBC,"

Phrase: "uninfected RBC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014792:RBC [Cell]
Processing 00000000.tx.300: References Top Abstract Introduction Materials and Methods Results Discussion References  Doolan, D., and M. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Doolan,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.301: Good. 

Phrase: "Good."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205170:Good [Qualitative Concept]
Processing 00000000.tx.302: 1999. 

Phrase: "1999."
Processing 00000000.tx.303: Immune effector mechanisms in malaria. 

Phrase: "Immune effector mechanisms in malaria."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0441712:Mechanisms [Functional Concept]
   726 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.304: Curr. 

Phrase: "Curr."
Processing 00000000.tx.305: Opin. 

Phrase: "Opin."
Processing 00000000.tx.306: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.307: 11:412419.[CrossRef][Medline] de Souza, J.B., and E.M. 

Phrase: "11"

Phrase: ":"

Phrase: "412419."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] de Souza,"

Phrase: "J.B.,"

Phrase: "and"

Phrase: "E.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.308: Riley. 

Phrase: "Riley."
Processing 00000000.tx.309: 2002. 

Phrase: "2002."
Processing 00000000.tx.310: Cerebral malaria: the contribution of animal studies to our understanding of immunopathogenesis. 

Phrase: "Cerebral malaria"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0024534:Malaria, Cerebral [Disease or Syndrome]
   861   C0024530:Malaria [Disease or Syndrome]
   861   C2984572:Malaria [Functional Concept]
   777 E C1721089:Marsh [Natural Phenomenon or Process]

Phrase: ":"

Phrase: "the contribution of animal studies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880177:Contribution [Activity]

Phrase: "to our understanding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understanding [Mental Process]

Phrase: "of immunopathogenesis."
Processing 00000000.tx.311: Microbes Infect. 

Phrase: "Microbes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0445623:Microbe [Organism]

Phrase: "Infect."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439663:infect [Functional Concept]
Processing 00000000.tx.312: 4:291300.[CrossRef][Medline] Engwerda, C., T. 

Phrase: "4"

Phrase: ":"

Phrase: "291300."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Engwerda,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.313: Mynott, S. 

Phrase: "Mynott,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.314: Sawhney, J.B. 

Phrase: "Sawhney,"

Phrase: "J.B."
Processing 00000000.tx.315: De Souza, Q. 

Phrase: "De Souza,"

Phrase: "Q."
Processing 00000000.tx.316: Bickle, and P. 

Phrase: "Bickle,"

Phrase: "and"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.317: Kaye. 

Phrase: "Kaye."
Processing 00000000.tx.318: 2002. 

Phrase: "2002."
Processing 00000000.tx.319: Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria. 

Phrase: "Locally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517927:Locally [Spatial Concept]

Phrase: "up-regulated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0547043:Up [Spatial Concept]
   861   C0851285:Regulated [Governmental or Regulatory Activity]
   861   C1282911:Up [Spatial Concept]

Phrase: "lymphotoxin alpha,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0024320:Lymphotoxin-alpha [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Lymphotoxin
  1000   C0812308:LYMPHOTOXIN-ALPHA [Gene or Genome]
  1000   C1527150:Lymphotoxin-Alpha [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
           Lymphotoxin
   861   C0439095:Alpha [Intellectual Product]
   861   C2003941:Alpha [Intellectual Product]
   861   C2350010:Alpha [Qualitative Concept]

Phrase: "not systemic tumor necrosis factor alpha,"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   901   C0041368:tumor necrosis factor-alpha [Amino Acid, Peptide, or Protein,Immunologic Factor]
           tumor necrosis factor
   901   C1168005:Tumor Necrosis Factor alpha [Laboratory Procedure]
   901   C1456820:Tumor Necrosis Factor-alpha [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Tumour necrosis factor
   861   C1323304:tumor necrosis factor [Molecular Function]
   827   C0333516:Tumor necrosis [Neoplastic Process]
   799   C0027540:Necrosis [Organ or Tissue Function]
   799   C0027651:Tumor [Neoplastic Process]
   799   C0439095:Alpha [Intellectual Product]
   799   C1334928:Necrosis [Finding]
   799   C1521761:Factor [Functional Concept]
   799   C1578706:Tumor [Intellectual Product]
   799   C2003941:Alpha [Intellectual Product]
   799   C2350010:Alpha [Qualitative Concept]
   799   C2827422:Factor [Conceptual Entity]
   799   C3273930:Tumor [Finding]

Phrase: "is"

Phrase: "the principle mediator of murine cerebral malaria."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.320: J. 

Phrase: "J."
Processing 00000000.tx.321: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.322: Med. 

Phrase: "Med."
Processing 00000000.tx.323: 195:13711377.[Abstract/Free FullText] Luty, A.J.F., B. 

Phrase: "195"

Phrase: ":"

Phrase: "13711377."

Phrase: "[Abstract/Free FullText"

Phrase: "] Luty,"

Phrase: "A.J.F.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]
   734   C1510707:A/J [Mammal]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.324: Lell, R. 

Phrase: "Lell,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.325: Schmidt-Ott, L.G. 

Phrase: "Schmidt-Ott,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1423088:OTT [Gene or Genome]
   861   C3273338:OTT [Gene or Genome]

Phrase: "L.G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439294:l g [Quantitative Concept]
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.326: Lehman, D. 

Phrase: "Lehman,"

Phrase: "D."
Processing 00000000.tx.327: Luckner, B. 

Phrase: "Luckner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.328: Greve, P. 

Phrase: "Greve,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.329: Matsusek, K. 

Phrase: "Matsusek,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.330: Herbich, D. 

Phrase: "Herbich,"

Phrase: "D."
Processing 00000000.tx.331: Schmid, F. 

Phrase: "Schmid,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331895:Schmid [Health Care Related Organization]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.332: Migot-Nabias, et al. 

Phrase: "Migot-Nabias,"

Phrase: "et al."
Processing 00000000.tx.333: 1999. 

Phrase: "1999."
Processing 00000000.tx.334: Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children. 

Phrase: "Interferon-gamma responses"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   827   C0871261:responses [Organism Attribute]
   793 E C1704632:Response [Finding]
   793 E C1706817:Response [Intellectual Product]
   793 E C2911692:Response [Mental Process]
   734   C0021740:Interferon Gamma [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C0021745:Interferon-gamma [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C1149405:interferon-gamma [Molecular Function]
   734   C2757040:Interferon gamma [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "are"

Phrase: "associated with resistance"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0237834:Resistance [Mental Process]
   790   C1514892:Resistance [Physiologic Function]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
   718 E C0332325:Resistant [Functional Concept]
   718 E C1550464:resistent [Idea or Concept]
   718 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "to reinfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205339:Reinfection [Functional Concept]

Phrase: "with Plasmodium falciparum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032150:Plasmodium falciparum [Eukaryote]
   861   C0032148:Plasmodium [Eukaryote]
   861   C3541306:Plasmodium [Laboratory Procedure]

Phrase: "in young African children."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   896   C0728836:Young Child [Age Group]
   827   C0008059:Children [Age Group]
   827   C0680063:Children [Family Group]
Processing 00000000.tx.335: J. 

Phrase: "J."
Processing 00000000.tx.336: Infect. 

Phrase: "Infect."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439663:infect [Functional Concept]
Processing 00000000.tx.337: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.338: 179:980988.[CrossRef][Medline] Kremsner, P.G., X. 

Phrase: "179"

Phrase: ":"

Phrase: "980988."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kremsner,"

Phrase: "P.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "X."
Processing 00000000.tx.339: Winkler, E. 

Phrase: "Winkler,"

Phrase: "E."
Processing 00000000.tx.340: Wilding, J. 

Phrase: "Wilding,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445392:wilding [Intellectual Product]

Phrase: "J."
Processing 00000000.tx.341: Prada, U. 

Phrase: "Prada,"

Phrase: "U."
Processing 00000000.tx.342: Bienzle, W. 

Phrase: "Bienzle,"

Phrase: "W."
Processing 00000000.tx.343: Graninger, and A. 

Phrase: "Graninger,"

Phrase: "and"

Phrase: "A."
Processing 00000000.tx.344: Nussler. 

Phrase: "Nussler."
Processing 00000000.tx.345: 1996. 

Phrase: "1996."
Processing 00000000.tx.346: High plasma levels of nitrogen oxides are associated with severe disease and correlate with rapid parasitological and clinical cure in Plasmodium falciparum malaria. 

Phrase: "High plasma levels of nitrogen oxides"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0032105:Plasma [Body Substance]
   753   C0441889:Levels [Qualitative Concept]
   753   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "associated with severe disease"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0205082:Severe [Qualitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "correlate with rapid parasitological"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205468:parasitological [Qualitative Concept]
   770   C0439831:Rapid [Qualitative Concept]

Phrase: "and"

Phrase: "clinical cure in Plasmodium falciparum malaria."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C3640840:Clinical Cure [Finding]
   753   C1880198:Cure [Conceptual Entity]
Processing 00000000.tx.347: Trans. 

Phrase: "Trans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2826298:TRANS [Idea or Concept]
Processing 00000000.tx.348: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.349: Soc. 

Phrase: "Soc."
Processing 00000000.tx.350: Trop. 

Phrase: "Trop."
Processing 00000000.tx.351: Med. 

Phrase: "Med."
Processing 00000000.tx.352: Hyg. 

Phrase: "Hyg."
Processing 00000000.tx.353: 90:4447.[Medline] Kremsner, P.G., X. 

Phrase: "90"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: ":"

Phrase: "4447."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kremsner,"

Phrase: "P.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "X."
Processing 00000000.tx.354: Winkler, C. 

Phrase: "Winkler,"

Phrase: "C."
Processing 00000000.tx.355: Brandts, E. 

Phrase: "Brandts,"

Phrase: "E."
Processing 00000000.tx.356: Wilding, L. 

Phrase: "Wilding,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445392:wilding [Intellectual Product]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.357: Jenne, W. 

Phrase: "Jenne,"

Phrase: "W."
Processing 00000000.tx.358: Graninger, J. 

Phrase: "Graninger,"

Phrase: "J."
Processing 00000000.tx.359: Prada, U. 

Phrase: "Prada,"

Phrase: "U."
Processing 00000000.tx.360: Bienzle, P. 

Phrase: "Bienzle,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.361: Juillard, and G.E. 

Phrase: "Juillard,"

Phrase: "and"

Phrase: "G.E."
Processing 00000000.tx.362: Grau. 

Phrase: "Grau."
Processing 00000000.tx.363: 1995. 

Phrase: "1995."
Processing 00000000.tx.364: Prediction of accelerated cure in Plasmodium falciparum malaria by the elevated capacity of tumour necrosis factor production. 

Phrase: "Prediction of accelerated cure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0681842:Prediction [Idea or Concept]

Phrase: "in Plasmodium falciparum malaria"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0024535:Plasmodium falciparum Malaria [Disease or Syndrome]
           Malaria, Falciparum
   901   C0032150:Plasmodium falciparum [Eukaryote]
   827   C0024530:Malaria [Disease or Syndrome]
   827   C0032148:Plasmodium [Eukaryote]
   827   C2984572:Malaria [Functional Concept]
   827   C3541306:Plasmodium [Laboratory Procedure]
   743 E C1721089:Marsh [Natural Phenomenon or Process]

Phrase: "by the elevated capacity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516240:Capacity [Quantitative Concept]

Phrase: "of tumour necrosis factor production."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1819464:tumor necrosis factor production [Organism Function]
   812   C0033268:production [Occupational Activity]
   756   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   756   C1323304:tumor necrosis factor [Molecular Function]
   756   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.365: Am. 

Phrase: "Am."
Processing 00000000.tx.366: J. 

Phrase: "J."
Processing 00000000.tx.367: Trop. 

Phrase: "Trop."
Processing 00000000.tx.368: Med. 

Phrase: "Med."
Processing 00000000.tx.369: Hyg. 

Phrase: "Hyg."
Processing 00000000.tx.370: 53:532538.[Medline] Dodoo, D., F. 

Phrase: "53"

Phrase: ":"

Phrase: "532538."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Dodoo,"

Phrase: "D."

Phrase: ","

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.371: Omer, J. 

Phrase: "Omer,"

Phrase: "J."
Processing 00000000.tx.372: Todd, B. 

Phrase: "Todd,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.373: Akanmori, K. 

Phrase: "Akanmori,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.374: Koram, and E.M. 

Phrase: "Koram,"

Phrase: "and"

Phrase: "E.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.375: Riley. 

Phrase: "Riley."
Processing 00000000.tx.376: 2002. 

Phrase: "2002."
Processing 00000000.tx.377: Absolute levels and ratios of pro-inflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to P. falciparum malaria. 

Phrase: "Absolute levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "ratios of pro-inflammatory"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0456603:Ratios [Quantitative Concept]
   770   C1610540:*Ratios [Quantitative Concept]
   737 E C1547037:Ratio [Intellectual Product]

Phrase: "and"

Phrase: "anti-inflammatory cytokine production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1327413:cytokine production [Organism Function]
   812   C0033268:production [Occupational Activity]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "predict"

Phrase: "clinical immunity to P. falciparum malaria."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0020964:Immunity [Physiologic Function]
Processing 00000000.tx.378: J. 

Phrase: "J."
Processing 00000000.tx.379: Infect. 

Phrase: "Infect."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439663:infect [Functional Concept]
Processing 00000000.tx.380: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.381: 185:971979.[CrossRef][Medline] Grau, G.E., T.E. 

Phrase: "185"

Phrase: ":"

Phrase: "971979."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Grau,"

Phrase: "G.E.,"

Phrase: "T.E."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.382: Taylor, M.E. 

Phrase: "Taylor,"

Phrase: "M."

Phrase: "E."
Processing 00000000.tx.383: Molyneux, J.J. 

Phrase: "Molyneux,"

Phrase: "J.J."
Processing 00000000.tx.384: Wirima, P. 

Phrase: "Wirima,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.385: Vassalli, M. 

Phrase: "Vassalli,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.386: Hommel, and P.H. 

Phrase: "Hommel,"

Phrase: "and"

Phrase: "P.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.387: Lambert. 

Phrase: "Lambert."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551092:Lambert [Quantitative Concept]
Processing 00000000.tx.388: 1989. 

Phrase: "1989."
Processing 00000000.tx.389: Tumor necrosis factor and disease severity in children with falciparum malaria. 

Phrase: "Tumor necrosis factor"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1323304:tumor necrosis factor [Molecular Function]
  1000   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0333516:Tumor necrosis [Neoplastic Process]
   827   C0027540:Necrosis [Organ or Tissue Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1334928:Necrosis [Finding]
   827   C1521761:Factor [Functional Concept]
   827   C1578706:Tumor [Intellectual Product]
   827   C2827422:Factor [Conceptual Entity]
   827   C3273930:Tumor [Finding]

Phrase: "and"

Phrase: "disease severity in children"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0521117:disease severity [Qualitative Concept]
   770   C0439793:Severity [Qualitative Concept]
   770   C2983285:Severity [Intellectual Product]

Phrase: "with falciparum malaria."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0024535:Malaria, Falciparum [Disease or Syndrome]
   861   C0024530:Malaria [Disease or Syndrome]
   861   C2984572:Malaria [Functional Concept]
   777 E C1721089:Marsh [Natural Phenomenon or Process]
Processing 00000000.tx.390: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.391: Engl. 

Phrase: "Engl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414400:ENGL [Gene or Genome]
Processing 00000000.tx.392: J. 

Phrase: "J."
Processing 00000000.tx.393: Med. 

Phrase: "Med."
Processing 00000000.tx.394: 320:15861591.[Abstract] Kwiatkowski, D., A.V.S. 

Phrase: "320"

Phrase: ":"

Phrase: "15861591."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kwiatkowski,"

Phrase: "D."

Phrase: ","

Phrase: "A.V.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C3642225:V/s [Quantitative Concept]
Processing 00000000.tx.395: Hill, I. 

Phrase: "Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442532:Hill [Spatial Concept]

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.396: Sambou, P. 

Phrase: "Sambou,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.397: Twumasi, J. 

Phrase: "Twumasi,"

Phrase: "J."
Processing 00000000.tx.398: Castracane, K.R. 

Phrase: "Castracane,"

Phrase: "K.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.399: Manogue, A. 

Phrase: "Manogue,"

Phrase: "A."
Processing 00000000.tx.400: Cerami, D. 

Phrase: "Cerami,"

Phrase: "D."
Processing 00000000.tx.401: Brewster, and B.M. 

Phrase: "Brewster,"

Phrase: "and"

Phrase: "B.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.402: Greenwood. 

Phrase: "Greenwood."
Processing 00000000.tx.403: 1990. 

Phrase: "1990."
Processing 00000000.tx.404: TNF concentration in fatal, non-fatal cerebral and uncomplicated Plasmodium falciparum malaria. 

Phrase: "TNF concentration in fatal, non-fatal cerebral"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0086045:Concentration [Mental Process]
   748   C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "uncomplicated Plasmodium falciparum malaria."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   923   C0024535:Plasmodium falciparum Malaria [Disease or Syndrome]
           Malaria, Falciparum
   861   C0032150:Plasmodium falciparum [Eukaryote]
   812   C0024530:Malaria [Disease or Syndrome]
   812   C0032148:Plasmodium [Eukaryote]
   812   C2984572:Malaria [Functional Concept]
   812   C3541306:Plasmodium [Laboratory Procedure]
   729 E C1721089:Marsh [Natural Phenomenon or Process]
Processing 00000000.tx.405: Lancet. 

Phrase: "Lancet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]
Processing 00000000.tx.406: 336:12011204.[Medline] Harpaz, R., R. 

Phrase: "336"

Phrase: ":"

Phrase: "12011204."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Harpaz,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.407: Edelman, S.S. 

Phrase: "Edelman,"

Phrase: "S.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.408: Wasserman, M.M. 

Phrase: "Wasserman,"

Phrase: "M."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.409: Levine, J.R. 

Phrase: "Levine,"

Phrase: "J.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.410: Davis, and M.B. 

Phrase: "Davis,"

Phrase: "and"

Phrase: "M.B."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.411: Sztein. 

Phrase: "Sztein."
Processing 00000000.tx.412: 1992. 

Phrase: "1992."
Processing 00000000.tx.413: Serum cytokine profiles in experimental human malaria. 

Phrase: "Serum cytokine profiles in experimental human malaria."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1979963:Profile [Laboratory Procedure]
   714   C2003903:Profile [Functional Concept]
Processing 00000000.tx.414: J. 

Phrase: "J."
Processing 00000000.tx.415: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.416: Invest. 

Phrase: "Invest."
Processing 00000000.tx.417: 90:515523.[Medline] Omer, F.M., J.A.L. 

Phrase: "90"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: ":"

Phrase: "515523."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Omer,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "J.A.L."
Processing 00000000.tx.418: Kurtzhals, and E.M. 

Phrase: "Kurtzhals,"

Phrase: "and"

Phrase: "E.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.419: Riley. 

Phrase: "Riley."
Processing 00000000.tx.420: 2000. 

Phrase: "2000."
Processing 00000000.tx.421: Maintaining the immunological balance in parasitic infections: a role for TGF-? 

Phrase: "Maintaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0024501:Maintain [Activity]

Phrase: "the immunological balance in parasitic infections"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0014653:Balance [Organism Function]
   753   C0205415:Balance [Functional Concept]
   753   C0560184:Balance [Finding]

Phrase: ":"

Phrase: "a role for TGF-"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   833   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   783   C0960756:factor A [Organic Chemical]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0035820:Role [Social Behavior]
   753   C0220844:growth [Physiologic Function]
   753   C1510411:Transforming [Pathologic Function]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C1705810:Role [Conceptual Entity]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]

Phrase: "?"
Processing 00000000.tx.422: Parasitol. 

Phrase: "Parasitol."
Processing 00000000.tx.423: Today. 

Phrase: "Today."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0310367:Today [Antibiotic,Organic Chemical]
  1000   C0750526:Today [Temporal Concept]
Processing 00000000.tx.424: 16:1823.[CrossRef][Medline] Omer, F.M., and E.M. 

Phrase: "16"

Phrase: ":"

Phrase: "1823."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Omer,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "E.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.425: Riley. 

Phrase: "Riley."
Processing 00000000.tx.426: 1998. 

Phrase: "1998."
Processing 00000000.tx.427: TGF- production is inversely correlated with severity of murine malaria infection. 

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "is"

Phrase: "inversely"

Phrase: "correlated with severity of murine malaria infection."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   774   C0517627:Infection severity [Finding]
   748   C0009450:Infection, NOS [Disease or Syndrome]
   748   C0024530:Malaria [Disease or Syndrome]
   748   C0026809:Murine [Mammal]
   748   C0439793:Severity [Qualitative Concept]
   748   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   748   C1707520:Correlated [Qualitative Concept]
   748   C2983285:Severity [Intellectual Product]
   748   C2984572:Malaria [Functional Concept]
Processing 00000000.tx.428: J. 

Phrase: "J."
Processing 00000000.tx.429: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.430: Med. 

Phrase: "Med."
Processing 00000000.tx.431: 188:3948.[Abstract/Free FullText] Li, C., I. 

Phrase: "188"

Phrase: ":"

Phrase: "3948."

Phrase: "[Abstract/Free FullText"

Phrase: "] Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.432: Corraliza, and J. 

Phrase: "Corraliza,"

Phrase: "and"

Phrase: "J."
Processing 00000000.tx.433: Langhorne. 

Phrase: "Langhorne."
Processing 00000000.tx.434: 1999. 

Phrase: "1999."
Processing 00000000.tx.435: A defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection in mice. 

Phrase: "A defect in interleukin-10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1457869:Defect [Functional Concept]
   760   C1861101:DEFECT [Disease or Syndrome]

Phrase: "leads to enhanced malarial disease"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   760   C0012634:Disease [Disease or Syndrome]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0181586:leads [Medical Device]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C2349975:Enhanced [Activity]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "in Plasmodium chabaudi chabaudi infection"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   902   C0024530:Plasmodium Infection [Disease or Syndrome]
   812   C0009450:Infection, NOS [Disease or Syndrome]
   741 E C0439663:Infected [Functional Concept]
   701 E C0030657:infectivity [Qualitative Concept]

Phrase: "in mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.436: Infect. 

Phrase: "Infect."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439663:infect [Functional Concept]
Processing 00000000.tx.437: Immun. 

Phrase: "Immun."
Processing 00000000.tx.438: 67:44354442.[Abstract/Free FullText] Li, C., L.A. 

Phrase: "67"

Phrase: ":"

Phrase: "44354442."

Phrase: "[Abstract/Free FullText"

Phrase: "] Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "L.A."
Processing 00000000.tx.439: Sanni, F.M. 

Phrase: "Sanni,"

Phrase: "F.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2348507:F/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.440: Omer, E.M. 

Phrase: "Omer,"

Phrase: "E.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.441: Riley, and J. 

Phrase: "Riley,"

Phrase: "and"

Phrase: "J."
Processing 00000000.tx.442: Langhorne. 

Phrase: "Langhorne."
Processing 00000000.tx.443: 2003. 

Phrase: "2003."
Processing 00000000.tx.444: Pathology and mortality of Plasmodium chabaudi chabaudi infection in IL-10-deficient mice is ameliorated by anti-TNF- and exacerbated by anti-TGF- antibodies. 

Phrase: "Pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030664:Pathology [Biomedical Occupation or Discipline]
  1000   C0205469:pathology [Functional Concept]
  1000   C0677042:pathology [Pathologic Function]
   928 E C1521733:Pathologic [Functional Concept]

Phrase: "and"

Phrase: "mortality of Plasmodium chabaudi chabaudi infection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0026565:Mortality [Quantitative Concept]
   753   C0026566:mortality [Quantitative Concept]

Phrase: "in IL-10-deficient mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "is"

Phrase: "ameliorated by anti-TNF-"

Phrase: "and"

Phrase: "exacerbated by anti-TGF-"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C0436331:Exacerbated [Finding]
   753   C1444749:Exacerbated [Qualitative Concept]
   753   C1510411:Transforming [Pathologic Function]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]

Phrase: "antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.445: Infect. 

Phrase: "Infect."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439663:infect [Functional Concept]
Processing 00000000.tx.446: Immun. 

Phrase: "Immun."
Processing 00000000.tx.447: 71:48504856.[Abstract/Free FullText] Wenisch, C., B. 

Phrase: "71"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]

Phrase: ":"

Phrase: "48504856."

Phrase: "[Abstract/Free FullText"

Phrase: "] Wenisch,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.448: Parschalk, H. 

Phrase: "Parschalk,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.449: Burgmann, S. 

Phrase: "Burgmann,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.450: Looareesuwan, and W. 

Phrase: "Looareesuwan,"

Phrase: "and"

Phrase: "W."
Processing 00000000.tx.451: Graninger. 

Phrase: "Graninger."
Processing 00000000.tx.452: 1995. 

Phrase: "1995."
Processing 00000000.tx.453: Decreased serum levels of TGF-beta in patients with acute Plasmodium falciparum malaria. 

Phrase: "Decreased serum levels of TGF-beta"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   744   C0229671:Serum [Body Substance]
   744   C0441889:Levels [Qualitative Concept]
   744   C1546774:Serum [Intellectual Product]
   744   C1550100:Serum [Body Substance]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with acute Plasmodium falciparum malaria."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   923   C0024535:Plasmodium falciparum Malaria [Disease or Syndrome]
           Malaria, Falciparum
   902   C2930826:Acute malaria [Disease or Syndrome]
   861   C0032150:Plasmodium falciparum [Eukaryote]
   812   C0024530:Malaria [Disease or Syndrome]
   812   C0032148:Plasmodium [Eukaryote]
   812   C2984572:Malaria [Functional Concept]
   812   C3541306:Plasmodium [Laboratory Procedure]
   729 E C1721089:Marsh [Natural Phenomenon or Process]
Processing 00000000.tx.454: J. 

Phrase: "J."
Processing 00000000.tx.455: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.456: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.457: 15:6973.[Medline] Perkins, D., J. 

Phrase: "15"

Phrase: ":"

Phrase: "6973."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Perkins,"

Phrase: "D."

Phrase: ","

Phrase: "J."
Processing 00000000.tx.458: Weinberg, and P. 

Phrase: "Weinberg,"

Phrase: "and"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.459: Kremsner. 

Phrase: "Kremsner."
Processing 00000000.tx.460: 2000. 

Phrase: "2000."
Processing 00000000.tx.461: Reduced interleukin-12 and transforming growth factor-1 in severe childhood malaria: relationship of cytokine balance with disease severity. 

Phrase: "Reduced interleukin-12"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0123759:Interleukin-12 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   901   C1524115:Interleukin 12 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "transforming growth factor-1 in severe childhood malaria"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   800   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   800   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0024530:Malaria [Disease or Syndrome]
   744   C0205082:Severe [Qualitative Concept]
   744   C0220844:growth [Physiologic Function]
   744   C0231335:Childhood [Temporal Concept]
   744   C1510411:Transforming [Pathologic Function]
   744   C1521761:Factor [Functional Concept]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]
   744   C2984572:Malaria [Functional Concept]

Phrase: ":"

Phrase: "relationship of cytokine balance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439849:Relationship [Qualitative Concept]
   770   C1705630:Relationship [Idea or Concept]
   770   C1706279:Relationship [Idea or Concept]
   770   C3540605:Relationship [Intellectual Product]

Phrase: "with disease severity."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0521117:disease severity [Qualitative Concept]
   861   C0439793:Severity [Qualitative Concept]
   861   C2983285:Severity [Intellectual Product]
   789 E C0205082:Severe [Qualitative Concept]
Processing 00000000.tx.462: J. 

Phrase: "J."
Processing 00000000.tx.463: Infect. 

Phrase: "Infect."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439663:infect [Functional Concept]
Processing 00000000.tx.464: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.465: 182:988992.[CrossRef][Medline] Omer, F.M., J.B. de Souza, and E.M. 

Phrase: "182"

Phrase: ":"

Phrase: "988992."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Omer,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "J.B. de Souza,"

Phrase: "and"

Phrase: "E.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.466: Riley. 

Phrase: "Riley."
Processing 00000000.tx.467: 2003. 

Phrase: "2003."
Processing 00000000.tx.468: Differential induction of TGF- regulates pro-inflammatory cytokine production and determines the outcome of lethal and nonlethal Plasmodium yoelii infections. 

Phrase: "Differential induction of TGF-"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   833   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C2752783:differential growth [Organism Function]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0205263:Induction [Functional Concept]
   753   C0220844:growth [Physiologic Function]
   753   C0443199:Differential [Qualitative Concept]
   753   C0857127:induction [Therapeutic or Preventive Procedure]
   753   C1510411:Transforming [Pathologic Function]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C1705242:Differential [Qualitative Concept]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]

Phrase: "regulates"

Phrase: "pro-inflammatory cytokine production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1327413:cytokine production [Organism Function]
   812   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "determines"

Phrase: "the outcome of lethal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1274040:Outcome [Functional Concept]

Phrase: "and"

Phrase: "nonlethal Plasmodium yoelii infections."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   875   C0024530:Plasmodium Infections [Disease or Syndrome]
   812   C0009450:Infections [Disease or Syndrome]
   729 E C0439663:Infected [Functional Concept]
Processing 00000000.tx.469: J. 

Phrase: "J."
Processing 00000000.tx.470: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.471: 171:54305436.[Abstract/Free FullText] Letterio, J.J., and A.B. 

Phrase: "171"

Phrase: ":"

Phrase: "54305436."

Phrase: "[Abstract/Free FullText"

Phrase: "] Letterio,"

Phrase: "J.J.,"

Phrase: "and"

Phrase: "A.B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1440044:A,B [Immunologic Factor]
Processing 00000000.tx.472: Roberts. 

Phrase: "Roberts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]
Processing 00000000.tx.473: 1998. 

Phrase: "1998."
Processing 00000000.tx.474: Regulation of immune responses by TGF-. 

Phrase: "Regulation of immune responses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   988   C1327458:regulation of immune response [Organism Function]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "by TGF-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0006539:BY [Geographic Area]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "."
Processing 00000000.tx.475: Annu. 

Phrase: "Annu."
Processing 00000000.tx.476: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.477: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.478: 16:137161.[CrossRef][Medline] Lawrence, D.A. 

Phrase: "16"

Phrase: ":"

Phrase: "137161."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lawrence,"

Phrase: "D.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.479: 1991. 

Phrase: "1991."
Processing 00000000.tx.480: Identification and activation of latent transforming growth factor beta. 

Phrase: "Identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020792:Identification [Mental Process]
  1000   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "activation of latent transforming growth factor beta."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   879   C3549171:transforming growth factor beta activation [Molecular Function]
   804   C2249824:activation of growth [Organism Function]
   748   C1879547:Activation [Activity]
Processing 00000000.tx.481: Methods Enzymol. 

Phrase: "Methods Enzymol."
Processing 00000000.tx.482: 198:327336.[Medline] Nunes, I., R.L. 

Phrase: "198"

Phrase: ":"

Phrase: "327336."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nunes,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "R.L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.483: Shapiro, and D.B. 

Phrase: "Shapiro,"

Phrase: "and"

Phrase: "D."

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.484: Rifkin. 

Phrase: "Rifkin."
Processing 00000000.tx.485: 1998. 

Phrase: "1998."
Processing 00000000.tx.486: Characterisation of latent TGF- activation by murine peritoneal macrophages. 

Phrase: "Characterisation of latent TGF-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880022:Characterization [Activity]

Phrase: "activation by murine peritoneal macrophages."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0024426:Macrophage Activation [Cell Function]
   781   C0920262:macrophage activation [Therapeutic or Preventive Procedure]
   760   C1879547:Activation [Activity]
Processing 00000000.tx.487: J. 

Phrase: "J."
Processing 00000000.tx.488: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.489: 155:14501459. 

Phrase: "155"

Phrase: ":"

Phrase: "14501459."
Processing 00000000.tx.490: Crawford, S.E., V. 

Phrase: "Crawford,"

Phrase: "S."

Phrase: "E.,"

Phrase: "V."
Processing 00000000.tx.491: Stellmach, J.E. 

Phrase: "Stellmach,"

Phrase: "J.E."
Processing 00000000.tx.492: Murphy-Ullrich, S.M.F. 

Phrase: "Murphy-Ullrich,"

Phrase: "S.M.F."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1306057:M-F [Temporal Concept]
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.493: Ribeiro, J. 

Phrase: "Ribeiro,"

Phrase: "J."
Processing 00000000.tx.494: Lawler, R.O. 

Phrase: "Lawler,"

Phrase: "R.O."
Processing 00000000.tx.495: Hynes, G.P. 

Phrase: "Hynes,"

Phrase: "G.P."
Processing 00000000.tx.496: Boivin, and N. 

Phrase: "Boivin,"

Phrase: "and"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.497: Bouck. 

Phrase: "Bouck."
Processing 00000000.tx.498: 1998. 

Phrase: "1998."
Processing 00000000.tx.499: Thrombospondin-1 is a major activator of TGF- 1 in vivo. 

Phrase: "Thrombospondin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0147139:Thrombospondin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336626:THROMBOSPONDIN I [Gene or Genome]
   861   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "a major activator of TGF-"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   814   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   814   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   774   C0960756:factor A [Organic Chemical]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0205164:Major [Qualitative Concept]
   748   C0220844:growth [Physiologic Function]
   748   C1510411:Transforming [Pathologic Function]
   748   C1521761:Factor [Functional Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]

Phrase: "1 in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.500: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.501: 93:11591170.[Medline] Schultz-Cherry, S., H. 

Phrase: "93"

Phrase: ":"

Phrase: "11591170."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Schultz-Cherry,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0330657:Cherry [Plant]
   861   C0770609:CHERRY [Food]
   861   C0936039:Cherry [Food]

Phrase: "S."

Phrase: ","

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.502: Chen, D.F. 

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "D."

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.503: Mosher, T.M. 

Phrase: "Mosher,"

Phrase: "T.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.504: Misenheimer, H.C. 

Phrase: "Misenheimer,"

Phrase: "H.C."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.505: Krutzsch, D.D. 

Phrase: "Krutzsch,"

Phrase: "D.D."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0112081:D-D [Hazardous or Poisonous Substance,Organic Chemical]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.506: Roberts, and J.E. 

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "and"

Phrase: "J.E."
Processing 00000000.tx.507: Murphy-Ullrich. 

Phrase: "Murphy-Ullrich."
Processing 00000000.tx.508: 1995. 

Phrase: "1995."
Processing 00000000.tx.509: Regulation of transforming growth factor- activation by discrete sequences of thrombospondin 1. 

Phrase: "Regulation of transforming growth factor- activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   820   C1160191:regulation of growth [Organism Function]
           growth regulation
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "by discrete sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "of thrombospondin 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0147139:Thrombospondin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336626:THROMBOSPONDIN I [Gene or Genome]
   861   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.510: J. 

Phrase: "J."
Processing 00000000.tx.511: Biol. 

Phrase: "Biol."
Processing 00000000.tx.512: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.513: 270:73047310.[Abstract/Free FullText] Abdelouahed, M., A. 

Phrase: "270"

Phrase: ":"

Phrase: "73047310."

Phrase: "[Abstract/Free FullText"

Phrase: "] Abdelouahed,"

Phrase: "M."

Phrase: ","

Phrase: "A."
Processing 00000000.tx.514: Ludlow, G. 

Phrase: "Ludlow,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.515: Brunner, and J. 

Phrase: "Brunner,"

Phrase: "and"

Phrase: "J."
Processing 00000000.tx.516: Lawler. 

Phrase: "Lawler."
Processing 00000000.tx.517: 2000. 

Phrase: "2000."
Processing 00000000.tx.518: Activation of platelet-transforming growth factor -1 in the absence of thrombospondin-1. 

Phrase: "Activation of platelet-transforming growth factor -1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C2249824:activation of growth [Organism Function]
   774   C0032173:Platelet Activation [Organ or Tissue Function]
   748   C1879547:Activation [Activity]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of thrombospondin-1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0147139:Thrombospondin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336626:THROMBOSPONDIN I [Gene or Genome]
   861   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.519: J. 

Phrase: "J."
Processing 00000000.tx.520: Biol. 

Phrase: "Biol."
Processing 00000000.tx.521: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.522: 275:1793317936.[Abstract/Free FullText] Artavanis-Tsakonas, K., and E.M. 

Phrase: "275"

Phrase: ":"

Phrase: "1793317936."

Phrase: "[Abstract/Free FullText"

Phrase: "] Artavanis-Tsakonas,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "E.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.523: Riley. 

Phrase: "Riley."
Processing 00000000.tx.524: 2002. 

Phrase: "2002."
Processing 00000000.tx.525: Innate immune response to malaria: rapid induction of IFN- from human NK cells by live Plasmodium falciparum-infected erythrocytes. 

Phrase: "Innate immune response to malaria"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0020969:Innate Immune Response [Organism Attribute,Pathologic Function]
   806   C0301872:Immune response [Organ or Tissue Function]
   760   C0439662:Immune [Functional Concept]
   760   C0871261:Response [Organism Attribute]
   760   C1704632:Response [Finding]
   760   C1706817:Response [Intellectual Product]
   760   C2911692:Response [Mental Process]

Phrase: ":"

Phrase: "rapid induction of IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "from human NK cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   913   C0427861:Human cells [Laboratory or Test Result]
   901   C0022688:NK Cells [Cell]
           NK
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "by live Plasmodium falciparum-infected erythrocytes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0014772:Erythrocytes [Laboratory Procedure]
   804   C0014792:Erythrocytes [Cell]
Processing 00000000.tx.526: J. 

Phrase: "J."
Processing 00000000.tx.527: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.528: 169:29562963.[Abstract/Free FullText] Sultan, A.A., V. 

Phrase: "169"

Phrase: ":"

Phrase: "29562963."

Phrase: "[Abstract/Free FullText"

Phrase: "] Sultan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0647895:Sultan [Biomedical or Dental Material,Organic Chemical]

Phrase: "A."

Phrase: "A.,"

Phrase: "V."
Processing 00000000.tx.529: Thathy, U. 

Phrase: "Thathy,"

Phrase: "U."
Processing 00000000.tx.530: Frevert, K.J.H. 

Phrase: "Frevert,"

Phrase: "K.J.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.531: Robson, A. 

Phrase: "Robson,"

Phrase: "A."
Processing 00000000.tx.532: Crisanti, V. 

Phrase: "Crisanti,"

Phrase: "V."
Processing 00000000.tx.533: Nussenzweig, R.S. 

Phrase: "Nussenzweig,"

Phrase: "R.S."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.534: Nussenzweig, and R. 

Phrase: "Nussenzweig,"

Phrase: "and"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.535: Menard. 

Phrase: "Menard."
Processing 00000000.tx.536: 1997. 

Phrase: "1997."
Processing 00000000.tx.537: TRAP is neccessary for gliding motility and infectivity of Plasmodium sporozoites. 

Phrase: "TRAP"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   812   C0001516:Adhesive [Manufactured Object]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0439849:Related [Qualitative Concept]
   812   C0445223:Related [Finding]
   812   C2982905:Adhesive [Manufactured Object]
   779 E C0163712:Relate [Organic Chemical]
   741 E C0080103:Relation [Family Group]
   741 E C0869014:Relations [Social Behavior]

Phrase: "is"

Phrase: "neccessary for gliding motility"

Phrase: "and"

Phrase: "infectivity of Plasmodium sporozoites."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030657:infectivity [Qualitative Concept]
   763   C0024530:Plasmodium Infection [Disease or Syndrome]
Processing 00000000.tx.538: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.539: 90:511522.[Medline] Schultz-Cherry, S., J. 

Phrase: "90"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: ":"

Phrase: "511522."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Schultz-Cherry,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0330657:Cherry [Plant]
   861   C0770609:CHERRY [Food]
   861   C0936039:Cherry [Food]

Phrase: "S."

Phrase: ","

Phrase: "J."
Processing 00000000.tx.540: Lawler, and J. 

Phrase: "Lawler,"

Phrase: "and"

Phrase: "J."
Processing 00000000.tx.541: Murphy-Ullrich. 

Phrase: "Murphy-Ullrich."
Processing 00000000.tx.542: 1994. 

Phrase: "1994."
Processing 00000000.tx.543: The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta. 

Phrase: "The type 1 repeats of thrombospondin 1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0205341:repeats [Functional Concept]
   748   C1705914:Repeats [Conceptual Entity]
   714 E C1547730:Repeat [Temporal Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "latent transforming growth factor-beta."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   937   C0040690:Transforming Growth Factor beta [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C0330390:Beta [Plant]
   804   C0439096:Beta [Intellectual Product]
   804   C1510411:Transforming [Pathologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2004068:Beta [Qualitative Concept]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
Processing 00000000.tx.544: J. 

Phrase: "J."
Processing 00000000.tx.545: Biol. 

Phrase: "Biol."
Processing 00000000.tx.546: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.547: 269:2678326788.[Abstract/Free FullText] Kropf, J., J. 

Phrase: "269"

Phrase: ":"

Phrase: "2678326788."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kropf,"

Phrase: "J.,"

Phrase: "J."
Processing 00000000.tx.548: Schurek, A. 

Phrase: "Schurek,"

Phrase: "A."
Processing 00000000.tx.549: Wollner, and A. 

Phrase: "Wollner,"

Phrase: "and"

Phrase: "A."
Processing 00000000.tx.550: Gressner. 

Phrase: "Gressner."
Processing 00000000.tx.551: 1997. 

Phrase: "1997."
Processing 00000000.tx.552: Immunological measurement of transforming growth factor-beta 1 (TGF-beta1) in blood; 

Phrase: "Immunological measurement of transforming growth factor-beta 1 (TGF-beta1)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0242485:Measurement [Functional Concept]
   703   C1366557:Transforming growth factor beta 1 [Gene or Genome]
   703   C1515406:Transforming Growth Factor-Beta 1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   703   C1704256:Transforming Growth Factor Beta 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "in blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.553: assay development and comparison. 

Phrase: "assay development"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0872102:assay development [Diagnostic Procedure]
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "and"

Phrase: "comparison."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]
Processing 00000000.tx.554: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.555: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.556: 43:19651974.[Abstract/Free FullText] Robson, K.J.H., J.R.S. 

Phrase: "43"

Phrase: ":"

Phrase: "19651974."

Phrase: "[Abstract/Free FullText"

Phrase: "] Robson,"

Phrase: "K.J.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "J."

Phrase: "R.S."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.557: Hall, M.W. 

Phrase: "Hall,"

Phrase: "M."

Phrase: "W."
Processing 00000000.tx.558: Jennings, T.J.R. 

Phrase: "Jennings,"

Phrase: "T.J.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.559: Harris, K. 

Phrase: "Harris,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.560: Marsh, C.I. 

Phrase: "Marsh,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1721089:Marsh [Natural Phenomenon or Process]
   916 E C0024530:Malaria [Disease or Syndrome]
   916 E C2984572:Malaria [Functional Concept]

Phrase: "C.I."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1547546:C-I [Classification]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.561: Newbold, V.E. 

Phrase: "Newbold,"

Phrase: "V.E."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231963:V E [Laboratory or Test Result]
Processing 00000000.tx.562: Tate, and D.J. 

Phrase: "Tate,"

Phrase: "and"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.563: Weatherall. 

Phrase: "Weatherall."
Processing 00000000.tx.564: 1994. 

Phrase: "1994."
Processing 00000000.tx.565: A highly conserved amino-acid sequence in thrombospondin, properdin and in proteins from sporozites and blood stages of a human malaria parasite. 

Phrase: "A highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "conserved"

Phrase: "amino-acid sequence in thrombospondin,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   806   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806   C2917660:Amino Acid [Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C0202406:Acid [Laboratory Procedure]
   760   C1519249:Sequence [Functional Concept]

Phrase: "properdin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033452:Properdin [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1418482:PROPERDIN [Gene or Genome]

Phrase: "and in proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1515981:And [Idea or Concept]

Phrase: "from sporozites"

Phrase: "and"

Phrase: "blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "stages of a human malaria parasite."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   783   C0585165:Human parasite [Eukaryote]
   754   C1271614:malarial parasite [Eukaryote]
   753   C0024530:Malaria [Disease or Syndrome]
   753   C0030498:Parasite [Eukaryote]
   753   C0086418:Human [Human]
   753   C0205390:Stage [Temporal Concept]
   753   C1300072:Stage [Clinical Attribute]
   753   C1306673:Stage [Qualitative Concept]
   753   C2984572:Malaria [Functional Concept]
Processing 00000000.tx.566: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.567: 335:7982.[CrossRef] Dolo, A., D. 

Phrase: "335"

Phrase: ":"

Phrase: "7982."

Phrase: "[CrossRef"

Phrase: "] Dolo,"

Phrase: "A.,"

Phrase: "D."
Processing 00000000.tx.568: Modiano, O. 

Phrase: "Modiano,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.569: Doumbo, A. 

Phrase: "Doumbo,"

Phrase: "A."
Processing 00000000.tx.570: Bosman, T. 

Phrase: "Bosman,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.571: Sidibe, M. 

Phrase: "Sidibe,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.572: Keita, S. 

Phrase: "Keita,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.573: Naitza, K. 

Phrase: "Naitza,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.574: Robson, and A. 

Phrase: "Robson,"

Phrase: "and"

Phrase: "A."
Processing 00000000.tx.575: Crisanti. 

Phrase: "Crisanti."
Processing 00000000.tx.576: 1999. 

Phrase: "1999."
Processing 00000000.tx.577: Thrombospondin related adhesive protein (TRAP), a potential malaria vaccine candidate. 

Phrase: "Thrombospondin related adhesive protein (TRAP),"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   812   C0001516:Adhesive [Manufactured Object]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0439849:Related [Qualitative Concept]
   812   C0445223:Related [Finding]
   812   C2982905:Adhesive [Manufactured Object]
   779 E C0163712:Relate [Organic Chemical]
   741 E C0080103:Relation [Family Group]
   741 E C0869014:Relations [Social Behavior]

Phrase: "a potential malaria vaccine candidate."
Processing 00000000.tx.578: Parassitologia. 

Phrase: "Parassitologia."
Processing 00000000.tx.579: 41:425428.[Medline] Flanagan, K., M. 

Phrase: "41"

Phrase: ":"

Phrase: "425428."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Flanagan,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.580: Plebanski, P. 

Phrase: "Plebanski,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.581: Akinwunmi, E. 

Phrase: "Akinwunmi,"

Phrase: "E."
Processing 00000000.tx.582: Lee, W. 

Phrase: "Lee,"

Phrase: "W."
Processing 00000000.tx.583: Reece, K. 

Phrase: "Reece,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.584: Robson, A. 

Phrase: "Robson,"

Phrase: "A."
Processing 00000000.tx.585: Hill, and M. 

Phrase: "Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442532:Hill [Spatial Concept]

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.586: Pinder. 

Phrase: "Pinder."
Processing 00000000.tx.587: 1999. 

Phrase: "1999."
Processing 00000000.tx.588: Broadly distributed T cell reactivity, with no immunodominant loci, to the pre-erythrocytic antigen thrombospondin-related adhesive protein of Plasmodium falciparum in West Africans. 

Phrase: "Broadly distributed T cell reactivity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   733   C0205332:Reactive [Qualitative Concept]

Phrase: "with no immunodominant loci,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]

Phrase: "to the pre-erythrocytic antigen thrombospondin-related adhesive protein"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   795   C0001516:Adhesive [Manufactured Object]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0439849:Related [Qualitative Concept]
   795   C0445223:Related [Finding]
   795   C2982905:Adhesive [Manufactured Object]
   762 E C0163712:Relate [Organic Chemical]
   724 E C0080103:Relation [Family Group]
   724 E C0869014:Relations [Social Behavior]

Phrase: "of Plasmodium falciparum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032150:Plasmodium falciparum [Eukaryote]
   861   C0032148:Plasmodium [Eukaryote]
   861   C3541306:Plasmodium [Laboratory Procedure]

Phrase: "in West Africans."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0238606:West Africans [Population Group]
   827   C0027567:African [Population Group]
Processing 00000000.tx.589: Eur. 

Phrase: "Eur."
Processing 00000000.tx.590: J. 

Phrase: "J."
Processing 00000000.tx.591: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.592: 29:19431954.[CrossRef][Medline] Muller, H.M., I. 

Phrase: "29"

Phrase: ":"

Phrase: "19431954."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Muller,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.593: Reckmann, M.R. 

Phrase: "Reckmann,"

Phrase: "M."

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.594: Hollingdale, H. 

Phrase: "Hollingdale,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.595: Bujard, K.J.H. 

Phrase: "Bujard,"

Phrase: "K.J.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.596: Robson, and A. 

Phrase: "Robson,"

Phrase: "and"

Phrase: "A."
Processing 00000000.tx.597: Crisanti. 

Phrase: "Crisanti."
Processing 00000000.tx.598: 1993. 

Phrase: "1993."
Processing 00000000.tx.599: Thrombospondin related anonymous protein (TRAP) of Plasmodium falciparum binds specifically to sulfated glycoconjugates and to HepG2 hepatoma cells suggesting a role for this molecule in sporozoite invasion of hepatocytes. 

Phrase: "Thrombospondin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "related"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439849:Related [Qualitative Concept]
  1000   C0445223:Related [Finding]
   966 E C0163712:Relate [Organic Chemical]

Phrase: "anonymous protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(TRAP"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   812   C0001516:Adhesive [Manufactured Object]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0439849:Related [Qualitative Concept]
   812   C0445223:Related [Finding]
   812   C2982905:Adhesive [Manufactured Object]
   779 E C0163712:Relate [Organic Chemical]
   741 E C0080103:Relation [Family Group]
   741 E C0869014:Relations [Social Behavior]

Phrase: ")"

Phrase: "of Plasmodium falciparum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032150:Plasmodium falciparum [Eukaryote]
   861   C0032148:Plasmodium [Eukaryote]
   861   C3541306:Plasmodium [Laboratory Procedure]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "specifically to sulfated glycoconjugates"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0017906:Glycoconjugates [Carbohydrate]
   737   C0038720:Sulfate [Inorganic Chemical]
   737   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   737   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "and to HepG2 hepatoma cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   797   C2717940:HepG2 Cells [Cell]
   773   C0677626:hepatoma cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0023903:Hepatoma [Neoplastic Process]
   760   C1515981:And [Idea or Concept]
   760   C2239176:Hepatoma [Neoplastic Process]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a role for this molecule"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in sporozoite invasion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1269955:Invasion [Finding]
   861   C2699153:Invasion [Pathologic Function]

Phrase: "of hepatocytes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0227525:Hepatocytes [Cell]
   966 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.600: EMBO. 

Phrase: "EMBO."
Processing 00000000.tx.601: J. 

Phrase: "J."
Processing 00000000.tx.602: 12:28812889.[Abstract] Fakruddin, J., S. 

Phrase: "12"

Phrase: ":"

Phrase: "28812889."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Fakruddin,"

Phrase: "J.,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.603: Biswas, and Y. 

Phrase: "Biswas,"

Phrase: "and"

Phrase: "Y."
Processing 00000000.tx.604: Sharma. 

Phrase: "Sharma."
Processing 00000000.tx.605: 2000. 

Phrase: "2000."
Processing 00000000.tx.606: Metalloprotease activity in a small heat shock protein of the human malaria parasite Plasmodium vivax. 

Phrase: "Metalloprotease activity in a small heat shock protein"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   822   C1149558:heat shock protein activity [Molecular Function]
   770   C1150224:metalloprotease activity [Molecular Function]
   767   C1537044:protein activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "of the human malaria parasite Plasmodium vivax."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   888   C0024537:malaria plasmodium vivax [Disease or Syndrome]
           malaria vivax
   840   C0032154:Plasmodium vivax [Eukaryote]
   804   C0032148:Plasmodium [Eukaryote]
   804   C3541306:Plasmodium [Laboratory Procedure]
Processing 00000000.tx.607: Infect. 

Phrase: "Infect."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439663:infect [Functional Concept]
Processing 00000000.tx.608: Immun. 

Phrase: "Immun."
Processing 00000000.tx.609: 68:12021206.[Abstract/Free FullText] Gomez-Escobar, N., A. van den Biggelaar, and R.M. 

Phrase: "68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ":"

Phrase: "12021206."

Phrase: "[Abstract/Free FullText"

Phrase: "] Gomez-Escobar,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "A. van den Biggelaar,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178587:DEN [Quantitative Concept]
   827   C0557775:Van [Manufactured Object]

Phrase: "and"

Phrase: "R.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0694746:r m [Immunologic Factor,Pharmacologic Substance]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.610: Maizels. 

Phrase: "Maizels."
Processing 00000000.tx.611: 1997. 

Phrase: "1997."
Processing 00000000.tx.612: A member of the TGF- receptor gene family in the parasitic nematode Brugia pahangi. 

Phrase: "A member of the TGF-"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   814   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   814   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   774   C0960756:factor A [Organic Chemical]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C0680022:member [Population Group]
   748   C1510411:Transforming [Pathologic Function]
   748   C1521761:Factor [Functional Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2698041:Member [Professional or Occupational Group]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]

Phrase: "receptor gene family in the parasitic nematode Brugia pahangi."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1517488:Gene Family [Gene or Genome]
   742   C0015576:Family [Family Group]
   742   C1704727:Family [Conceptual Entity]
Processing 00000000.tx.613: Gene. 

Phrase: "Gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.614: 199:101109.[CrossRef][Medline] Gomez-Escobar, N., E. 

Phrase: "199"

Phrase: ":"

Phrase: "101109."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gomez-Escobar,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "E."
Processing 00000000.tx.615: Lewis, and R.M. 

Phrase: "Lewis,"

Phrase: "and"

Phrase: "R.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0694746:r m [Immunologic Factor,Pharmacologic Substance]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.616: Maizels. 

Phrase: "Maizels."
Processing 00000000.tx.617: 1998. 

Phrase: "1998."
Processing 00000000.tx.618: A novel member of the transforming growth factor- (TGF-) superfamily from the filarial nematodes Brugia malayia and B. pahangi. 

Phrase: "A novel member of the transforming growth factor- (TGF-) superfamily"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0680022:member [Population Group]
   742   C2698041:Member [Professional or Occupational Group]

Phrase: "from the filarial nematodes Brugia malayia"

Phrase: "and"

Phrase: "B. pahangi."
Processing 00000000.tx.619: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.620: Parasitol. 

Phrase: "Parasitol."
Processing 00000000.tx.621: 88:200209.[CrossRef][Medline] Osman, A., E. 

Phrase: "88"

Phrase: ":"

Phrase: "200209."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Osman,"

Phrase: "A.,"

Phrase: "E."
Processing 00000000.tx.622: Niles, and P. 

Phrase: "Niles,"

Phrase: "and"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.623: LoVerde. 

Phrase: "LoVerde."
Processing 00000000.tx.624: 2001. 

Phrase: "2001."
Processing 00000000.tx.625: Identification and characterization of a Smad2 homologue from Schistosoma mansoni, a transforming growth factor-beta signal transducer. 

Phrase: "Identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020792:Identification [Mental Process]
  1000   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "characterization of a Smad2 homologue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]

Phrase: "from Schistosoma mansoni,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0036319:Schistosoma mansoni [Eukaryote]
   861   C0036315:Schistosoma [Eukaryote]
   789 E C0521080:Schistosomal [Functional Concept]
   768 E C0036323:Bilharzia [Disease or Syndrome]
   761 E C0036321:Schistosome, NOS [Eukaryote]

Phrase: "a transforming growth factor-beta signal transducer."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0040661:Transducer [Medical Device]
   799   C1705162:Transducer [Manufactured Object]
   799   C1710082:Signal [Phenomenon or Process]
   734   C0040690:Transforming Growth Factor beta [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.626: J. 

Phrase: "J."
Processing 00000000.tx.627: Biol. 

Phrase: "Biol."
Processing 00000000.tx.628: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.629: 276:1007210082.[Abstract/Free FullText] Beall, M., S. 

Phrase: "276"

Phrase: ":"

Phrase: "1007210082."

Phrase: "[Abstract/Free FullText"

Phrase: "] Beall,"

Phrase: "M."

Phrase: ","

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.630: McGonigle, and E. 

Phrase: "McGonigle,"

Phrase: "and"

Phrase: "E."
Processing 00000000.tx.631: Pearce. 

Phrase: "Pearce."
Processing 00000000.tx.632: 2000. 

Phrase: "2000."
Processing 00000000.tx.633: Functional conservation of Schistosoma mansoni Smads in TGF-beta signaling. 

Phrase: "Functional conservation of Schistosoma mansoni Smads"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2347858:Conservation [Qualitative Concept]

Phrase: "in TGF-beta signaling."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0037083:Signaling [Cell Function]
   804   C3537152:signaling [Biologic Function]
   771   C0040690:Transforming Growth Factor beta [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.634: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.635: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.636: Parasitol. 

Phrase: "Parasitol."
Processing 00000000.tx.637: 111:131142.[CrossRef][Medline] Beall, M., and E. 

Phrase: "111"

Phrase: ":"

Phrase: "131142."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Beall,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "E."
Processing 00000000.tx.638: Pearce. 

Phrase: "Pearce."
Processing 00000000.tx.639: 2001. 

Phrase: "2001."
Processing 00000000.tx.640: Human transforming growth factor-beta activates a receptor serine/threonine kinase from the intravascular parasite Schistosoma mansoni. 

Phrase: "Human transforming growth factor-beta"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   937   C0040690:Transforming Growth Factor beta [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0086418:Human [Human]
   804   C0220844:growth [Physiologic Function]
   804   C0330390:Beta [Plant]
   804   C0439096:Beta [Intellectual Product]
   804   C1510411:Transforming [Pathologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2004068:Beta [Qualitative Concept]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "a receptor serine/threonine kinase from the intravascular parasite Schistosoma mansoni."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0219806:Receptor Serine/Threonine Kinase [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   775   C0072402:Serine-Threonine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           Threonine Kinase
           Serine Kinase
   775   C1414387:serine/threonine kinase [Gene or Genome]
   738   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.641: J. 

Phrase: "J."
Processing 00000000.tx.642: Biol. 

Phrase: "Biol."
Processing 00000000.tx.643: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.644: 276:3161331619.[Abstract/Free FullText] Ming, M., M.E. 

Phrase: "276"

Phrase: ":"

Phrase: "3161331619."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ming,"

Phrase: "M."

Phrase: ","

Phrase: "M."

Phrase: "E."
Processing 00000000.tx.645: Ewen, and M.E.A. 

Phrase: "Ewen,"

Phrase: "and"

Phrase: "M."

Phrase: "E.A."
Processing 00000000.tx.646: Pereira. 

Phrase: "Pereira."
Processing 00000000.tx.647: 1995. 

Phrase: "1995."
Processing 00000000.tx.648: Trypanosome invasion of mammalian cells requires activation of the TGF signalling pathway. 

Phrase: "Trypanosome invasion of mammalian cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C2699153:Cell Invasion [Pathologic Function]
           Invasion
   760   C1269955:Invasion [Finding]

Phrase: "requires"

Phrase: "activation of the TGF signalling pathway."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C2249824:activation of growth [Organism Function]
   744   C1879547:Activation [Activity]
Processing 00000000.tx.649: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.650: 82:287296.[Medline] Silva, J.S., P.J. 

Phrase: "82"

Phrase: ":"

Phrase: "287296."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Silva,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   928   C0144237:Silvan [Organic Chemical]
   907 E C0043217:Wood [Substance]
   907 E C0442548:Woods [Geographic Area]

Phrase: "J.S.,"

Phrase: "P.J."
Processing 00000000.tx.651: Morrissey, K.H. 

Phrase: "Morrissey,"

Phrase: "K.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.652: Grabstein, K.M. 

Phrase: "Grabstein,"

Phrase: "K.M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.653: Mohler, and S.G. 

Phrase: "Mohler,"

Phrase: "and S.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.654: Reed. 

Phrase: "Reed."
Processing 00000000.tx.655: 1991. 

Phrase: "1991."
Processing 00000000.tx.656: Regulation of Trypansoma cruzi infections in vitro by transforming growth factor , TGF. 

Phrase: "Regulation of Trypansoma cruzi infections"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "in vitro by transforming growth factor ,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0021135:In Vitro [Intellectual Product]
   790   C1533691:in vitro [Qualitative Concept]
           vitro
   790   C2827718:In Vitro [Functional Concept]

Phrase: "TGF."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]
Processing 00000000.tx.657: J. 

Phrase: "J."
Processing 00000000.tx.658: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.659: Med. 

Phrase: "Med."
Processing 00000000.tx.660: 174:539548.[Abstract] Olsson, T., M. 

Phrase: "174"

Phrase: ":"

Phrase: "539548."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Olsson,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.661: Bakhiet, B. 

Phrase: "Bakhiet,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.662: Hojeberg, A. 

Phrase: "Hojeberg,"

Phrase: "A."
Processing 00000000.tx.663: Ljungdahl, C. 

Phrase: "Ljungdahl,"

Phrase: "C."
Processing 00000000.tx.664: Edlund, G. 

Phrase: "Edlund,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.665: Andersson, H.-P. 

Phrase: "Andersson,"

Phrase: "H.-P."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.666: Ekre, W.P. 

Phrase: "Ekre,"

Phrase: "W.P."
Processing 00000000.tx.667: Fung-Leung, T. 

Phrase: "Fung-Leung,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.668: Mak, and K. 

Phrase: "Mak,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416988:MAK [Gene or Genome]
  1000   C1538267:MAK [Gene or Genome]

Phrase: "and"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.669: Kristensson. 

Phrase: "Kristensson."
Processing 00000000.tx.670: 1993. 

Phrase: "1993."
Processing 00000000.tx.671: CD8 is critically involved in lymphocyte activation by a T. brucei brucei-released molecule. 

Phrase: "CD8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3538720:CD8 [Laboratory Procedure]
  1000   C3540595:CD8 [Gene or Genome]

Phrase: "is"

Phrase: "critically"

Phrase: "involved in lymphocyte activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0024262:Lymphocyte Activation [Cell Function]
   770   C0024264:Lymphocyte [Cell]
   770   C1314939:Involved [Functional Concept]
   770   C1879547:Activation [Activity]

Phrase: "by a T. brucei brucei-released molecule."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0567416:Molecule [Substance]
   727 E C1521991:Molecular [Qualitative Concept]
Processing 00000000.tx.672: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.673: 72:715727.[Medline] Derynck, R., J. 

Phrase: "72"

Phrase: ":"

Phrase: "715727."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Derynck,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "J."
Processing 00000000.tx.674: Jarrett, E. 

Phrase: "Jarrett,"

Phrase: "E."
Processing 00000000.tx.675: Chen, D. 

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "D."
Processing 00000000.tx.676: Eaton, J. 

Phrase: "Eaton,"

Phrase: "J."
Processing 00000000.tx.677: Bell, R. 

Phrase: "Bell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706917:Bell [Manufactured Object]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.678: Assoian, A. 

Phrase: "Assoian,"

Phrase: "A."
Processing 00000000.tx.679: Roberts, M. 

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.680: Sporn, and D. 

Phrase: "Sporn,"

Phrase: "and"

Phrase: "D."
Processing 00000000.tx.681: Goeddel. 

Phrase: "Goeddel."
Processing 00000000.tx.682: 1985. 

Phrase: "1985."
Processing 00000000.tx.683: Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. 

Phrase: "Human transforming growth factor-beta complementary DNA sequence"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   812   C0006556:DNA, Complementary [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0162326:DNA Sequence [Nucleotide Sequence]
           Sequence
   793   C0004793:Sequence [Nucleotide Sequence]
   793   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   793   C0162327:Sequence [Nucleotide Sequence]
   793   C1519249:Sequence [Functional Concept]
   721 E C1548958:Sequential [Idea or Concept]
   721 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "expression in normal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "transformed cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.684: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.685: 316:701705.[Medline] Sime, P., Z. 

Phrase: "316"

Phrase: ":"

Phrase: "701705."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sime,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Z."
Processing 00000000.tx.686: Xing, F. 

Phrase: "Xing,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.687: Graham, K. 

Phrase: "Graham, K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.688: Csaky, and J. 

Phrase: "Csaky,"

Phrase: "and"

Phrase: "J."
Processing 00000000.tx.689: Gauldie. 

Phrase: "Gauldie."
Processing 00000000.tx.690: 1997. 

Phrase: "1997."
Processing 00000000.tx.691: Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. 

Phrase: "Adenovector-mediated gene transfer of active transforming growth factor-beta1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   777   C0812325:Growth Factor Gene [Gene or Genome]
   760   C1517499:Gene Transfer [Molecular Biology Research Technique]
   757   C0029016:Transforming Gene [Gene or Genome]
   757   C0040673:Transfer Factor [Immunologic Factor]
   757   C1280474:Transfer factor [Finding]
   739   C0017337:Gene [Gene or Genome]
   739   C0040671:Transfer [Mental Process]
   739   C1705822:Transfer [Activity]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "prolonged severe fibrosis in rat lung."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0034069:FIBROSIS LUNG [Disease or Syndrome]
   753   C0016059:Fibrosis [Pathologic Function]
Processing 00000000.tx.692: J. 

Phrase: "J."
Processing 00000000.tx.693: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.694: Invest. 

Phrase: "Invest."
Processing 00000000.tx.695: 100:768776.[Abstract/Free FullText] Tsutsui, N., and T. 

Phrase: "100"

Phrase: ":"

Phrase: "768776."

Phrase: "[Abstract/Free FullText"

Phrase: "] Tsutsui,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.696: Kamiyama. 

Phrase: "Kamiyama."
Processing 00000000.tx.697: 1999. 

Phrase: "1999."
Processing 00000000.tx.698: Transforming growth factor -induced failure of resistance to infection with blood-stage Plasmodium chabaudi in mice. 

Phrase: "Transforming growth factor -induced failure of resistance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0015544:growth failure [Disease or Syndrome]
   774   C0878787:Growth failure [Disease or Syndrome]
   748   C0231174:Failure [Functional Concept]
   748   C0680095:failure [Individual Behavior]

Phrase: "to infection"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0009450:Infection, NOS [Disease or Syndrome]
   928 E C0439663:Infected [Functional Concept]
   888 E C0030657:infectivity [Qualitative Concept]

Phrase: "with blood-stage Plasmodium chabaudi"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0085322:Plasmodium chabaudi [Eukaryote]
   812   C0032148:Plasmodium [Eukaryote]
   812   C3541306:Plasmodium [Laboratory Procedure]

Phrase: "in mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.699: Infect. 

Phrase: "Infect."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439663:infect [Functional Concept]
Processing 00000000.tx.700: Immun. 

Phrase: "Immun."
Processing 00000000.tx.701: 67:23062311.[Abstract/Free FullText] Barral-Netto, M., A. 

Phrase: "67"

Phrase: ":"

Phrase: "23062311."

Phrase: "[Abstract/Free FullText"

Phrase: "] Barral-Netto,"

Phrase: "M."

Phrase: ","

Phrase: "A."
Processing 00000000.tx.702: Barral, C.E. 

Phrase: "Barral,"

Phrase: "C.E."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.703: Brownwell, Y.A.W. 

Phrase: "Brownwell,"

Phrase: "Y.A.W."
Processing 00000000.tx.704: Skeiky, L.R. 

Phrase: "Skeiky,"

Phrase: "L.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.705: Ellingsworth, D.R. 

Phrase: "Ellingsworth,"

Phrase: "D.R."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.706: Twardzik, and S.G. 

Phrase: "Twardzik,"

Phrase: "and S.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.707: Reed. 

Phrase: "Reed."
Processing 00000000.tx.708: 1992. 

Phrase: "1992."
Processing 00000000.tx.709: Transforming growth factor  in Leishmanial infections: a parasite escape mechanism. 

Phrase: "Transforming growth factor  in Leishmanial infections"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1510411:Transforming [Pathologic Function]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]

Phrase: ":"

Phrase: "a parasite escape mechanism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.710: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.711: 257:545548.[Medline] Somanna, A., V. 

Phrase: "257"

Phrase: ":"

Phrase: "545548."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Somanna,"

Phrase: "A.,"

Phrase: "V."
Processing 00000000.tx.712: Mundodi, and L. 

Phrase: "Mundodi,"

Phrase: "and"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.713: Gedamu. 

Phrase: "Gedamu."
Processing 00000000.tx.714: 2002. 

Phrase: "2002."
Processing 00000000.tx.715: Functional analysis of cathepsin B-like cysteine proteases from Leishmania donovani complex. 

Phrase: "Functional analysis of cathepsin B-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0558024:Functional analysis [Health Care Activity]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "like cysteine proteases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C2717970:Cysteine Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   983 E C0758959:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   983 E C0769345:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Proteases [Enzyme]

Phrase: "from Leishmania donovani complex."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]
   734   C0023273:Leishmania donovani [Eukaryote]
Processing 00000000.tx.716: J. 

Phrase: "J."
Processing 00000000.tx.717: Biol. 

Phrase: "Biol."
Processing 00000000.tx.718: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.719: 277:2530525312.[Abstract/Free FullText] Gantt, K., S. 

Phrase: "277"

Phrase: ":"

Phrase: "2530525312."

Phrase: "[Abstract/Free FullText"

Phrase: "] Gantt,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.720: Schultz-Cherry, N. 

Phrase: "Schultz-Cherry,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0330657:Cherry [Plant]
   861   C0770609:CHERRY [Food]
   861   C0936039:Cherry [Food]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.721: Rodriguez, S. 

Phrase: "Rodriguez,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.722: Jeronimo, E. 

Phrase: "Jeronimo,"

Phrase: "E."
Processing 00000000.tx.723: Nascimento, T. 

Phrase: "Nascimento,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.724: Goldman, T. 

Phrase: "Goldman,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.725: Recker, M. 

Phrase: "Recker,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.726: Miller, and M. 

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.727: Wilson. 

Phrase: "Wilson."
Processing 00000000.tx.728: 2003. 

Phrase: "2003."
Processing 00000000.tx.729: Activation of TGF-beta by Leishmania chagasi: importance for parasite survival in macrophages. 

Phrase: "Activation of TGF-beta"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C3549171:transforming growth factor beta activation [Molecular Function]
   820   C2249824:activation of growth [Organism Function]
   753   C1879547:Activation [Activity]
   716   C0040690:Transforming Growth Factor beta [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "by Leishmania chagasi"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0446195:Leishmania chagasi [Eukaryote]
   861   C0023270:Leishmania [Eukaryote]
   861   C1095819:Leishmania [Eukaryote]

Phrase: ":"

Phrase: "importance for parasite survival"

Phrase: "in macrophages."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024432:Macrophages [Cell]
  1000   C1546706:Macrophages [Intellectual Product]
  1000   C1550652:Macrophages [Body Substance]
Processing 00000000.tx.730: J. 

Phrase: "J."
Processing 00000000.tx.731: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.732: 170:26132620.[Abstract/Free FullText] Schultz-Cherry, S., and V.S. 

Phrase: "170"

Phrase: ":"

Phrase: "26132620."

Phrase: "[Abstract/Free FullText"

Phrase: "] Schultz-Cherry,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0330657:Cherry [Plant]
   861   C0770609:CHERRY [Food]
   861   C0936039:Cherry [Food]

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "V.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642225:V/s [Quantitative Concept]
Processing 00000000.tx.733: Hinshaw. 

Phrase: "Hinshaw."
Processing 00000000.tx.734: 1996. 

Phrase: "1996."
Processing 00000000.tx.735: Influenza virus neuraminidase activates latent transforming growth factor-. 

Phrase: "Influenza virus neuraminidase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027803:Neuraminidase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0029341:Influenza virus [Virus]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "latent transforming growth factor-."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
Processing 00000000.tx.736: J. 

Phrase: "J."
Processing 00000000.tx.737: Virol. 

Phrase: "Virol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0965991:virol [Lipid]
Processing 00000000.tx.738: 70:86248629.[Abstract] Oh, S., J. 

Phrase: "70"

Phrase: ":"

Phrase: "86248629."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Oh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220853:OH- [Element, Ion, or Isotope]

Phrase: "S."

Phrase: ","

Phrase: "J."
Processing 00000000.tx.739: McCaffery, and M. 

Phrase: "McCaffery,"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.740: Eichelberger. 

Phrase: "Eichelberger."
Processing 00000000.tx.741: 2000. 

Phrase: "2000."
Processing 00000000.tx.742: Dose-dependent changes in influenza virus-infected dendritic cells result in increased allogeneic T-cell proliferation at low, but not high, doses of virus. 

Phrase: "Dose-dependent changes in influenza virus-infected dendritic cells"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   742   C0392747:changes [Functional Concept]
   742   C0443172:changes [Quantitative Concept]
   708 E C1705241:Change [Quantitative Concept]

Phrase: "result in increased allogeneic T-cell proliferation"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   814   C1155046:T-Cell Proliferation [Cell Function]
   778   C0039194:T-cell [Cell]
   778   C0596290:Cell Proliferation [Cell Function]
   748   C0007634:Cell [Cell]
   748   C0205217:Increased [Quantitative Concept]
   748   C0334094:Proliferation [Pathologic Function]
   748   C0442805:Increased [Functional Concept]
   748   C1269647:Cell [Cell]
   748   C1274040:Result [Functional Concept]
   748   C1514485:Proliferation [Functional Concept]
   748   C1515895:Allogeneic [Qualitative Concept]
   748   C1546471:Result [Idea or Concept]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C2825142:Result [Finding]

Phrase: "at low,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "but"

Phrase: "not high, doses of virus."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   851   C0445104:Not high-dose [Quantitative Concept]
   790   C0444956:High dose [Quantitative Concept]
   760   C0178602:Doses [Quantitative Concept]
   726 E C0869039:Dose [Quantitative Concept]
   726 E C1114758:Dose # [Clinical Attribute]
   726 E C1428722:DOS [Gene or Genome]
Processing 00000000.tx.743: J. 

Phrase: "J."
Processing 00000000.tx.744: Virol. 

Phrase: "Virol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0965991:virol [Lipid]
Processing 00000000.tx.745: 74:54605469.[Abstract/Free FullText] Grainger, D.J., and E. 

Phrase: "74"

Phrase: ":"

Phrase: "54605469."

Phrase: "[Abstract/Free FullText"

Phrase: "] Grainger,"

Phrase: "D.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "E."
Processing 00000000.tx.746: Frow. 

Phrase: "Frow."
Processing 00000000.tx.747: 2000. 

Phrase: "2000."
Processing 00000000.tx.748: Thrombospondin 1 does not activate transforming growth factor  1 in a chemically defined system or in smooth-muscle-cell cultures. 

Phrase: "Thrombospondin 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0147139:Thrombospondin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336626:THROMBOSPONDIN I [Gene or Genome]
   861   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "transforming growth factor  1 in a chemically defined system"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   790   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0960756:factor A [Organic Chemical]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0220806:Chemically [Chemical]
   742   C0220844:growth [Physiologic Function]
   742   C0449913:System [Functional Concept]
   742   C1510411:Transforming [Pathologic Function]
   742   C1521761:Factor [Functional Concept]
   742   C1553451:System [Manufactured Object]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C1704459:System [Medical Device]
   742   C1704788:Defined [Conceptual Entity]
   742   C2827422:Factor [Conceptual Entity]
   742   C2911660:Growth [Activity]
   742   C3539106:Defined [Intellectual Product]

Phrase: "or in smooth-muscle-cell cultures."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   833   C1135918:Smooth muscle cell [Cell]
   790   C0007585:Cell Cultures [Laboratory Procedure]
   790   C0596981:Muscle cell [Cell]
   790   C1267092:Muscle, Smooth [Tissue]
   753   C0007634:Cell [Cell]
   753   C0010453:Cultures [Idea or Concept]
   753   C0026845:Muscle [Tissue]
   753   C0205357:Smooth [Qualitative Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   719 E C0220814:culture [Functional Concept]
   719 E C0430400:Culture [Laboratory Procedure]
   719 E C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.749: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.750: J. 

Phrase: "J."
Processing 00000000.tx.751: 350:291298.[CrossRef][Medline] Bailly, S., C. 

Phrase: "350"

Phrase: ":"

Phrase: "291298."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bailly,"

Phrase: "S."

Phrase: ","

Phrase: "C."
Processing 00000000.tx.752: Brand, E. 

Phrase: "Brand,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0645690:BrAnd [Pharmacologic Substance,Steroid]

Phrase: "E."
Processing 00000000.tx.753: Chambaz, and J.-J. 

Phrase: "Chambaz,"

Phrase: "and"

Phrase: "J.-J."
Processing 00000000.tx.754: Feige. 

Phrase: "Feige."
Processing 00000000.tx.755: 1997. 

Phrase: "1997."
Processing 00000000.tx.756: Analysis of small latent transforming growth factor- complex formation and dissociation by surface plasmon resonance. 

Phrase: "Analysis of small latent transforming growth factor- complex formation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0085801:Analysis, Factor [Quantitative Concept]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "dissociation by surface plasmon resonance."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0086168:Dissociation [Mental or Behavioral Dysfunction]
Processing 00000000.tx.757: J. 

Phrase: "J."
Processing 00000000.tx.758: Biol. 

Phrase: "Biol."
Processing 00000000.tx.759: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.760: 272:1632916334.[Abstract/Free FullText] Yang, Z., T.R. 

Phrase: "272"

Phrase: ":"

Phrase: "1632916334."

Phrase: "[Abstract/Free FullText"

Phrase: "] Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "Z.,"

Phrase: "T.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.761: Kyriakides, and P. 

Phrase: "Kyriakides,"

Phrase: "and"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.762: Bornstein. 

Phrase: "Bornstein."
Processing 00000000.tx.763: 2000. 

Phrase: "2000."
Processing 00000000.tx.764: Matricellular proteins as modulators of cell-matrix interactions: adhesive defect in thrombospondin 2-null fibroblasts is a consequence of increased levels of matric metalloproteinase-2. 

Phrase: "Matricellular proteins as modulators of cell-matrix interactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   750   C0872079:interactions protein [Molecular Function]
   744   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "adhesive defect in thrombospondin 2-null fibroblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1457869:Defect [Functional Concept]
   748   C1861101:DEFECT [Disease or Syndrome]

Phrase: "is"

Phrase: "a consequence of increased levels of matric metalloproteinase-2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0686907:Consequence of [Functional Concept]
           Consequence
Processing 00000000.tx.765: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.766: Biol. 

Phrase: "Biol."
Processing 00000000.tx.767: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.768: 11:33533364.[Abstract/Free FullText] Sharma, P., A. 

Phrase: "11"

Phrase: ":"

Phrase: "33533364."

Phrase: "[Abstract/Free FullText"

Phrase: "] Sharma,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "A."
Processing 00000000.tx.769: Bharadwaj, V.K. 

Phrase: "Bharadwaj,"

Phrase: "V.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.770: Bhasin, V.N. 

Phrase: "Bhasin,"

Phrase: "V.N."
Processing 00000000.tx.771: Sailaja, and V.S. 

Phrase: "Sailaja,"

Phrase: "and"

Phrase: "V.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642225:V/s [Quantitative Concept]
Processing 00000000.tx.772: Chauhan. 

Phrase: "Chauhan."
Processing 00000000.tx.773: 1996. 

Phrase: "1996."
Processing 00000000.tx.774: Antibodies to a conserved motif peptide sequence of the Plasmodium falciparum thrombospondin-related anonymous protein and circumsporozoite protein recognise a 78 kilodalton protein in the sexual blood stages of the parasite and inhibit merozoite invasion in vitro. 

Phrase: "Antibodies to a conserved motif peptide sequence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   714 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "of the Plasmodium falciparum thrombospondin-related anonymous protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0526837:thrombospondin-related anonymous protein, Plasmodium falciparum [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "circumsporozoite protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0055782:circumsporozoite protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "recognise"

Phrase: "a 78 kilodalton protein in the sexual blood"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0005832:blood protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "stages of the parasite"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0030498:Parasite [Eukaryote]
   770   C0205390:Stage [Temporal Concept]
   770   C1300072:Stage [Clinical Attribute]
   770   C1306673:Stage [Qualitative Concept]

Phrase: "and"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "merozoite invasion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1269955:Invasion [Finding]
   861   C2699153:Invasion [Pathologic Function]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.775: Infect. 

Phrase: "Infect."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439663:infect [Functional Concept]
Processing 00000000.tx.776: Immun. 

Phrase: "Immun."
Processing 00000000.tx.777: 64:21722179.[Abstract] Carruthers, V., G. 

Phrase: "64"

Phrase: ":"

Phrase: "21722179."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Carruthers,"

Phrase: "V.,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.778: Sherman, and L. 

Phrase: "Sherman,"

Phrase: "and"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.779: Sibley. 

Phrase: "Sibley."
Processing 00000000.tx.780: 2000. 

Phrase: "2000."
Processing 00000000.tx.781: The Toxoplasma adhesive protein MIC2 is proteolytically processed at multiple sites by two parasite-derived proteases. 

Phrase: "The Toxoplasma adhesive protein MIC2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0058889:Protein MIC2 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C3539707:MIC2 [Gene or Genome]

Phrase: "is"

Phrase: "proteolytically"

Phrase: "processed at multiple sites"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0205145:Sites [Spatial Concept]
   770   C0439064:Multiple [Quantitative Concept]
   770   C1522240:Processed [Phenomenon or Process]
   737 E C1184743:Process [Body Part, Organ, or Organ Component]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]

Phrase: "by two parasite-derived proteases."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C1947941:Proteases [Enzyme]
Processing 00000000.tx.782: J. 

Phrase: "J."
Processing 00000000.tx.783: Biol. 

Phrase: "Biol."
Processing 00000000.tx.784: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.785: 275:1434614353.[Abstract/Free FullText] Kappe, S., T. 

Phrase: "275"

Phrase: ":"

Phrase: "1434614353."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kappe,"

Phrase: "S."

Phrase: ","

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.786: Bruderer, S. 

Phrase: "Bruderer,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.787: Gantt, H. 

Phrase: "Gantt,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.788: Fujioka, V. 

Phrase: "Fujioka,"

Phrase: "V."
Processing 00000000.tx.789: Nussenzweig, and R. 

Phrase: "Nussenzweig,"

Phrase: "and"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.790: Menard. 

Phrase: "Menard."
Processing 00000000.tx.791: 1999. 

Phrase: "1999."
Processing 00000000.tx.792: Conservation of a gliding motility and cell invasion machinery in apicomplexan parasites. 

Phrase: "Conservation of a gliding motility"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2347858:Conservation [Qualitative Concept]

Phrase: "and"

Phrase: "cell invasion machinery in apicomplexan parasites."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0337076:machinery [Manufactured Object]
Processing 00000000.tx.793: J. 

Phrase: "J."
Processing 00000000.tx.794: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.795: 147:937944.[Abstract/Free FullText] Opitz, C., M. 

Phrase: "147"

Phrase: ":"

Phrase: "937944."

Phrase: "[Abstract/Free FullText"

Phrase: "] Opitz,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.796: Di Cristina, M. 

Phrase: "Di Cristina,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.797: Reiss, T. 

Phrase: "Reiss,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.798: Ruppert, A. 

Phrase: "Ruppert,"

Phrase: "A."
Processing 00000000.tx.799: Crisanti, and D. 

Phrase: "Crisanti,"

Phrase: "and"

Phrase: "D."
Processing 00000000.tx.800: Soldati. 

Phrase: "Soldati."
Processing 00000000.tx.801: 2002. 

Phrase: "2002."
Processing 00000000.tx.802: Intramembrane cleavage of microneme proteins at the surface of the apicomplexan parasite Toxoplasma gondii. 

Phrase: "Intramembrane cleavage of microneme proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C0597304:Protein Cleavage [Molecular Function]
   760   C0010813:cleavage [Cell Function]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]

Phrase: "at the surface"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205148:Surface [Spatial Concept]

Phrase: "of the apicomplexan parasite Toxoplasma gondii."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040557:Toxoplasma gondii [Eukaryote]
   812   C0040556:Toxoplasma [Eukaryote]
Processing 00000000.tx.803: EMBO J. 

Phrase: "EMBO J."
Processing 00000000.tx.804: 21:15771585.[Abstract/Free FullText] Rawson, R., N. 

Phrase: "21"

Phrase: ":"

Phrase: "15771585."

Phrase: "[Abstract/Free FullText"

Phrase: "] Rawson,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.805: Zelenski, D. 

Phrase: "Zelenski,"

Phrase: "D."
Processing 00000000.tx.806: Nijhawan, J. 

Phrase: "Nijhawan,"

Phrase: "J."
Processing 00000000.tx.807: Ye, J. 

Phrase: "Ye,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043402:YE [Geographic Area]

Phrase: "J."
Processing 00000000.tx.808: Sakai, M. 

Phrase: "Sakai,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.809: Hasan, T. 

Phrase: "Hasan,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.810: Chang, M. 

Phrase: "Chang,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.811: Brown, and J. 

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "J."
Processing 00000000.tx.812: Goldstein. 

Phrase: "Goldstein."
Processing 00000000.tx.813: 1999. 

Phrase: "1999."
Processing 00000000.tx.814: Complementation cloning of S2P, a gene encoding a putative metalloprotease required for intramembrane cleavage of SREBPs. 

Phrase: "Complementation cloning of S2P,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0009015:Cloning [Research Activity]

Phrase: "a gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "a putative metalloprotease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025543:METALLOPROTEASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "required for intramembrane cleavage of SREBPs."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C1327378:SREBP cleavage [Molecular Function]
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]
   753   C1514873:Required [Functional Concept]
Processing 00000000.tx.815: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.816: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.817: 1:4757. 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "4757."
Processing 00000000.tx.818: Mu, D., S. 

Phrase: "Mu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0347978:Mu [Intellectual Product]

Phrase: "D."

Phrase: ","

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.819: Cambier, L. 

Phrase: "Cambier,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.820: Fjellbirkeland, J. 

Phrase: "Fjellbirkeland,"

Phrase: "J."
Processing 00000000.tx.821: Baron, J. 

Phrase: "Baron,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331778:Baron [Health Care Related Organization]

Phrase: "J."
Processing 00000000.tx.822: Munger, H. 

Phrase: "Munger,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.823: Kawakatsu, D. 

Phrase: "Kawakatsu,"

Phrase: "D."
Processing 00000000.tx.824: Sheppard, V. 

Phrase: "Sheppard,"

Phrase: "V."
Processing 00000000.tx.825: Broaddus, and S. 

Phrase: "Broaddus,"

Phrase: "and"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.826: Nishimura. 

Phrase: "Nishimura."
Processing 00000000.tx.827: 2002. 

Phrase: "2002."
Processing 00000000.tx.828: The integrin (v)8 mediates epithelial homeostasis through MT1-MMPdependent activation of TGF-1. 

Phrase: "The integrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "(v)8"

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "epithelial homeostasis through MT1-MMPdependent activation of TGF-"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   782   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   782   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   777   C2249824:activation of growth [Organism Function]
   760   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0018270:'growth' NOS [Organism Function]
   739   C0019868:Homeostasis [Biologic Function]
   739   C0220844:growth [Physiologic Function]
   739   C0221908:Epithelial [Qualitative Concept]
   739   C1510411:Transforming [Pathologic Function]
   739   C1521761:Factor [Functional Concept]
   739   C1621966:Growth [Organ or Tissue Function]
   739   C1879547:Activation [Activity]
   739   C2827422:Factor [Conceptual Entity]
   739   C2911660:Growth [Activity]
   739   C3540571:MT1 [Gene or Genome]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.829: J. 

Phrase: "J."
Processing 00000000.tx.830: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.831: 157:493507.[Abstract/Free FullText] Hurskainen, T., S. 

Phrase: "157"

Phrase: ":"

Phrase: "493507."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hurskainen,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.832: Hirohata, M. 

Phrase: "Hirohata,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.833: Seldin, and S. 

Phrase: "Seldin,"

Phrase: "and"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.834: Apte. 

Phrase: "Apte."
Processing 00000000.tx.835: 1999. 

Phrase: "1999."
Processing 00000000.tx.836: ADAM-TS5, ADAM-TS6, and ADAM-TS7, novel members of a new family of zinc metalloproteases. 

Phrase: "ADAM-TS5,"

Phrase: "ADAM-TS6,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412212:ADAM-TS6 [Gene or Genome]

Phrase: "and"

Phrase: "ADAM-TS7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412213:ADAM-TS7 [Gene or Genome]

Phrase: "novel members of a new family of zinc metalloproteases."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   762   C0086282:Family Members [Family Group]
   745 E C1611821:Family Member [Intellectual Product]
   742   C0680022:members [Population Group]
   708 E C2698041:Member [Professional or Occupational Group]
Processing 00000000.tx.837: General features and genomic distribution of the ADAM-TS family. 

Phrase: "General features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1521970:Feature [Qualitative Concept]
   827   C1706388:Feature [Conceptual Entity]
   827   C2346469:Feature [Qualitative Concept]
   827   C2348519:Feature [Qualitative Concept]

Phrase: "and"

Phrase: "genomic distribution of the ADAM-TS family."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0520511:distribution [Idea or Concept]
   748   C1704711:Distribution [Functional Concept]
Processing 00000000.tx.838: J. 

Phrase: "J."
Processing 00000000.tx.839: Biol. 

Phrase: "Biol."
Processing 00000000.tx.840: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.841: 274:2555525563.[Abstract/Free FullText]

Phrase: "274"

Phrase: ":"

Phrase: "2555525563."

Phrase: "[Abstract/Free FullText"

Phrase: "]"

